kw1	kw2	pg	iteration	R1C1	inv_edge_weight	crit_p	edge_weight
porphyrins/pharmacology	apoptosis	4.0086966293984005e-05	0	1	0.6431935215825413	8.39827114146965e-05	0.1228101724887232
porphyrins/pharmacology	esters	0.0	0	1	0.6431935215825413	0.0	0.0254237288135593
porphyrins/pharmacology	iron	0.0001190696848334	0	1	0.6431935215825413	0.0002366340025258	0.0991023393127427
porphyrins/pharmacology	bone neoplasms/drug therapy	0.0	0	1	0.6431935215825413	0.0	0.0254237288135593
porphyrins/pharmacology	ferric compounds	4.157156320294675e-07	0	1	0.6431935215825413	1.0523544285088806e-06	0.0504128639721861
porphyrins/pharmacology	tissue distribution	4.0086966293984005e-05	0	1	0.6431935215825413	8.39827114146965e-05	0.0991023393127427
porphyrins/pharmacology	neoplasms/diagnostic imaging	1.4421568432787524e-05	0	1	0.6431935215825413	3.147169859962992e-05	0.0991023393127427
porphyrins/pharmacology	photosensitizing agents/pharmacology	1.887485931095778e-05	0	2	0.3223370757289844	4.064391932050256e-05	0.0368205727644652
porphyrins/pharmacology	ferroptosis	0.0001087479227059	0	3	0.1299847034619319	0.0002175404874163	0.0430097858502306
porphyrins/pharmacology	osteosarcoma/drug therapy	0.0	0	1	0.6431935215825413	0.0	0.0254237288135593
porphyrins/pharmacology	ferritins	0.0	0	1	0.6431935215825413	0.0	0.0254237288135593
porphyrins/pharmacology	photosensitizing agents/therapeutic use	4.0086966293984005e-05	0	1	0.6431935215825413	8.39827114146965e-05	0.0991023393127427
porphyrins/pharmacology	SDHD	7.771561172376097e-16	0	1	0.6431935215825413	5.694859788419355e-15	0.0254237288135593
apoptosis	esters	5.927480728473711e-13	0	1	0.6431935215825413	2.7404756726615176e-12	0.0423728813559322
apoptosis	carcinoma hepatocellular/drug therapy	4.0086966293984005e-05	0	1	0.6431935215825413	8.39827114146965e-05	0.122810172488723
apoptosis	sorafenib/pharmacology	8.665466092794283e-06	0	1	0.6431935215825413	1.940570600651955e-05	0.0832971171954222
apoptosis	doxorubicin	0.0	0	1	0.6431935215825413	0.0	0.0423728813559322
apoptosis	hemin/pharmacology	4.157156320294675e-07	0	1	0.6431935215825413	1.0523544285088806e-06	0.0832971171954222
apoptosis	mitochondria	1.8543679924931662e-09	0	1	0.6431935215825413	6.288333491593041e-09	0.0832971171954222
apoptosis	glutathione	2.5289116018401003e-05	0	1	0.6431935215825413	5.414493073711252e-05	0.1609488606413867
apoptosis	bone neoplasms/drug therapy	5.927480728473711e-13	0	1	0.6431935215825413	2.7404756726615176e-12	0.0423728813559322
apoptosis	oxides	0.0	0	1	0.6431935215825413	0.0	0.0423728813559322
apoptosis	manganese compounds	0.0	0	1	0.6431935215825413	0.0	0.0423728813559322
apoptosis	coordination complexes/pharmacology	6.8833827526759706e-15	0	1	0.6431935215825413	4.639380934134164e-14	0.0423728813559322
apoptosis	tissue distribution	0.0006545726870674	0	1	0.6431935215825413	0.001162439032099	0.1609488606413867
apoptosis	photosensitizing agents/pharmacology	1.0079526691075813e-07	0	3	0.1299847034619319	2.70918552485452e-07	0.0117492547214349
apoptosis	ferroptosis	6.023435883406593e-08	0	5	0.0123899221684959	1.6583165570531257e-07	0.0048619757917651
apoptosis	iridium/pharmacology	6.8833827526759706e-15	0	1	0.6431935215825413	4.639380934134164e-14	0.0423728813559322
apoptosis	hypoxia	6.8833827526759706e-15	0	1	0.6431935215825413	4.639380934134164e-14	0.0423728813559322
apoptosis	osteosarcoma/drug therapy	5.927480728473711e-13	0	1	0.6431935215825413	2.7404756726615176e-12	0.0423728813559322
esters	bone neoplasms/drug therapy	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
esters	photosensitizing agents/pharmacology	0.0001097950475641	0	1	0.6431935215825413	0.0002188266939795	0.1186440677966107
esters	osteosarcoma/drug therapy	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
iron	dna catalytic	2.786690866951602e-07	0	1	0.6431935215825413	7.200182711906234e-07	0.0338983050847457
iron	cd8-positive t-lymphocytes/metabolism	2.786690866951602e-07	0	1	0.6431935215825413	7.200182711906234e-07	0.0338983050847457
iron	deferoxamine	0.0	0	1	0.6431935215825413	0.0	0.0338983050847457
iron	hydrogen peroxide	2.786690866951602e-07	0	1	0.6431935215825413	7.200182711906234e-07	0.0338983050847457
iron	ferric compounds	7.90928279311709e-05	0	1	0.6431935215825413	0.0001613308290115	0.0669274228596264
iron	hemorrhage	0.0	0	1	0.6431935215825413	0.0	0.0338983050847457
iron	oxygen	0.0003328270951356	0	1	0.6431935215825413	0.0006164448630162	0.0991023393127429
iron	ferroptosis	9.9151873118819e-05	0	4	0.0434987478385336	0.0002000691833159	0.0145859273752955
iron	hypoxia/drug therapy	0.0009389048097199	0	1	0.6431935215825413	0.0016398864293065	0.0991023393127429
iron	stroke/prevention & control	0.0	0	1	0.6431935215825413	0.0	0.0338983050847457
iron	hemin	2.786690866951602e-07	0	1	0.6431935215825413	7.200182711906234e-07	0.0338983050847457
iron	ferritins	2.701172618913006e-13	0	1	0.6431935215825413	1.2841769923866417e-12	0.0338983050847457
iron	photosensitizing agents/therapeutic use	0.0014262093564235	0	1	0.6431935215825413	0.0024114913927314	0.1304379101192554
iron	CD274	0.0062849942792518	0	1	0.6431935215825413	0.0096068937022567	0.1304379101192554
iron	HIF1A	2.786690866951602e-07	0	1	0.6431935215825413	7.200182711906234e-07	0.0338983050847457
iron	IDO1	2.786690866951602e-07	0	1	0.6431935215825413	7.200182711906234e-07	0.0338983050847457
iron	NCL	2.786690866951602e-07	0	1	0.6431935215825413	7.200182711906234e-07	0.0338983050847457
iron	NOC2L	2.786690866951602e-07	0	1	0.6431935215825413	7.200182711906234e-07	0.0338983050847457
iron	catalase	2.786690866951602e-07	0	1	0.6431935215825413	7.200182711906234e-07	0.0338983050847457
iron	hypoxia-inducible factor 1 alpha subunit	2.786690866951602e-07	0	1	0.6431935215825413	7.200182711906234e-07	0.0338983050847457
iron	chlorophyll	2.786690866951602e-07	0	1	0.6431935215825413	7.200182711906234e-07	0.0338983050847457
iron	urinary bladder neoplasms/drug therapy	2.786690866951602e-07	0	1	0.6431935215825413	7.200182711906234e-07	0.0338983050847457
bone neoplasms/drug therapy	photosensitizing agents/pharmacology	0.0001097950475641	0	1	0.6431935215825413	0.0002188266939795	0.1186440677966107
bone neoplasms/drug therapy	osteosarcoma/drug therapy	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
ferric compounds	tumor microenvironment	6.700055926733839e-07	0	2	0.3223370757289844	1.6786309784562467e-06	0.0112994350282485
ferric compounds	cd8-positive t-lymphocytes/metabolism	1.683175820943461e-11	0	1	0.6431935215825413	6.818051351169979e-11	0.0169491525423728
ferric compounds	urinary bladder neoplasms/drug therapy	1.683175820943461e-11	0	1	0.6431935215825413	6.818051351169979e-11	0.0169491525423728
ferric compounds	chlorophyll	1.683175820943461e-11	0	1	0.6431935215825413	6.818051351169979e-11	0.0169491525423728
ferric compounds	tissue distribution	2.5289116018401003e-05	0	1	0.6431935215825413	5.414493073711252e-05	0.0669274228596261
ferric compounds	neoplasms/diagnostic imaging	8.665466092794283e-06	0	1	0.6431935215825413	1.940570600651955e-05	0.0669274228596261
ferric compounds	photosensitizing agents/pharmacology	1.0978322877441826e-05	0	2	0.3223370757289844	2.431698517353365e-05	0.0131826741996232
ferric compounds	CD274	0.0002880744925515	0	1	0.6431935215825413	0.000541375627537	0.0669274228596261
ferric compounds	IDO1	1.683175820943461e-11	0	1	0.6431935215825413	6.818051351169979e-11	0.0169491525423728
ferric compounds	NOC2L	1.683175820943461e-11	0	1	0.6431935215825413	6.818051351169979e-11	0.0169491525423728
ferric compounds	SDHD	1.1102230246251563e-16	0	1	0.6431935215825413	8.259720303814333e-16	0.0169491525423728
tissue distribution	iron/metabolism	0.0014410068847887	0	2	0.3223370757289844	0.002435666510432	0.0685775756189703
tissue distribution	tumor microenvironment	7.525371253136459e-05	0	2	0.3223370757289844	0.0001536929342687	0.0595041462319685
tissue distribution	neoplasm metastasis	1.683175820943461e-11	0	1	0.6431935215825413	6.818051351169979e-11	0.0338983050847457
tissue distribution	cell proliferation	0.0005216203689482	0	1	0.6431935215825413	0.0009466875448359	0.0669274228596261
tissue distribution	doxorubicin	0.0	0	1	0.6431935215825413	0.0	0.0338983050847457
tissue distribution	oxides	0.0	0	1	0.6431935215825413	0.0	0.0338983050847457
tissue distribution	homeostasis	1.8651746813702633e-14	0	2	0.3223370757289844	1.2467758878350196e-13	0.0025775899533935
tissue distribution	ferroptosis/physiology	8.956939430038169e-05	0	1	0.6431935215825413	0.0001817117645402	0.0991023393127427
tissue distribution	neoplasms/diagnostic imaging	0.0003154877109791	0	1	0.6431935215825413	0.0005892570393258	0.1304379101192554
tissue distribution	covid-19/metabolism	2.287315892246511e-10	0	1	0.6431935215825413	8.330411317576418e-10	0.0338983050847457
tissue distribution	mitochondria/metabolism	1.683175820943461e-11	0	1	0.6431935215825413	6.818051351169979e-11	0.0338983050847457
tissue distribution	ceruloplasmin/metabolism	2.287315892246511e-10	0	1	0.6431935215825413	8.330411317576418e-10	0.0338983050847457
tissue distribution	ferroptosis	0.0021973803786964	0	3	0.1299847034619319	0.0036138489994558	0.1282813612750346
tissue distribution	inflammation/metabolism	2.287315892246511e-10	0	1	0.6431935215825413	8.330411317576418e-10	0.0338983050847457
tissue distribution	ferritins/chemistry	2.287315892246511e-10	0	1	0.6431935215825413	8.330411317576418e-10	0.0338983050847457
tissue distribution	neoplastic stem cells/metabolism	1.683175820943461e-11	0	1	0.6431935215825413	6.818051351169979e-11	0.0338983050847457
tissue distribution	neoplasms/diagnosis	2.287315892246511e-10	0	1	0.6431935215825413	8.330411317576418e-10	0.0338983050847457
tissue distribution	SDHD	1.683175820943461e-11	0	1	0.6431935215825413	6.818051351169979e-11	0.0338983050847457
tissue distribution	biomarkers/chemistry	2.287315892246511e-10	0	1	0.6431935215825413	8.330411317576418e-10	0.0338983050847457
tissue distribution	manganese compounds	0.0	0	1	0.6431935215825413	0.0	0.0338983050847457
neoplasms/diagnostic imaging	doxorubicin/administration & dosage	9.192074035269117e-08	0	1	0.6431935215825413	2.4816053614330416e-07	0.0669274228596261
neoplasms/diagnostic imaging	porphyrins/therapeutic use	0.0	0	1	0.6431935215825413	0.0	0.0338983050847457
neoplasms/diagnostic imaging	calreticulin/metabolism	1.2460033005368132e-12	0	1	0.6431935215825413	5.627223432359491e-12	0.0338983050847457
neoplasms/diagnostic imaging	iron compounds/administration & dosage	2.220446049250313e-16	0	1	0.6431935215825413	1.6369491071099513e-15	0.0338983050847457
neoplasms/diagnostic imaging	ascorbic acid/pharmacology	1.2460033005368132e-12	0	1	0.6431935215825413	5.627223432359491e-12	0.0338983050847457
neoplasms/diagnostic imaging	antibiotics antineoplastic/administration & dosage	2.220446049250313e-16	0	1	0.6431935215825413	1.6369491071099513e-15	0.0338983050847457
neoplasms/diagnostic imaging	ferric compounds/chemistry	8.665466092794283e-06	0	1	0.6431935215825413	1.940570600651955e-05	0.0669274228596261
neoplasms/diagnostic imaging	iron/therapeutic use	0.0	0	1	0.6431935215825413	0.0	0.0338983050847457
neoplasms/diagnostic imaging	photosensitizing agents/pharmacology	0.0002127682617329	0	2	0.3223370757289844	0.0004145620709415	0.0685775756189704
neoplasms/diagnostic imaging	t-lymphocytes cytotoxic/metabolism	1.2460033005368132e-12	0	1	0.6431935215825413	5.627223432359491e-12	0.0338983050847457
neoplasms/diagnostic imaging	carbon monoxide/administration & dosage	2.220446049250313e-16	0	1	0.6431935215825413	1.6369491071099513e-15	0.0338983050847457
neoplasms/diagnostic imaging	CALR	1.2460033005368132e-12	0	1	0.6431935215825413	5.627223432359491e-12	0.0338983050847457
neoplasms/diagnostic imaging	SDHD	1.2460033005368132e-12	0	1	0.6431935215825413	5.627223432359491e-12	0.0338983050847457
photosensitizing agents/pharmacology	neoplasms/drug therapy	0.004767357373147	0	4	0.0434987478385336	0.0073656729484291	0.1908426908294623
photosensitizing agents/pharmacology	tumor microenvironment	7.784175383607206e-05	0	4	0.0434987478385336	0.0001589119675086	0.047942214497929
photosensitizing agents/pharmacology	ferroptosis	2.828248746311601e-09	0	11	5.495235028225341e-07	9.564230493252207e-09	0.0006409815067119
photosensitizing agents/pharmacology	cell line tumor/drug effects	0.000309857999695	0	1	0.6431935215825413	0.0005791860500629	0.1186440677966107
photosensitizing agents/pharmacology	porphyrins/therapeutic use	4.136361622331108e-06	0	1	0.6431935215825413	9.539275998873398e-06	0.1186440677966107
photosensitizing agents/pharmacology	nih 3t3 cells	0.000309857999695	0	1	0.6431935215825413	0.0005791860500629	0.1186440677966107
photosensitizing agents/pharmacology	keloid/drug therapy	0.0001097950475641	0	1	0.6431935215825413	0.0002188266939795	0.1186440677966107
photosensitizing agents/pharmacology	cd8-positive t-lymphocytes/metabolism	0.0036351049700664	0	1	0.6431935215825413	0.0057699890941804	0.1186440677966107
photosensitizing agents/pharmacology	gallic acid/chemistry	0.0036351049700664	0	1	0.6431935215825413	0.0057699890941804	0.1186440677966107
photosensitizing agents/pharmacology	zeolites/chemistry	0.0036351049700664	0	1	0.6431935215825413	0.0057699890941804	0.1186440677966107
photosensitizing agents/pharmacology	urinary bladder neoplasms/drug therapy	0.0036351049700664	0	1	0.6431935215825413	0.0057699890941804	0.1186440677966107
photosensitizing agents/pharmacology	chlorophyll	0.0036351049700664	0	1	0.6431935215825413	0.0057699890941804	0.1186440677966107
photosensitizing agents/pharmacology	mitochondria	0.0013457411628009	0	1	0.6431935215825413	0.0022770127383086	0.2241054613935961
photosensitizing agents/pharmacology	glutathione	2.3513080371628803e-11	0	3	0.1299847034619319	9.469358731483235e-11	0.0050635699099602
photosensitizing agents/pharmacology	glypicans/therapeutic use	0.0001097950475641	0	1	0.6431935215825413	0.0002188266939795	0.1186440677966107
photosensitizing agents/pharmacology	lung neoplasms/drug therapy	0.000309857999695	0	1	0.6431935215825413	0.0005791860500629	0.1186440677966107
photosensitizing agents/pharmacology	chlorophyllides/pharmacology	0.000309857999695	0	1	0.6431935215825413	0.0005791860500629	0.1186440677966107
photosensitizing agents/pharmacology	tumor hypoxia/drug effects	0.0036351049700664	0	1	0.6431935215825413	0.0057699890941804	0.1186440677966107
photosensitizing agents/pharmacology	coordination complexes/pharmacology	2.7828753947689577e-05	0	1	0.6431935215825413	5.914065328700013e-05	0.1186440677966107
photosensitizing agents/pharmacology	immunogenic cell death	2.426232326158129e-07	0	1	0.6431935215825413	6.404675040828039e-07	0.1186440677966107
photosensitizing agents/pharmacology	azo compounds/chemistry	0.0036351049700664	0	1	0.6431935215825413	0.0057699890941804	0.1186440677966107
photosensitizing agents/pharmacology	iron/therapeutic use	4.136361622331108e-06	0	1	0.6431935215825413	9.539275998873398e-06	0.1186440677966107
photosensitizing agents/pharmacology	glucose oxidase/chemistry	0.0036351049700664	0	1	0.6431935215825413	0.0057699890941804	0.1186440677966107
photosensitizing agents/pharmacology	chlorophyllides/metabolism	0.000309857999695	0	1	0.6431935215825413	0.0005791860500629	0.1186440677966107
photosensitizing agents/pharmacology	aminolevulinic acid/pharmacology	0.0001097950475641	0	1	0.6431935215825413	0.0002188266939795	0.11864406779661
photosensitizing agents/pharmacology	porphyrins	0.000309857999695	0	1	0.6431935215825413	0.0005791860500629	0.11864406779661
photosensitizing agents/pharmacology	iridium/pharmacology	2.7828753947689577e-05	0	1	0.6431935215825413	5.914065328700013e-05	0.11864406779661
photosensitizing agents/pharmacology	hypoxia/drug therapy	0.0002885715331087	0	2	0.3223370757289844	0.0005421006479719	0.0368205727644652
photosensitizing agents/pharmacology	hypoxia	2.7828753947689577e-05	0	1	0.6431935215825413	5.914065328700013e-05	0.11864406779661
photosensitizing agents/pharmacology	carcinoma hepatocellular/diagnostic imaging	0.0001097950475641	0	1	0.6431935215825413	0.0002188266939795	0.11864406779661
photosensitizing agents/pharmacology	lipid peroxides	0.0001097950475641	0	1	0.6431935215825413	0.0002188266939795	0.11864406779661
photosensitizing agents/pharmacology	fibroblasts	0.0001097950475641	0	1	0.6431935215825413	0.0002188266939795	0.11864406779661
photosensitizing agents/pharmacology	osteosarcoma/drug therapy	0.0001097950475641	0	1	0.6431935215825413	0.0002188266939795	0.11864406779661
photosensitizing agents/pharmacology	oxygen/pharmacology	0.000309857999695	0	1	0.6431935215825413	0.0005791860500629	0.11864406779661
photosensitizing agents/pharmacology	IDO1	0.0036351049700664	0	1	0.6431935215825413	0.0057699890941804	0.11864406779661
photosensitizing agents/pharmacology	NOC2L	0.0036351049700664	0	1	0.6431935215825413	0.0057699890941804	0.11864406779661
photosensitizing agents/pharmacology	SDHD	0.000309857999695	0	1	0.6431935215825413	0.0005791860500629	0.11864406779661
ferroptosis	neoplasms/drug therapy	0.0001539992774125	0	9	2.3071580053367016e-05	0.0003021088884184	0.2372512553332346
ferroptosis	colitis/drug therapy	3.061511622437507e-06	0	1	0.6431935215825413	7.165584119182504e-06	0.3559322033898315
ferroptosis	gastritis	3.061511622437507e-06	0	1	0.6431935215825413	7.165584119182504e-06	0.3559322033898315
ferroptosis	tumor microenvironment	1.6986412276764895e-14	0	12	7.518963968454966e-08	1.1370163052840017e-13	1.2447591916269312e-05
ferroptosis	breast neoplasms/pathology	0.0039116091932672	0	1	0.6431935215825413	0.0061172245182257	0.3559322033898315
ferroptosis	porphyrins/therapeutic use	0.0039116091932672	0	1	0.6431935215825413	0.0061172245182257	0.3559322033898315
ferroptosis	cerebral hemorrhage	0.0039116091932672	0	1	0.6431935215825413	0.0061172245182257	0.3559322033898315
ferroptosis	photosensitizing agents	0.0001991486075938	0	2	0.3223370757289844	0.0003889583826873	0.1247283789656664
ferroptosis	doxorubicin	0.0039116091932672	0	1	0.6431935215825413	0.0061172245182257	0.3559322033898315
ferroptosis	mitochondria	8.45202817866264e-05	0	2	0.3223370757289844	0.0001721133861873	0.1247283789656664
ferroptosis	oxides	0.0039116091932672	0	1	0.6431935215825413	0.0061172245182257	0.3559322033898315
ferroptosis	glutathione	5.2063188760165247e-08	0	4	0.0434987478385336	1.4341657367342296e-07	0.0145859273752955
ferroptosis	hemin/pharmacology	0.0012673000382422	0	2	0.3223370757289844	0.0021683824039166	0.1247283789656664
ferroptosis	phospholipid hydroperoxide glutathione peroxidase	0.0011510004700587	0	1	0.6431935215825413	0.0019756341284242	0.3559322033898315
ferroptosis	neoplastic stem cells/pathology	0.0001554587450249	0	1	0.6431935215825413	0.0003044816979528	0.3559322033898315
ferroptosis	doxorubicin/pharmacology	0.0001554587450249	0	1	0.6431935215825413	0.0003044816979528	0.3559322033898315
ferroptosis	curcumin/pharmacology	0.0039116091932672	0	1	0.6431935215825413	0.0061172245182257	0.3559322033898315
ferroptosis	adenosine triphosphate	0.0039116091932672	0	1	0.6431935215825413	0.0061172245182257	0.3559322033898315
ferroptosis	manganese compounds	0.0039116091932672	0	1	0.6431935215825413	0.0061172245182257	0.3559322033898315
ferroptosis	immunogenic cell death	0.0011510004700587	0	1	0.6431935215825413	0.0019756341284242	0.3559322033898315
ferroptosis	lipid peroxides/therapeutic use	0.0039116091932672	0	1	0.6431935215825413	0.0061172245182257	0.3559322033898315
ferroptosis	deferoxamine	0.0011510004700587	0	1	0.6431935215825413	0.0019756341284242	0.3559322033898315
ferroptosis	singlet oxygen	0.0011510004700587	0	1	0.6431935215825413	0.0019756341284242	0.3559322033898315
ferroptosis	iron/therapeutic use	0.0039116091932672	0	1	0.6431935215825413	0.0061172245182257	0.3559322033898315
ferroptosis	carbonic anhydrase ix/metabolism	0.0001554587450249	0	1	0.6431935215825413	0.0003044816979528	0.3559322033898315
ferroptosis	oxygen	0.000379286112256	0	3	0.1299847034619319	0.0006982475349541	0.0430097858502306
ferroptosis	neoplasms	0.0011510004700587	0	1	0.6431935215825413	0.0019756341284242	0.3559322033898315
ferroptosis	erythrocytes	0.0039116091932672	0	1	0.6431935215825413	0.0061172245182257	0.3559322033898303
ferroptosis	autophagy	0.000407971358342	0	2	0.3223370757289844	0.0007493571161706	0.2881655651965419
ferroptosis	stroke/prevention & control	0.0011510004700587	0	1	0.6431935215825413	0.0019756341284242	0.3559322033898303
ferroptosis	biomarkers tumor/metabolism	0.0039116091932672	0	1	0.6431935215825413	0.0061172245182257	0.3559322033898303
ferroptosis	pharmaceutical preparations	0.0039116091932672	0	1	0.6431935215825413	0.0061172245182257	0.3559322033898303
ferroptosis	photosensitizing agents/therapeutic use	0.0021973803786964	0	3	0.1299847034619319	0.0036138489994558	0.1282813612750339
ferroptosis	HDAC1	0.0039116091932672	0	1	0.6431935215825413	0.0061172245182257	0.3559322033898303
ferroptosis	KEAP1	0.0039116091932672	0	1	0.6431935215825413	0.0061172245182257	0.3559322033898303
ferroptosis	MCU	0.0011510004700587	0	1	0.6431935215825413	0.0019756341284242	0.3559322033898303
ferroptosis	P4HB	0.0039116091932672	0	1	0.6431935215825413	0.0061172245182257	0.3559322033898303
ferroptosis	PADI1	0.0039116091932672	0	1	0.6431935215825413	0.0061172245182257	0.3559322033898303
ferroptosis	PCLAF	0.0011510004700587	0	1	0.6431935215825413	0.0019756341284242	0.3559322033898303
ferroptosis	PDCD1	0.0039116091932672	0	1	0.6431935215825413	0.0061172245182257	0.3559322033898303
ferroptosis	PDIA2	0.0039116091932672	0	1	0.6431935215825413	0.0061172245182257	0.3559322033898303
ferroptosis	SERPINB6	0.0039116091932672	0	1	0.6431935215825413	0.0061172245182257	0.3559322033898303
ferroptosis	doxorubicin/therapeutic use	0.0001554587450249	0	1	0.6431935215825413	0.0003044816979528	0.3559322033898315
ferroptosis	breast neoplasms/therapy	0.0039116091932672	0	1	0.6431935215825413	0.0061172245182257	0.3559322033898315
ferroptosis	hemorrhage	0.0011510004700587	0	1	0.6431935215825413	0.0019756341284242	0.3559322033898315
ferroptosis	covid-19	0.0039116091932672	0	1	0.6431935215825413	0.0061172245182257	0.3559322033898315
ferritins	reactive oxygen species/metabolism	0.0009513001672776	0	1	0.6431935215825413	0.0016561935388152	0.144067796610169
ferritins	photosensitizing agents/therapeutic use	6.8833827526759706e-15	0	1	0.6431935215825413	4.639380934134164e-14	0.0338983050847457
photosensitizing agents/therapeutic use	pyroptosis/drug effects	0.0001765303011255	0	1	0.6431935215825413	0.0003450590282329	0.0991023393127427
photosensitizing agents/therapeutic use	retinal drusen/genetics	4.157156320294675e-07	0	1	0.6431935215825413	1.0523544285088806e-06	0.0338983050847457
photosensitizing agents/therapeutic use	macular degeneration/genetics	4.157156320294675e-07	0	1	0.6431935215825413	1.0523544285088806e-06	0.0338983050847457
photosensitizing agents/therapeutic use	bevacizumab/therapeutic use	4.157156320294675e-07	0	1	0.6431935215825413	1.0523544285088806e-06	0.0338983050847457
photosensitizing agents/therapeutic use	verteporfin/therapeutic use	4.157156320294675e-07	0	1	0.6431935215825413	1.0523544285088806e-06	0.0338983050847457
photosensitizing agents/therapeutic use	lipid peroxides/therapeutic use	0.0	0	1	0.6431935215825413	0.0	0.0338983050847457
photosensitizing agents/therapeutic use	vascular endothelial growth factor a/antagonists & inhibitors	4.157156320294675e-07	0	1	0.6431935215825413	1.0523544285088806e-06	0.0338983050847457
photosensitizing agents/therapeutic use	aging/genetics	4.157156320294675e-07	0	1	0.6431935215825413	1.0523544285088806e-06	0.0338983050847457
photosensitizing agents/therapeutic use	oxygen	0.0001274847587391	0	1	0.6431935215825413	0.0002516132966123	0.0991023393127427
photosensitizing agents/therapeutic use	erythrocytes	0.0	0	1	0.6431935215825413	0.0	0.0338983050847457
photosensitizing agents/therapeutic use	ranibizumab/therapeutic use	4.157156320294675e-07	0	1	0.6431935215825413	1.0523544285088806e-06	0.0338983050847457
photosensitizing agents/therapeutic use	necroptosis/drug effects	0.0019772394864053	0	1	0.6431935215825413	0.0032705661973025	0.1304379101192554
photosensitizing agents/therapeutic use	RPE	4.157156320294675e-07	0	1	0.6431935215825413	1.0523544285088806e-06	0.0338983050847457
photosensitizing agents/therapeutic use	SERPINB6	0.0	0	1	0.6431935215825413	0.0	0.0338983050847457
photosensitizing agents/therapeutic use	retinal pigment epithelium/drug effects	4.157156320294675e-07	0	1	0.6431935215825413	1.0523544285088806e-06	0.0338983050847457
photosensitizing agents/therapeutic use	mcf-7 cells	8.956939430038169e-05	0	1	0.6431935215825413	0.0001817117645402	0.0991023393127427
photosensitizing agents/therapeutic use	breast neoplasms/therapy	0.0	0	1	0.6431935215825413	0.0	0.0338983050847457
photosensitizing agents/therapeutic use	epithelial cells/drug effects	0.0004092087658349	0	1	0.6431935215825413	0.0007499339285121	0.0669274228596261
SDHD	tumor microenvironment	5.1804063198046535e-05	0	1	0.6431935215825413	0.0001071482173022	0.1101694915254237
carcinoma hepatocellular/drug therapy	glutathione/metabolism	0.0063896485175681	0	1	0.6431935215825413	0.0097607389423541	0.146098397997872
carcinoma hepatocellular/drug therapy	antineoplastic agents/chemistry	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.1228101724887232
carcinoma hepatocellular/drug therapy	oxidative stress/drug effects	0.0002317229095878	0	1	0.6431935215825413	0.0004428179366358	0.0991023393127427
carcinoma hepatocellular/drug therapy	sorafenib/pharmacology	9.192074035269117e-08	0	1	0.6431935215825413	2.4816053614330416e-07	0.0504128639721861
carcinoma hepatocellular/drug therapy	manganese compounds/chemistry	2.462782872525437e-06	0	1	0.6431935215825413	5.792056437170105e-06	0.0504128639721861
carcinoma hepatocellular/drug therapy	hemin/pharmacology	1.262072557572935e-09	0	1	0.6431935215825413	4.340211413587095e-09	0.0504128639721861
carcinoma hepatocellular/drug therapy	sorafenib/analogs & derivatives	3.0420110874729296e-14	0	1	0.6431935215825413	1.9764960039007447e-13	0.0254237288135593
carcinoma hepatocellular/drug therapy	sorafenib/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0254237288135593
carcinoma hepatocellular/drug therapy	artesunate/administration & dosage	3.79209288414728e-08	0	1	0.6431935215825413	1.1527678493106485e-07	0.0504128639721861
carcinoma hepatocellular/drug therapy	phospholipid hydroperoxide glutathione peroxidase/metabolism	0.0002317229095878	0	1	0.6431935215825413	0.0004428179366358	0.0991023393127427
carcinoma hepatocellular/drug therapy	silicon dioxide/chemistry	2.462782872525437e-06	0	1	0.6431935215825413	5.792056437170105e-06	0.0504128639721861
carcinoma hepatocellular/drug therapy	hep g2 cells	4.0086966293984005e-05	0	1	0.6431935215825413	8.39827114146965e-05	0.0749711519729055
carcinoma hepatocellular/drug therapy	chlorides/chemistry	3.0420110874729296e-14	0	1	0.6431935215825413	1.9764960039007447e-13	0.0254237288135593
sorafenib/pharmacology	artemisinins/pharmacology	3.056738128559555e-05	0	1	0.6431935215825413	6.462249414520916e-05	0.0504128639721861
sorafenib/pharmacology	antineoplastic agents/pharmacology	0.0028023171301814	0	1	0.6431935215825413	0.0045187595550542	0.0832971171954223
sorafenib/pharmacology	hemin/pharmacology	5.145583958920952e-11	0	1	0.6431935215825413	2.0107803233217158e-10	0.0337534405331015
sorafenib/pharmacology	liver neoplasms/drug therapy	1.2460033005368132e-12	0	1	0.6431935215825413	5.627223432359491e-12	0.0169491525423728
sorafenib/pharmacology	energy metabolism/drug effects	1.2460033005368132e-12	0	1	0.6431935215825413	5.627223432359491e-12	0.0169491525423728
sorafenib/pharmacology	hep g2 cells	8.665466092794283e-06	0	1	0.6431935215825413	1.940570600651955e-05	0.0504128639721861
sorafenib/pharmacology	depression chemical	1.2460033005368132e-12	0	1	0.6431935215825413	5.627223432359491e-12	0.0169491525423728
sorafenib/pharmacology	GCLC	6.604701641632627e-05	0	1	0.6431935215825413	0.0001359725859724	0.0504128639721861
sorafenib/pharmacology	HMOX1	0.0057173262133574	0	1	0.6431935215825413	0.0087529156888754	0.0832971171954223
doxorubicin	oxides	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
doxorubicin	manganese compounds	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hemin/pharmacology	tumor microenvironment	1.6608648900628962e-09	0	2	0.3223370757289844	5.6955627088504535e-09	0.0112994350282485
hemin/pharmacology	chlorophyllides/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
hemin/pharmacology	hypoxia/drug therapy	1.574785828406533e-07	0	1	0.6431935215825413	4.175153069545722e-07	0.0504128639721861
hemin/pharmacology	oxygen/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
hemin/pharmacology	CD47	1.6704915228871187e-10	0	1	0.6431935215825413	6.148266760595867e-10	0.0337534405331015
mitochondria	neoplasms/drug therapy	0.0049242016949817	0	1	0.6431935215825413	0.007586353101374	0.3114587860350568
mitochondria	photosensitizing agents/chemistry	2.286392930761494e-06	0	1	0.6431935215825413	5.411166950753161e-06	0.0832971171954223
mitochondria	reactive oxygen species	1.8543679924931662e-09	0	1	0.6431935215825413	6.288333491593041e-09	0.0669274228596261
mitochondria	hypoxia	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
glutathione	neoplasms/drug therapy	0.0001309798406315	0	2	0.3223370757289844	0.0002584067868007	0.1328716345868785
glutathione	reactive oxygen species	2.5289116018401003e-05	0	1	0.6431935215825413	5.414493073711252e-05	0.1304379101192554
glutathione	antineoplastic agents/therapeutic use	1.8127564932468587e-05	0	1	0.6431935215825413	3.90519999628291e-05	0.1304379101192554
glutathione	glypicans/therapeutic use	0.0	0	1	0.6431935215825413	0.0	0.0338983050847457
glutathione	coordination complexes/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0338983050847457
glutathione	iridium/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0338983050847457
glutathione	carcinoma hepatocellular/diagnostic imaging	0.0	0	1	0.6431935215825413	0.0	0.0338983050847457
glutathione	lipid peroxides	0.0	0	1	0.6431935215825413	0.0	0.0338983050847457
oxides	manganese compounds	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
coordination complexes/pharmacology	iridium/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hypoxia	neoplasms/drug therapy	0.0002250279626806	0	1	0.6431935215825413	0.0004312077318689	0.1694915254237282
mitochondria/drug effects	mitochondrial membrane transport proteins/genetics	0.0043666431821266	0	1	0.6431935215825413	0.0067852845110022	0.0508474576271186
mitochondria/drug effects	carcinoma pancreatic ductal/drug therapy	0.0015615735142621	0	1	0.6431935215825413	0.0026248871110725	0.0508474576271186
mitochondria/drug effects	iron-binding proteins/genetics	0.0003269716938369	0	1	0.6431935215825413	0.0006081423908655	0.0508474576271186
mitochondria/drug effects	adenosine triphosphate/metabolism	0.0015615735142621	0	1	0.6431935215825413	0.0026248871110725	0.0508474576271186
mitochondria/drug effects	biological products	6.604701641632627e-05	0	1	0.6431935215825413	0.0001359725859724	0.0508474576271186
mitochondria/drug effects	indoles/pharmacology	0.0003269716938369	0	1	0.6431935215825413	0.0006081423908655	0.0508474576271186
mitochondria/drug effects	drug resistance neoplasm	0.0036389826234235	0	2	0.3223370757289844	0.0057742632119644	0.0202602671765057
mitochondria/drug effects	rna interference	0.0005988108866488	0	1	0.6431935215825413	0.0010731906769546	0.0508474576271186
mitochondria/drug effects	iron/metabolism	0.0062285169608057	0	3	0.1299847034619319	0.0095235529181067	0.0218073646148041
mitochondria/drug effects	protein kinase inhibitors/pharmacology	0.0043666431821266	0	1	0.6431935215825413	0.0067852845110022	0.0508474576271186
mitochondria/drug effects	erlotinib hydrochloride/pharmacology	0.0043666431821266	0	1	0.6431935215825413	0.0067852845110022	0.0508474576271186
mitochondria/drug effects	glutathione peroxidase/metabolism	0.0003269716938369	0	1	0.6431935215825413	0.0006081423908655	0.0508474576271186
mitochondria/drug effects	monocarboxylic acid transporters/genetics	0.0043666431821266	0	1	0.6431935215825413	0.0067852845110022	0.0508474576271186
mitochondria/drug effects	glutaredoxins/antagonists & inhibitors	0.0005988108866488	0	1	0.6431935215825413	0.0010731906769546	0.0508474576271186
mitochondria/drug effects	carbon/pharmacology	6.604701641632627e-05	0	1	0.6431935215825413	0.0001359725859724	0.0508474576271186
mitochondria/drug effects	dna damage	0.0015615735142621	0	1	0.6431935215825413	0.0026248871110725	0.0508474576271186
mitochondria/drug effects	glutamate dehydrogenase/antagonists & inhibitors	0.0003269716938369	0	1	0.6431935215825413	0.0006081423908655	0.0508474576271186
mitochondria/drug effects	sulfasalazine/pharmacology	0.0005988108866488	0	1	0.6431935215825413	0.0010731906769546	0.0508474576271186
mitochondria/drug effects	friedreich ataxia/drug therapy	0.0003269716938369	0	1	0.6431935215825413	0.0006081423908655	0.0508474576271186
mitochondria/drug effects	CASP3	0.0003269716938369	0	1	0.6431935215825413	0.0006081423908655	0.0508474576271186
mitochondria/drug effects	FXN	0.0003269716938369	0	1	0.6431935215825413	0.0006081423908655	0.0508474576271186
mitochondria/drug effects	GAA	0.0003269716938369	0	1	0.6431935215825413	0.0006081423908655	0.0508474576271186
mitochondria/drug effects	GLRX5	0.0005988108866488	0	1	0.6431935215825413	0.0010731906769546	0.0508474576271186
mitochondria/drug effects	KDM5A	0.0043666431821266	0	1	0.6431935215825413	0.0067852845110022	0.0508474576271186
mitochondria/drug effects	MPC1	0.0043666431821266	0	1	0.6431935215825413	0.0067852845110022	0.0508474576271186
mitochondria/drug effects	neoplasms/therapy	0.0010020122946788	0	1	0.6431935215825413	0.0017314914581454	0.099521946979574
mitochondria/drug effects	glutathione/biosynthesis	0.0043666431821266	0	1	0.6431935215825413	0.0067852845110022	0.099521946979574
mitochondria/drug effects	head and neck neoplasms/drug therapy	2.141806363342713e-05	0	2	0.3223370757289844	4.601861732173299e-05	0.0021729682746631
mitochondria/drug effects	immunogenic cell death/drug effects	0.0003269716938369	0	1	0.6431935215825413	0.0006081423908655	0.0508474576271186
mitochondria/drug effects	water	6.604701641632627e-05	0	1	0.6431935215825413	0.0001359725859724	0.0508474576271186
mitochondria/drug effects	triterpenes/pharmacology	6.604701641632627e-05	0	1	0.6431935215825413	0.0001359725859724	0.0508474576271186
mitochondria/drug effects	cisplatin/pharmacology	0.0026008680646647	0	2	0.3223370757289844	0.0042204562368003	0.0124442342062345
mitochondria/drug effects	retinoblastoma-binding protein 2/genetics	0.0043666431821266	0	1	0.6431935215825413	0.0067852845110022	0.0508474576271186
mitochondrial membrane transport proteins/genetics	head and neck neoplasms/drug therapy	3.134932342052643e-06	0	1	0.6431935215825413	7.31284121724391e-06	0.0169491525423728
mitochondrial membrane transport proteins/genetics	epithelial-mesenchymal transition/drug effects	5.038360652676044e-05	0	1	0.6431935215825413	0.0001044763040871	0.0169491525423728
mitochondrial membrane transport proteins/genetics	drug resistance neoplasm	0.0008380238695684	0	1	0.6431935215825413	0.0014726614916721	0.0423728813559322
mitochondrial membrane transport proteins/genetics	protein kinase inhibitors/pharmacology	9.048801707933761e-10	0	1	0.6431935215825413	3.1140403052797473e-09	0.0084745762711864
mitochondrial membrane transport proteins/genetics	erlotinib hydrochloride/pharmacology	9.048801707933761e-10	0	1	0.6431935215825413	3.1140403052797473e-09	0.0084745762711864
mitochondrial membrane transport proteins/genetics	monocarboxylic acid transporters/genetics	9.048801707933761e-10	0	1	0.6431935215825413	3.1140403052797473e-09	0.0084745762711864
mitochondrial membrane transport proteins/genetics	phospholipid hydroperoxide glutathione peroxidase/genetics	0.0020598616168203	0	1	0.6431935215825413	0.0033980046238204	0.0423728813559322
mitochondrial membrane transport proteins/genetics	amino acid transport system y+/genetics	9.373898991138496e-06	0	1	0.6431935215825413	2.0915297520063137e-05	0.0169491525423728
mitochondrial membrane transport proteins/genetics	gene expression regulation neoplastic	0.0038180553533372	0	1	0.6431935215825413	0.0060133754805469	0.0423728813559322
mitochondrial membrane transport proteins/genetics	KDM5A	9.048801707933761e-10	0	1	0.6431935215825413	3.1140403052797473e-09	0.0084745762711864
mitochondrial membrane transport proteins/genetics	MPC1	9.048801707933761e-10	0	1	0.6431935215825413	3.1140403052797473e-09	0.0084745762711864
mitochondrial membrane transport proteins/genetics	retinoblastoma-binding protein 2/genetics	9.048801707933761e-10	0	1	0.6431935215825413	3.1140403052797473e-09	0.0084745762711864
carcinoma pancreatic ductal/drug therapy	neoplasm invasiveness	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
carcinoma pancreatic ductal/drug therapy	cisplatin/pharmacology	0.0001393995799914	0	1	0.6431935215825413	0.0002739089327815	0.0338983050847457
carcinoma pancreatic ductal/drug therapy	drug synergism	0.0041678963404995	0	1	0.6431935215825413	0.0065096663036071	0.0677966101694916
carcinoma pancreatic ductal/drug therapy	adenosine triphosphate/metabolism	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
carcinoma pancreatic ductal/drug therapy	drug resistance neoplasm	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0423728813559322
carcinoma pancreatic ductal/drug therapy	cell movement/drug effects	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
carcinoma pancreatic ductal/drug therapy	dna damage	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
carcinoma pancreatic ductal/drug therapy	cell proliferation/drug effects	4.899385134715661e-05	0	1	0.6431935215825413	0.0001019415190498	0.0338983050847457
carcinoma pancreatic ductal/drug therapy	artemisinins/pharmacology	2.0677437484462047e-06	0	1	0.6431935215825413	4.9296063043925415e-06	0.0254237288135593
carcinoma pancreatic ductal/drug therapy	FTH1	0.0005722347310298	0	1	0.6431935215825413	0.0010320132658432	0.0338983050847457
iron-binding proteins/genetics	piperazines/pharmacology	6.797857805773688e-06	0	1	0.6431935215825413	1.529361084373739e-05	0.0338983050847457
iron-binding proteins/genetics	cell line	2.739195073708789e-05	0	1	0.6431935215825413	5.82886357824582e-05	0.0423728813559322
iron-binding proteins/genetics	glutathione/biosynthesis	2.220446049250313e-14	0	1	0.6431935215825413	1.464172340730281e-13	0.0169491525423728
iron-binding proteins/genetics	iron/metabolism	0.0048702200144618	0	1	0.6431935215825413	0.0075055604460696	0.1186440677966107
iron-binding proteins/genetics	oxidative stress/drug effects	2.6925185070414415e-07	0	1	0.6431935215825413	7.027660784581116e-07	0.0338983050847457
iron-binding proteins/genetics	friedreich ataxia/drug therapy	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
iron-binding proteins/genetics	CASP3	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
iron-binding proteins/genetics	FXN	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
iron-binding proteins/genetics	GAA	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
adenosine triphosphate/metabolism	neoplasm invasiveness	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
adenosine triphosphate/metabolism	cisplatin/pharmacology	0.0001393995799914	0	1	0.6431935215825413	0.0002739089327815	0.0338983050847457
adenosine triphosphate/metabolism	drug synergism	0.0041678963404995	0	1	0.6431935215825413	0.0065096663036071	0.0677966101694916
adenosine triphosphate/metabolism	drug resistance neoplasm	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0423728813559322
adenosine triphosphate/metabolism	cell movement/drug effects	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
adenosine triphosphate/metabolism	dna damage	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
adenosine triphosphate/metabolism	cell proliferation/drug effects	4.899385134715661e-05	0	1	0.6431935215825413	0.0001019415190498	0.0338983050847457
adenosine triphosphate/metabolism	artemisinins/pharmacology	2.0677437484462047e-06	0	1	0.6431935215825413	4.9296063043925415e-06	0.0254237288135593
adenosine triphosphate/metabolism	FTH1	0.0005722347310298	0	1	0.6431935215825413	0.0010320132658432	0.0338983050847457
biological products	water	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
biological products	neoplasms/drug therapy	0.0029186400071936	0	1	0.6431935215825413	0.0046970055333734	0.1694915254237277
biological products	carbon/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
biological products	autophagy/drug effects	1.0308646052337167e-06	0	1	0.6431935215825413	2.470931245107674e-06	0.0338983050847457
biological products	triterpenes/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
biological products	antineoplastic agents/chemistry	6.067571897139246e-07	0	1	0.6431935215825413	1.5209505069320752e-06	0.0423728813559322
biological products	apoptosis/drug effects	0.0012608286884825	0	1	0.6431935215825413	0.0021580675092994	0.0847457627118643
indoles/pharmacology	glutathione/metabolism	0.0001204419165107	0	1	0.6431935215825413	0.0002389712781582	0.0508474576271186
indoles/pharmacology	homeostasis/drug effects	7.824340964024401e-08	0	1	0.6431935215825413	2.1312472620285585e-07	0.0254237288135593
indoles/pharmacology	immunogenic cell death/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
indoles/pharmacology	neoplasms/therapy	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
indoles/pharmacology	apoptosis/drug effects	0.0037717988488256	0	1	0.6431935215825413	0.0059578527683394	0.0847457627118643
indoles/pharmacology	glutathione peroxidase/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
indoles/pharmacology	glutamate dehydrogenase/antagonists & inhibitors	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
drug resistance neoplasm	glutathione/biosynthesis	0.0008380238695684	0	1	0.6431935215825413	0.0014726614916721	0.0832971171954223
drug resistance neoplasm	alcohol oxidoreductases/genetics	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0423728813559322
drug resistance neoplasm	retinoblastoma-binding protein 2/genetics	0.0008380238695684	0	1	0.6431935215825413	0.0014726614916721	0.0423728813559322
drug resistance neoplasm	cytosol/metabolism	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0423728813559322
drug resistance neoplasm	oxidants/chemistry	1.0320496013349612e-08	0	1	0.6431935215825413	3.2978214474132894e-08	0.0423728813559322
drug resistance neoplasm	protein kinase inhibitors/pharmacology	0.0008380238695684	0	1	0.6431935215825413	0.0014726614916721	0.0423728813559322
drug resistance neoplasm	erlotinib hydrochloride/pharmacology	0.0008380238695684	0	1	0.6431935215825413	0.0014726614916721	0.0423728813559322
drug resistance neoplasm	monocarboxylic acid transporters/genetics	0.0008380238695684	0	1	0.6431935215825413	0.0014726614916721	0.0423728813559322
drug resistance neoplasm	dna damage	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0423728813559322
drug resistance neoplasm	reactive oxygen species/chemistry	1.0320496013349612e-08	0	1	0.6431935215825413	3.2978214474132894e-08	0.0423728813559322
drug resistance neoplasm	deoxycytidine/analogs & derivatives	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0423728813559322
drug resistance neoplasm	flavonoids/pharmacology	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0423728813559322
drug resistance neoplasm	pancreatic neoplasms	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0423728813559322
drug resistance neoplasm	antineoplastic agents/adverse effects	3.286172911454166e-06	0	1	0.6431935215825413	7.64003845301343e-06	0.0832971171954222
drug resistance neoplasm	CBR1	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0423728813559322
drug resistance neoplasm	FTH1	0.0013208520769592	0	2	0.3223370757289844	0.0022512001360258	0.0083941080307303
drug resistance neoplasm	KDM5A	0.0008380238695684	0	1	0.6431935215825413	0.0014726614916721	0.0423728813559322
drug resistance neoplasm	MPC1	0.0008380238695684	0	1	0.6431935215825413	0.0014726614916721	0.0423728813559322
rna interference	mutation	1.824043087683691e-07	0	1	0.6431935215825413	4.825495095701752e-07	0.0169491525423728
rna interference	head and neck neoplasms/drug therapy	2.512418173505893e-08	0	1	0.6431935215825413	7.75856385265793e-08	0.0169491525423728
rna interference	drug resistance neoplasm/drug effects	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.0593220338983051
rna interference	cisplatin/pharmacology	3.6685232443489646e-05	0	1	0.6431935215825413	7.715456957148253e-05	0.0338983050847457
rna interference	glutaredoxins/antagonists & inhibitors	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
rna interference	sulfasalazine/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
rna interference	GLRX5	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
rna interference	TF	0.0023666487764341	0	1	0.6431935215825413	0.0038493589744871	0.059322033898305
iron/metabolism	artesunate/pharmacology	0.0048702200144618	0	1	0.6431935215825413	0.0075055604460696	0.1186440677966107
iron/metabolism	neoplasm metastasis	0.0008437390094017	0	1	0.6431935215825413	0.0014757861424316	0.1186440677966107
iron/metabolism	lysosomes/metabolism	0.0008437390094017	0	1	0.6431935215825413	0.0014757861424316	0.1186440677966107
iron/metabolism	maleic anhydrides/chemistry	0.0008437390094017	0	1	0.6431935215825413	0.0014757861424316	0.1186440677966107
iron/metabolism	lung diseases/drug therapy	0.0001035162500716	0	1	0.6431935215825413	0.0002075862907815	0.1186440677966107
iron/metabolism	cell differentiation	0.0003417535464999	0	1	0.6431935215825413	0.0006324971637273	0.1186440677966107
iron/metabolism	homeostasis	2.6741607817015733e-08	0	3	0.1299847034619319	8.252809049545136e-08	0.0013637249172024
iron/metabolism	starch/analogs & derivatives	0.0008437390094017	0	1	0.6431935215825413	0.0014757861424316	0.1186440677966107
iron/metabolism	antimalarials/pharmacology	0.0048702200144618	0	1	0.6431935215825413	0.0075055604460696	0.1186440677966107
iron/metabolism	ceruloplasmin/metabolism	0.0017145101095644	0	1	0.6431935215825413	0.0028573213966852	0.11864406779661
iron/metabolism	iron overload/drug therapy	0.0001035162500716	0	1	0.6431935215825413	0.0002075862907815	0.11864406779661
iron/metabolism	inflammation/metabolism	0.0017145101095644	0	1	0.6431935215825413	0.0028573213966852	0.11864406779661
iron/metabolism	autophagy	7.72332818810284e-08	0	2	0.3223370757289844	2.1119965353886166e-07	0.0368205727644652
iron/metabolism	ferritins/chemistry	0.0017145101095644	0	1	0.6431935215825413	0.0028573213966852	0.11864406779661
iron/metabolism	hemolysis	0.0008437390094017	0	1	0.6431935215825413	0.0014757861424316	0.11864406779661
iron/metabolism	friedreich ataxia/drug therapy	0.0048702200144618	0	1	0.6431935215825413	0.0075055604460696	0.11864406779661
iron/metabolism	neoplastic stem cells/metabolism	0.0008437390094017	0	1	0.6431935215825413	0.0014757861424316	0.11864406779661
iron/metabolism	antineoplastic agents/adverse effects	0.0017145101095644	0	1	0.6431935215825413	0.0028573213966852	0.2241054613935977
iron/metabolism	neoplasms/diagnosis	0.0017145101095644	0	1	0.6431935215825413	0.0028573213966852	0.11864406779661
iron/metabolism	pyroptosis	0.0001035162500716	0	1	0.6431935215825413	0.0002075862907815	0.11864406779661
iron/metabolism	CASP3	0.0048702200144618	0	1	0.6431935215825413	0.0075055604460696	0.11864406779661
iron/metabolism	FXN	0.0048702200144618	0	1	0.6431935215825413	0.0075055604460696	0.11864406779661
iron/metabolism	GAA	0.0048702200144618	0	1	0.6431935215825413	0.0075055604460696	0.11864406779661
iron/metabolism	MAPK1	0.0048702200144618	0	1	0.6431935215825413	0.0075055604460696	0.11864406779661
iron/metabolism	neoplastic stem cells/pathology	2.8886264269445405e-08	0	1	0.6431935215825413	8.797672861562966e-08	0.1186440677966107
iron/metabolism	biomarkers/chemistry	0.0017145101095644	0	1	0.6431935215825413	0.0028573213966852	0.1186440677966107
iron/metabolism	lipid metabolism/drug effects	0.0008437390094017	0	1	0.6431935215825413	0.0014757861424316	0.2241054613935961
iron/metabolism	neoplastic stem cells/drug effects	0.0003417535464999	0	1	0.6431935215825413	0.0006324971637273	0.11864406779661
iron/metabolism	necrosis	0.0001035162500716	0	1	0.6431935215825413	0.0002075862907815	0.11864406779661
iron/metabolism	antineoplastic agents/administration & dosage	0.004430334714236	0	2	0.3223370757289844	0.0068493087127132	0.1064631228839939
iron/metabolism	covid-19/metabolism	0.0017145101095644	0	1	0.6431935215825413	0.0028573213966852	0.11864406779661
iron/metabolism	mitochondria/metabolism	0.0008437390094017	0	1	0.6431935215825413	0.0014757861424316	0.11864406779661
protein kinase inhibitors/pharmacology	epithelial-mesenchymal transition/drug effects	5.038360652676044e-05	0	1	0.6431935215825413	0.0001044763040871	0.0169491525423728
protein kinase inhibitors/pharmacology	head and neck neoplasms/drug therapy	3.134932342052643e-06	0	1	0.6431935215825413	7.31284121724391e-06	0.0169491525423728
protein kinase inhibitors/pharmacology	retinoblastoma-binding protein 2/genetics	9.048801707933761e-10	0	1	0.6431935215825413	3.1140403052797473e-09	0.0084745762711864
protein kinase inhibitors/pharmacology	erlotinib hydrochloride/pharmacology	9.048801707933761e-10	0	1	0.6431935215825413	3.1140403052797473e-09	0.0084745762711864
protein kinase inhibitors/pharmacology	monocarboxylic acid transporters/genetics	9.048801707933761e-10	0	1	0.6431935215825413	3.1140403052797473e-09	0.0084745762711864
protein kinase inhibitors/pharmacology	phospholipid hydroperoxide glutathione peroxidase/genetics	0.0020598616168203	0	1	0.6431935215825413	0.0033980046238204	0.0423728813559322
protein kinase inhibitors/pharmacology	amino acid transport system y+/genetics	9.373898991138496e-06	0	1	0.6431935215825413	2.0915297520063137e-05	0.0169491525423728
protein kinase inhibitors/pharmacology	gene expression regulation neoplastic	0.0038180553533372	0	1	0.6431935215825413	0.0060133754805469	0.0423728813559322
protein kinase inhibitors/pharmacology	KDM5A	9.048801707933761e-10	0	1	0.6431935215825413	3.1140403052797473e-09	0.0084745762711864
protein kinase inhibitors/pharmacology	MPC1	9.048801707933761e-10	0	1	0.6431935215825413	3.1140403052797473e-09	0.0084745762711864
erlotinib hydrochloride/pharmacology	epithelial-mesenchymal transition/drug effects	5.038360652676044e-05	0	1	0.6431935215825413	0.0001044763040871	0.0169491525423728
erlotinib hydrochloride/pharmacology	head and neck neoplasms/drug therapy	3.134932342052643e-06	0	1	0.6431935215825413	7.31284121724391e-06	0.0169491525423728
erlotinib hydrochloride/pharmacology	retinoblastoma-binding protein 2/genetics	9.048801707933761e-10	0	1	0.6431935215825413	3.1140403052797473e-09	0.0084745762711864
erlotinib hydrochloride/pharmacology	monocarboxylic acid transporters/genetics	9.048801707933761e-10	0	1	0.6431935215825413	3.1140403052797473e-09	0.0084745762711864
erlotinib hydrochloride/pharmacology	phospholipid hydroperoxide glutathione peroxidase/genetics	0.0020598616168203	0	1	0.6431935215825413	0.0033980046238204	0.0423728813559322
erlotinib hydrochloride/pharmacology	amino acid transport system y+/genetics	9.373898991138496e-06	0	1	0.6431935215825413	2.0915297520063137e-05	0.0169491525423728
erlotinib hydrochloride/pharmacology	gene expression regulation neoplastic	0.0038180553533372	0	1	0.6431935215825413	0.0060133754805469	0.0423728813559322
erlotinib hydrochloride/pharmacology	KDM5A	9.048801707933761e-10	0	1	0.6431935215825413	3.1140403052797473e-09	0.0084745762711864
erlotinib hydrochloride/pharmacology	MPC1	9.048801707933761e-10	0	1	0.6431935215825413	3.1140403052797473e-09	0.0084745762711864
glutathione peroxidase/metabolism	glutathione/metabolism	0.0001204419165107	0	1	0.6431935215825413	0.0002389712781582	0.0508474576271186
glutathione peroxidase/metabolism	apoptosis/drug effects	0.0037717988488256	0	1	0.6431935215825413	0.0059578527683394	0.0847457627118641
glutathione peroxidase/metabolism	homeostasis/drug effects	7.824340964024401e-08	0	1	0.6431935215825413	2.1312472620285585e-07	0.0254237288135593
glutathione peroxidase/metabolism	immunogenic cell death/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
glutathione peroxidase/metabolism	neoplasms/therapy	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
glutathione peroxidase/metabolism	glutamate dehydrogenase/antagonists & inhibitors	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
monocarboxylic acid transporters/genetics	epithelial-mesenchymal transition/drug effects	5.038360652676044e-05	0	1	0.6431935215825413	0.0001044763040871	0.0169491525423728
monocarboxylic acid transporters/genetics	head and neck neoplasms/drug therapy	3.134932342052643e-06	0	1	0.6431935215825413	7.31284121724391e-06	0.0169491525423728
monocarboxylic acid transporters/genetics	retinoblastoma-binding protein 2/genetics	9.048801707933761e-10	0	1	0.6431935215825413	3.1140403052797473e-09	0.0084745762711864
monocarboxylic acid transporters/genetics	phospholipid hydroperoxide glutathione peroxidase/genetics	0.0020598616168203	0	1	0.6431935215825413	0.0033980046238204	0.0423728813559322
monocarboxylic acid transporters/genetics	amino acid transport system y+/genetics	9.373898991138496e-06	0	1	0.6431935215825413	2.0915297520063137e-05	0.0169491525423728
monocarboxylic acid transporters/genetics	gene expression regulation neoplastic	0.0038180553533372	0	1	0.6431935215825413	0.0060133754805469	0.0423728813559322
monocarboxylic acid transporters/genetics	KDM5A	9.048801707933761e-10	0	1	0.6431935215825413	3.1140403052797473e-09	0.0084745762711864
monocarboxylic acid transporters/genetics	MPC1	9.048801707933761e-10	0	1	0.6431935215825413	3.1140403052797473e-09	0.0084745762711864
glutaredoxins/antagonists & inhibitors	mutation	1.824043087683691e-07	0	1	0.6431935215825413	4.825495095701752e-07	0.0169491525423728
glutaredoxins/antagonists & inhibitors	head and neck neoplasms/drug therapy	2.512418173505893e-08	0	1	0.6431935215825413	7.75856385265793e-08	0.0169491525423728
glutaredoxins/antagonists & inhibitors	drug resistance neoplasm/drug effects	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.0593220338983051
glutaredoxins/antagonists & inhibitors	cisplatin/pharmacology	3.6685232443489646e-05	0	1	0.6431935215825413	7.715456957148253e-05	0.0338983050847457
glutaredoxins/antagonists & inhibitors	sulfasalazine/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
glutaredoxins/antagonists & inhibitors	GLRX5	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
glutaredoxins/antagonists & inhibitors	TF	0.0023666487764341	0	1	0.6431935215825413	0.0038493589744871	0.059322033898305
carbon/pharmacology	water	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
carbon/pharmacology	neoplasms/drug therapy	0.0029186400071936	0	1	0.6431935215825413	0.0046970055333734	0.1694915254237282
carbon/pharmacology	autophagy/drug effects	1.0308646052337167e-06	0	1	0.6431935215825413	2.470931245107674e-06	0.0338983050847457
carbon/pharmacology	triterpenes/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
carbon/pharmacology	antineoplastic agents/chemistry	6.067571897139246e-07	0	1	0.6431935215825413	1.5209505069320752e-06	0.0423728813559322
carbon/pharmacology	apoptosis/drug effects	0.0012608286884825	0	1	0.6431935215825413	0.0021580675092994	0.0847457627118641
dna damage	neoplasm invasiveness	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
dna damage	cell movement/drug effects	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
dna damage	cell proliferation/drug effects	4.899385134715661e-05	0	1	0.6431935215825413	0.0001019415190498	0.0338983050847457
dna damage	cisplatin/pharmacology	0.0001393995799914	0	1	0.6431935215825413	0.0002739089327815	0.0338983050847457
dna damage	drug synergism	0.0041678963404995	0	1	0.6431935215825413	0.0065096663036071	0.0677966101694916
dna damage	artemisinins/pharmacology	2.0677437484462047e-06	0	1	0.6431935215825413	4.9296063043925415e-06	0.0254237288135593
dna damage	FTH1	0.0005722347310298	0	1	0.6431935215825413	0.0010320132658432	0.0338983050847457
glutamate dehydrogenase/antagonists & inhibitors	glutathione/metabolism	0.0001204419165107	0	1	0.6431935215825413	0.0002389712781582	0.0508474576271186
glutamate dehydrogenase/antagonists & inhibitors	apoptosis/drug effects	0.0037717988488256	0	1	0.6431935215825413	0.0059578527683394	0.0847457627118641
glutamate dehydrogenase/antagonists & inhibitors	homeostasis/drug effects	7.824340964024401e-08	0	1	0.6431935215825413	2.1312472620285585e-07	0.0254237288135593
glutamate dehydrogenase/antagonists & inhibitors	immunogenic cell death/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
glutamate dehydrogenase/antagonists & inhibitors	neoplasms/therapy	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
sulfasalazine/pharmacology	mutation	1.824043087683691e-07	0	1	0.6431935215825413	4.825495095701752e-07	0.0169491525423728
sulfasalazine/pharmacology	head and neck neoplasms/drug therapy	2.512418173505893e-08	0	1	0.6431935215825413	7.75856385265793e-08	0.0169491525423728
sulfasalazine/pharmacology	drug resistance neoplasm/drug effects	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.0593220338983051
sulfasalazine/pharmacology	cisplatin/pharmacology	3.6685232443489646e-05	0	1	0.6431935215825413	7.715456957148253e-05	0.0338983050847457
sulfasalazine/pharmacology	GLRX5	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
sulfasalazine/pharmacology	TF	0.0023666487764341	0	1	0.6431935215825413	0.0038493589744871	0.059322033898305
friedreich ataxia/drug therapy	piperazines/pharmacology	6.797857805773688e-06	0	1	0.6431935215825413	1.529361084373739e-05	0.0338983050847457
friedreich ataxia/drug therapy	oxidative stress/drug effects	2.6925185070414415e-07	0	1	0.6431935215825413	7.027660784581116e-07	0.0338983050847457
friedreich ataxia/drug therapy	cell line	2.739195073708789e-05	0	1	0.6431935215825413	5.82886357824582e-05	0.0423728813559322
friedreich ataxia/drug therapy	glutathione/biosynthesis	2.220446049250313e-14	0	1	0.6431935215825413	1.464172340730281e-13	0.0169491525423728
friedreich ataxia/drug therapy	CASP3	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
friedreich ataxia/drug therapy	FXN	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
friedreich ataxia/drug therapy	GAA	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
CASP3	piperazines/pharmacology	6.797857805773688e-06	0	1	0.6431935215825413	1.529361084373739e-05	0.0338983050847457
CASP3	oxidative stress/drug effects	2.6925185070414415e-07	0	1	0.6431935215825413	7.027660784581116e-07	0.0338983050847457
CASP3	cell line	2.739195073708789e-05	0	1	0.6431935215825413	5.82886357824582e-05	0.0423728813559322
CASP3	glutathione/biosynthesis	2.220446049250313e-14	0	1	0.6431935215825413	1.464172340730281e-13	0.0169491525423728
CASP3	FXN	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
CASP3	GAA	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
FXN	piperazines/pharmacology	6.797857805773688e-06	0	1	0.6431935215825413	1.529361084373739e-05	0.0338983050847457
FXN	oxidative stress/drug effects	2.6925185070414415e-07	0	1	0.6431935215825413	7.027660784581116e-07	0.0338983050847457
FXN	cell line	2.739195073708789e-05	0	1	0.6431935215825413	5.82886357824582e-05	0.0423728813559322
FXN	glutathione/biosynthesis	2.220446049250313e-14	0	1	0.6431935215825413	1.464172340730281e-13	0.0169491525423728
FXN	GAA	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
GAA	piperazines/pharmacology	6.797857805773688e-06	0	1	0.6431935215825413	1.529361084373739e-05	0.0338983050847457
GAA	oxidative stress/drug effects	2.6925185070414415e-07	0	1	0.6431935215825413	7.027660784581116e-07	0.0338983050847457
GAA	cell line	2.739195073708789e-05	0	1	0.6431935215825413	5.82886357824582e-05	0.0423728813559322
GAA	glutathione/biosynthesis	2.220446049250313e-14	0	1	0.6431935215825413	1.464172340730281e-13	0.0169491525423728
GLRX5	mutation	1.824043087683691e-07	0	1	0.6431935215825413	4.825495095701752e-07	0.0169491525423728
GLRX5	head and neck neoplasms/drug therapy	2.512418173505893e-08	0	1	0.6431935215825413	7.75856385265793e-08	0.0169491525423728
GLRX5	drug resistance neoplasm/drug effects	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.0593220338983051
GLRX5	cisplatin/pharmacology	3.6685232443489646e-05	0	1	0.6431935215825413	7.715456957148253e-05	0.0338983050847457
GLRX5	TF	0.0023666487764341	0	1	0.6431935215825413	0.0038493589744871	0.059322033898305
KDM5A	epithelial-mesenchymal transition/drug effects	5.038360652676044e-05	0	1	0.6431935215825413	0.0001044763040871	0.0169491525423728
KDM5A	phospholipid hydroperoxide glutathione peroxidase/genetics	0.0020598616168203	0	1	0.6431935215825413	0.0033980046238204	0.0423728813559322
KDM5A	amino acid transport system y+/genetics	9.373898991138496e-06	0	1	0.6431935215825413	2.0915297520063137e-05	0.0169491525423728
KDM5A	gene expression regulation neoplastic	0.0038180553533372	0	1	0.6431935215825413	0.0060133754805469	0.0423728813559322
KDM5A	head and neck neoplasms/drug therapy	3.134932342052643e-06	0	1	0.6431935215825413	7.31284121724391e-06	0.0169491525423728
KDM5A	retinoblastoma-binding protein 2/genetics	9.048801707933761e-10	0	1	0.6431935215825413	3.1140403052797473e-09	0.0084745762711864
KDM5A	MPC1	9.048801707933761e-10	0	1	0.6431935215825413	3.1140403052797473e-09	0.0084745762711864
MPC1	epithelial-mesenchymal transition/drug effects	5.038360652676044e-05	0	1	0.6431935215825413	0.0001044763040871	0.0169491525423728
MPC1	phospholipid hydroperoxide glutathione peroxidase/genetics	0.0020598616168203	0	1	0.6431935215825413	0.0033980046238204	0.0423728813559322
MPC1	amino acid transport system y+/genetics	9.373898991138496e-06	0	1	0.6431935215825413	2.0915297520063137e-05	0.0169491525423728
MPC1	gene expression regulation neoplastic	0.0038180553533372	0	1	0.6431935215825413	0.0060133754805469	0.0423728813559322
MPC1	head and neck neoplasms/drug therapy	3.134932342052643e-06	0	1	0.6431935215825413	7.31284121724391e-06	0.0169491525423728
MPC1	retinoblastoma-binding protein 2/genetics	9.048801707933761e-10	0	1	0.6431935215825413	3.1140403052797473e-09	0.0084745762711864
neoplasms/therapy	glutathione/metabolism	0.0004265954659604	0	1	0.6431935215825413	0.0007815036487313	0.099521946979574
neoplasms/therapy	tumor microenvironment	0.0017145101095644	0	1	0.6431935215825413	0.0028573213966852	0.2090395480225995
neoplasms/therapy	homeostasis/drug effects	8.187841766815751e-07	0	1	0.6431935215825413	1.996964611095753e-06	0.0504128639721861
neoplasms/therapy	immunogenic cell death/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
glutathione/biosynthesis	piperazines/pharmacology	0.0003328270951356	0	1	0.6431935215825413	0.0006164448630162	0.0669274228596261
glutathione/biosynthesis	oxidative stress/drug effects	3.950338465419368e-05	0	1	0.6431935215825413	8.293838579055828e-05	0.0669274228596261
glutathione/biosynthesis	photosensitizing agents/chemistry	0.0003328270951356	0	1	0.6431935215825413	0.0006164448630162	0.0832971171954223
glutathione/biosynthesis	cell line	0.0008380238695684	0	1	0.6431935215825413	0.0014726614916721	0.0832971171954222
glutathione/biosynthesis	oxidants/chemistry	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
glutathione/biosynthesis	reactive oxygen species/chemistry	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
head and neck neoplasms/drug therapy	epithelial-mesenchymal transition/drug effects	0.0022098042998848	0	1	0.6431935215825413	0.0036318301360332	0.0337534405331015
head and neck neoplasms/drug therapy	mutation	0.0009701044822025	0	1	0.6431935215825413	0.0016871231769354	0.0337534405331015
head and neck neoplasms/drug therapy	amino acid transport system y+/genetics	0.0007987709474506	0	1	0.6431935215825413	0.0014133663133358	0.0337534405331015
head and neck neoplasms/drug therapy	retinoblastoma-binding protein 2/genetics	3.134932342052643e-06	0	1	0.6431935215825413	7.31284121724391e-06	0.0169491525423728
immunogenic cell death/drug effects	glutathione/metabolism	0.0001204419165107	0	1	0.6431935215825413	0.0002389712781582	0.0508474576271186
immunogenic cell death/drug effects	apoptosis/drug effects	0.0037717988488256	0	1	0.6431935215825413	0.0059578527683394	0.0847457627118643
immunogenic cell death/drug effects	homeostasis/drug effects	7.824340964024401e-08	0	1	0.6431935215825413	2.1312472620285585e-07	0.0254237288135593
water	neoplasms/drug therapy	0.0029186400071936	0	1	0.6431935215825413	0.0046970055333734	0.1694915254237277
water	autophagy/drug effects	1.0308646052337167e-06	0	1	0.6431935215825413	2.470931245107674e-06	0.0338983050847457
water	triterpenes/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
water	antineoplastic agents/chemistry	6.067571897139246e-07	0	1	0.6431935215825413	1.5209505069320752e-06	0.0423728813559322
water	apoptosis/drug effects	0.0012608286884825	0	1	0.6431935215825413	0.0021580675092994	0.0847457627118643
triterpenes/pharmacology	neoplasms/drug therapy	0.0029186400071936	0	1	0.6431935215825413	0.0046970055333734	0.1694915254237277
triterpenes/pharmacology	antineoplastic agents/chemistry	6.067571897139246e-07	0	1	0.6431935215825413	1.5209505069320752e-06	0.0423728813559322
triterpenes/pharmacology	apoptosis/drug effects	0.0012608286884825	0	1	0.6431935215825413	0.0021580675092994	0.0847457627118643
triterpenes/pharmacology	autophagy/drug effects	1.0308646052337167e-06	0	1	0.6431935215825413	2.470931245107674e-06	0.0338983050847457
cisplatin/pharmacology	neoplasm invasiveness	4.147818855049224e-08	0	2	0.3223370757289844	1.2585505156074016e-07	0.0008691873098652
cisplatin/pharmacology	cell movement/drug effects	4.147818855049224e-08	0	2	0.3223370757289844	1.2585505156074016e-07	0.0008691873098652
cisplatin/pharmacology	cell proliferation/drug effects	6.469466325498274e-05	0	2	0.3223370757289844	0.0001337535401109	0.0050956268932026
cisplatin/pharmacology	cell cycle checkpoints/drug effects	3.6685232443489646e-05	0	1	0.6431935215825413	7.715456957148253e-05	0.0338983050847457
cisplatin/pharmacology	drug resistance neoplasm/drug effects	0.0054211728080586	0	2	0.3223370757289844	0.0083440856265539	0.017217597198793
cisplatin/pharmacology	n-acetylgalactosaminyltransferases/metabolism	0.0001393995799914	0	1	0.6431935215825413	0.0002739089327815	0.0338983050847457
cisplatin/pharmacology	amp-activated protein kinases/metabolism	3.6685232443489646e-05	0	1	0.6431935215825413	7.715456957148253e-05	0.0338983050847457
cisplatin/pharmacology	ribosome inactivating proteins type 2/isolation & purification	3.6685232443489646e-05	0	1	0.6431935215825413	7.715456957148253e-05	0.0338983050847457
cisplatin/pharmacology	sirolimus/analogs & derivatives	0.0001393995799914	0	1	0.6431935215825413	0.0002739089327815	0.0338983050847457
cisplatin/pharmacology	ovarian neoplasms/drug therapy	4.147818855049224e-08	0	2	0.3223370757289844	1.2585505156074016e-07	0.0008691873098652
cisplatin/pharmacology	antineoplastic agents phytogenic/isolation & purification	3.6685232443489646e-05	0	1	0.6431935215825413	7.715456957148253e-05	0.0338983050847457
cisplatin/pharmacology	erbb receptors/metabolism	0.0001393995799914	0	1	0.6431935215825413	0.0002739089327815	0.0338983050847457
cisplatin/pharmacology	tor serine-threonine kinases/antagonists & inhibitors	0.0042006311134247	0	1	0.6431935215825413	0.0065544910072746	0.0669274228596264
cisplatin/pharmacology	ovary/pathology	0.0001393995799914	0	1	0.6431935215825413	0.0002739089327815	0.0338983050847457
cisplatin/pharmacology	GALNT14	0.0001393995799914	0	1	0.6431935215825413	0.0002739089327815	0.0338983050847457
cisplatin/pharmacology	MTOR	0.0042006311134247	0	1	0.6431935215825413	0.0065544910072746	0.0669274228596264
cisplatin/pharmacology	PRKAA2	3.6685232443489646e-05	0	1	0.6431935215825413	7.715456957148253e-05	0.0338983050847457
retinoblastoma-binding protein 2/genetics	epithelial-mesenchymal transition/drug effects	5.038360652676044e-05	0	1	0.6431935215825413	0.0001044763040871	0.0169491525423728
retinoblastoma-binding protein 2/genetics	phospholipid hydroperoxide glutathione peroxidase/genetics	0.0020598616168203	0	1	0.6431935215825413	0.0033980046238204	0.0423728813559322
retinoblastoma-binding protein 2/genetics	amino acid transport system y+/genetics	9.373898991138496e-06	0	1	0.6431935215825413	2.0915297520063137e-05	0.0169491525423728
retinoblastoma-binding protein 2/genetics	gene expression regulation neoplastic	0.0038180553533372	0	1	0.6431935215825413	0.0060133754805469	0.0423728813559322
neoplasm invasiveness	cell cycle checkpoints/drug effects	3.831546191435109e-09	0	1	0.6431935215825413	1.2649813408443961e-08	0.0169491525423728
neoplasm invasiveness	ribosome inactivating proteins type 2/isolation & purification	3.831546191435109e-09	0	1	0.6431935215825413	1.2649813408443961e-08	0.0169491525423728
neoplasm invasiveness	ovarian neoplasms/drug therapy	7.51783010494167e-05	0	1	0.6431935215825413	0.0001536032960225	0.0337534405331015
neoplasm invasiveness	antineoplastic agents phytogenic/isolation & purification	3.831546191435109e-09	0	1	0.6431935215825413	1.2649813408443961e-08	0.0169491525423728
neoplasm invasiveness	cell movement/drug effects	2.4424906541753444e-15	0	2	0.3223370757289844	1.6906614996869962e-14	0.0001448645516442
neoplasm invasiveness	cell proliferation/drug effects	4.666442676715121e-09	0	2	0.3223370757289844	1.5385368852254932e-08	0.0008691873098652
neoplasm invasiveness	artemisinins/pharmacology	0.0005809982081789	0	1	0.6431935215825413	0.0010470429986892	0.0504128639721861
neoplasm invasiveness	PRKAA2	3.831546191435109e-09	0	1	0.6431935215825413	1.2649813408443961e-08	0.0169491525423728
neoplasm invasiveness	drug synergism	4.671754172569376e-05	0	2	0.3223370757289844	9.737150591501526e-05	0.0040562074460379
neoplasm invasiveness	amp-activated protein kinases/metabolism	3.831546191435109e-09	0	1	0.6431935215825413	1.2649813408443961e-08	0.0169491525423728
cell cycle checkpoints/drug effects	cell movement/drug effects	3.831546191435109e-09	0	1	0.6431935215825413	1.2649813408443961e-08	0.0169491525423728
cell cycle checkpoints/drug effects	cell proliferation/drug effects	1.0932638977112497e-05	0	1	0.6431935215825413	2.422680751954033e-05	0.0338983050847457
cell cycle checkpoints/drug effects	drug synergism	0.0018574249692088	0	1	0.6431935215825413	0.003085997911679	0.0677966101694917
cell cycle checkpoints/drug effects	amp-activated protein kinases/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cell cycle checkpoints/drug effects	ribosome inactivating proteins type 2/isolation & purification	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cell cycle checkpoints/drug effects	ovarian neoplasms/drug therapy	3.831546191435109e-09	0	1	0.6431935215825413	1.2649813408443961e-08	0.0169491525423728
cell cycle checkpoints/drug effects	antineoplastic agents phytogenic/isolation & purification	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cell cycle checkpoints/drug effects	PRKAA2	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
ribosome inactivating proteins type 2/isolation & purification	cell movement/drug effects	3.831546191435109e-09	0	1	0.6431935215825413	1.2649813408443961e-08	0.0169491525423728
ribosome inactivating proteins type 2/isolation & purification	cell proliferation/drug effects	1.0932638977112497e-05	0	1	0.6431935215825413	2.422680751954033e-05	0.0338983050847457
ribosome inactivating proteins type 2/isolation & purification	drug synergism	0.0018574249692088	0	1	0.6431935215825413	0.003085997911679	0.0677966101694916
ribosome inactivating proteins type 2/isolation & purification	amp-activated protein kinases/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
ribosome inactivating proteins type 2/isolation & purification	ovarian neoplasms/drug therapy	3.831546191435109e-09	0	1	0.6431935215825413	1.2649813408443961e-08	0.0169491525423728
ribosome inactivating proteins type 2/isolation & purification	antineoplastic agents phytogenic/isolation & purification	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
ribosome inactivating proteins type 2/isolation & purification	PRKAA2	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
ovarian neoplasms/drug therapy	cell movement/drug effects	7.51783010494167e-05	0	1	0.6431935215825413	0.0001536032960225	0.0337534405331015
ovarian neoplasms/drug therapy	cell proliferation/drug effects	0.0033997442232595	0	1	0.6431935215825413	0.00542822857141	0.0669274228596261
ovarian neoplasms/drug therapy	EGFR	0.0055997402124934	0	1	0.6431935215825413	0.008586385794676	0.0504128639721861
ovarian neoplasms/drug therapy	n-acetylgalactosaminyltransferases/metabolism	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
ovarian neoplasms/drug therapy	amp-activated protein kinases/metabolism	3.831546191435109e-09	0	1	0.6431935215825413	1.2649813408443961e-08	0.0169491525423728
ovarian neoplasms/drug therapy	sirolimus/analogs & derivatives	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
ovarian neoplasms/drug therapy	antineoplastic agents phytogenic/isolation & purification	3.831546191435109e-09	0	1	0.6431935215825413	1.2649813408443961e-08	0.0169491525423728
ovarian neoplasms/drug therapy	erbb receptors/metabolism	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
ovarian neoplasms/drug therapy	tor serine-threonine kinases/antagonists & inhibitors	3.6685232443489646e-05	0	1	0.6431935215825413	7.715456957148253e-05	0.0337534405331015
ovarian neoplasms/drug therapy	ovary/pathology	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
ovarian neoplasms/drug therapy	GALNT14	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
ovarian neoplasms/drug therapy	MTOR	3.6685232443489646e-05	0	1	0.6431935215825413	7.715456957148253e-05	0.0337534405331015
ovarian neoplasms/drug therapy	PRKAA2	3.831546191435109e-09	0	1	0.6431935215825413	1.2649813408443961e-08	0.0169491525423728
antineoplastic agents phytogenic/isolation & purification	cell movement/drug effects	3.831546191435109e-09	0	1	0.6431935215825413	1.2649813408443961e-08	0.0169491525423728
antineoplastic agents phytogenic/isolation & purification	cell proliferation/drug effects	1.0932638977112497e-05	0	1	0.6431935215825413	2.422680751954033e-05	0.0338983050847457
antineoplastic agents phytogenic/isolation & purification	drug synergism	0.0018574249692088	0	1	0.6431935215825413	0.003085997911679	0.0677966101694916
antineoplastic agents phytogenic/isolation & purification	amp-activated protein kinases/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
antineoplastic agents phytogenic/isolation & purification	PRKAA2	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cell movement/drug effects	drug synergism	4.671754172569376e-05	0	2	0.3223370757289844	9.737150591501526e-05	0.0040562074460379
cell movement/drug effects	amp-activated protein kinases/metabolism	3.831546191435109e-09	0	1	0.6431935215825413	1.2649813408443961e-08	0.0169491525423728
cell movement/drug effects	cell proliferation/drug effects	4.666442676715121e-09	0	2	0.3223370757289844	1.5385368852254932e-08	0.0008691873098652
cell movement/drug effects	artemisinins/pharmacology	0.0005809982081789	0	1	0.6431935215825413	0.0010470429986892	0.0504128639721861
cell movement/drug effects	PRKAA2	3.831546191435109e-09	0	1	0.6431935215825413	1.2649813408443961e-08	0.0169491525423728
cell proliferation/drug effects	lymphoma/drug therapy	3.413343128144675e-07	0	1	0.6431935215825413	8.800646065316932e-07	0.0338983050847457
cell proliferation/drug effects	piperazines/chemistry	3.413343128144675e-07	0	1	0.6431935215825413	8.800646065316932e-07	0.0338983050847457
cell proliferation/drug effects	lipid metabolism/genetics	3.413343128144675e-07	0	1	0.6431935215825413	8.800646065316932e-07	0.0338983050847457
cell proliferation/drug effects	ketones/chemistry	3.413343128144675e-07	0	1	0.6431935215825413	8.800646065316932e-07	0.0338983050847457
cell proliferation/drug effects	artesunate/pharmacology	4.230565558316357e-06	0	1	0.6431935215825413	9.74269658113214e-06	0.0338983050847457
cell proliferation/drug effects	antineoplastic agents	0.0027768736118364	0	1	0.6431935215825413	0.0045000682110006	0.0669274228596261
cell proliferation/drug effects	imidazoles/chemistry	0.0010280532583318	0	1	0.6431935215825413	0.0017758608748143	0.0669274228596261
cell proliferation/drug effects	drug synergism	0.0037655426676029	0	2	0.3223370757289844	0.0059578527683394	0.0226861797263037
cell proliferation/drug effects	amp-activated protein kinases/metabolism	1.0932638977112497e-05	0	1	0.6431935215825413	2.422680751954033e-05	0.0338983050847457
cell proliferation/drug effects	antimalarials/pharmacology	4.230565558316357e-06	0	1	0.6431935215825413	9.74269658113214e-06	0.0338983050847457
cell proliferation/drug effects	glioblastoma/drug therapy	0.0001521403702234	0	1	0.6431935215825413	0.0002985823697539	0.0669274228596261
cell proliferation/drug effects	MAPK1	4.230565558316357e-06	0	1	0.6431935215825413	9.74269658113214e-06	0.0338983050847457
cell proliferation/drug effects	PRKAA2	1.0932638977112497e-05	0	1	0.6431935215825413	2.422680751954033e-05	0.0338983050847457
artemisinins/pharmacology	drug synergism	0.0004950321005164	0	2	0.3223370757289844	0.0009036812408369	0.0117490146712823
artemisinins/pharmacology	cell line tumor/drug effects	2.6673407926836035e-10	0	1	0.6431935215825413	9.692730561332738e-10	0.0254237288135593
artemisinins/pharmacology	lung neoplasms/drug therapy	2.6673407926836035e-10	0	1	0.6431935215825413	9.692730561332738e-10	0.0254237288135593
artemisinins/pharmacology	liver neoplasms/drug therapy	2.786690866951602e-07	0	1	0.6431935215825413	7.200182711906234e-07	0.0254237288135593
artemisinins/pharmacology	phospholipid hydroperoxide glutathione peroxidase/metabolism	0.0043666431821266	0	1	0.6431935215825413	0.0067852845110022	0.0991023393127429
artemisinins/pharmacology	GCLC	0.0043666431821266	0	1	0.6431935215825413	0.0067852845110022	0.0749711519729055
artemisinins/pharmacology	chlorophyllides/metabolism	2.6673407926836035e-10	0	1	0.6431935215825413	9.692730561332738e-10	0.0254237288135593
artemisinins/pharmacology	depression chemical	2.786690866951602e-07	0	1	0.6431935215825413	7.200182711906234e-07	0.0254237288135593
artemisinins/pharmacology	hep g2 cells	0.0014262093564235	0	1	0.6431935215825413	0.0024114913927314	0.0749711519729055
artemisinins/pharmacology	energy metabolism/drug effects	2.786690866951602e-07	0	1	0.6431935215825413	7.200182711906234e-07	0.0254237288135593
PRKAA2	drug synergism	0.0018574249692088	0	1	0.6431935215825413	0.003085997911679	0.0677966101694916
PRKAA2	amp-activated protein kinases/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
drug synergism	myocardial infarction/metabolism	0.0002907338317896	0	1	0.6431935215825413	0.0005451119516395	0.0677966101694917
drug synergism	protein isoforms/genetics	0.000607861146487	0	1	0.6431935215825413	0.0010866131206277	0.0677966101694916
drug synergism	myocytes cardiac/drug effects	0.0002907338317896	0	1	0.6431935215825413	0.0005451119516395	0.0677966101694916
drug synergism	liver neoplasms/drug therapy	0.0018574249692088	0	1	0.6431935215825413	0.003085997911679	0.0677966101694916
drug synergism	antineoplastic agents/pharmacology	0.0002754886086545	0	3	0.1299847034619319	0.0005219502293832	0.0019631301483684
drug synergism	deferoxamine/pharmacology	0.0002907338317896	0	1	0.6431935215825413	0.0005451119516395	0.0677966101694916
drug synergism	myocardial reperfusion injury/metabolism	0.0002907338317896	0	1	0.6431935215825413	0.0005451119516395	0.0677966101694916
drug synergism	crispr-cas systems	0.000607861146487	0	1	0.6431935215825413	0.0010866131206277	0.0677966101694916
drug synergism	sorafenib/administration & dosage	7.685313776484293e-06	0	1	0.6431935215825413	1.7258310614197218e-05	0.0677966101694916
drug synergism	carcinoma hepatocellular/diagnosis	0.000607861146487	0	1	0.6431935215825413	0.0010866131206277	0.0677966101694916
drug synergism	receptors androgen/genetics	0.000607861146487	0	1	0.6431935215825413	0.0010866131206277	0.0677966101694916
drug synergism	docetaxel/pharmacology	0.000607861146487	0	1	0.6431935215825413	0.0010866131206277	0.0677966101694916
drug synergism	pyridazines/pharmacology	0.0002907338317896	0	1	0.6431935215825413	0.0005451119516395	0.0677966101694916
drug synergism	energy metabolism/drug effects	0.0018574249692088	0	1	0.6431935215825413	0.003085997911679	0.0677966101694916
drug synergism	phosphotransferases (alcohol group acceptor)/antagonists & inhibitors	0.000607861146487	0	1	0.6431935215825413	0.0010866131206277	0.0677966101694916
drug synergism	depression chemical	0.0018574249692088	0	1	0.6431935215825413	0.003085997911679	0.0677966101694916
drug synergism	PSTK	0.000607861146487	0	1	0.6431935215825413	0.0010866131206277	0.0677966101694916
drug synergism	amp-activated protein kinases/metabolism	0.0018574249692088	0	1	0.6431935215825413	0.003085997911679	0.0677966101694917
lymphoma/drug therapy	piperazines/chemistry	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
lymphoma/drug therapy	lipid metabolism/genetics	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
lymphoma/drug therapy	ketones/chemistry	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
lymphoma/drug therapy	antineoplastic agents/chemistry	6.067571897139246e-07	0	1	0.6431935215825413	1.5209505069320752e-06	0.0423728813559322
lymphoma/drug therapy	SLC9A1	8.4546925016582e-10	0	1	0.6431935215825413	2.953384699683184e-09	0.0254237288135593
lymphoma/drug therapy	imidazoles/chemistry	3.0420110874729296e-14	0	1	0.6431935215825413	1.9764960039007447e-13	0.0169491525423728
piperazines/chemistry	imidazoles/chemistry	3.0420110874729296e-14	0	1	0.6431935215825413	1.9764960039007447e-13	0.0169491525423728
piperazines/chemistry	lipid metabolism/genetics	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
piperazines/chemistry	ketones/chemistry	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
piperazines/chemistry	antineoplastic agents/chemistry	6.067571897139246e-07	0	1	0.6431935215825413	1.5209505069320752e-06	0.0423728813559322
piperazines/chemistry	SLC9A1	8.4546925016582e-10	0	1	0.6431935215825413	2.953384699683184e-09	0.0254237288135593
lipid metabolism/genetics	imidazoles/chemistry	3.0420110874729296e-14	0	1	0.6431935215825413	1.9764960039007447e-13	0.0169491525423728
lipid metabolism/genetics	ketones/chemistry	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
lipid metabolism/genetics	antineoplastic agents/chemistry	6.067571897139246e-07	0	1	0.6431935215825413	1.5209505069320752e-06	0.0423728813559322
lipid metabolism/genetics	SLC9A1	8.4546925016582e-10	0	1	0.6431935215825413	2.953384699683184e-09	0.0254237288135593
ketones/chemistry	imidazoles/chemistry	3.0420110874729296e-14	0	1	0.6431935215825413	1.9764960039007447e-13	0.0169491525423728
ketones/chemistry	antineoplastic agents/chemistry	6.067571897139246e-07	0	1	0.6431935215825413	1.5209505069320752e-06	0.0423728813559322
ketones/chemistry	SLC9A1	8.4546925016582e-10	0	1	0.6431935215825413	2.953384699683184e-09	0.0254237288135593
antineoplastic agents/chemistry	glutathione/metabolism	0.0006247844548458	0	2	0.3223370757289844	0.001115228808961	0.0202602671765057
antineoplastic agents/chemistry	b7-h1 antigen/metabolism	6.067571897139246e-07	0	1	0.6431935215825413	1.5209505069320752e-06	0.0423728813559322
antineoplastic agents/chemistry	manganese compounds/chemistry	0.0022317857690734	0	1	0.6431935215825413	0.0036630151743667	0.0832971171954223
antineoplastic agents/chemistry	imidazoles/chemistry	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.0832971171954223
antineoplastic agents/chemistry	kidney	6.067571897139246e-07	0	1	0.6431935215825413	1.5209505069320752e-06	0.0423728813559322
antineoplastic agents/chemistry	sorafenib/analogs & derivatives	6.067571897139246e-07	0	1	0.6431935215825413	1.5209505069320752e-06	0.0423728813559322
antineoplastic agents/chemistry	hydroxyl radical/metabolism	1.691390996205744e-05	0	1	0.6431935215825413	3.6453552961126e-05	0.0423728813559322
antineoplastic agents/chemistry	human umbilical vein endothelial cells	1.691390996205744e-05	0	1	0.6431935215825413	3.6453552961126e-05	0.0423728813559322
antineoplastic agents/chemistry	iron/chemistry	0.0002120713226091	0	1	0.6431935215825413	0.0004133694220297	0.0832971171954222
antineoplastic agents/chemistry	silicon dioxide/chemistry	0.0022317857690734	0	1	0.6431935215825413	0.0036630151743667	0.0832971171954222
antineoplastic agents/chemistry	hep g2 cells	1.157296339870939e-07	0	2	0.3223370757289844	3.108878205177005e-07	0.0042710066088207
antineoplastic agents/chemistry	chlorides/chemistry	6.067571897139246e-07	0	1	0.6431935215825413	1.5209505069320752e-06	0.0423728813559322
antineoplastic agents/chemistry	oxygen/metabolism	1.691390996205744e-05	0	1	0.6431935215825413	3.6453552961126e-05	0.0423728813559322
antineoplastic agents/chemistry	PEBP1	1.691390996205744e-05	0	1	0.6431935215825413	3.6453552961126e-05	0.0423728813559322
antineoplastic agents/chemistry	XAB2	1.691390996205744e-05	0	1	0.6431935215825413	3.6453552961126e-05	0.0423728813559322
antineoplastic agents/chemistry	hemin/chemistry	1.691390996205744e-05	0	1	0.6431935215825413	3.6453552961126e-05	0.0423728813559322
SLC9A1	biological transport	8.4546925016582e-10	0	1	0.6431935215825413	2.953384699683184e-09	0.0254237288135593
SLC9A1	histones/genetics	9.73918094393511e-07	0	1	0.6431935215825413	2.3413433024072912e-06	0.0254237288135593
SLC9A1	imidazoles/chemistry	7.141548729572289e-05	0	1	0.6431935215825413	0.0001462831734308	0.0504128639721861
SLC9A1	glutathione/antagonists & inhibitors	9.73918094393511e-07	0	1	0.6431935215825413	2.3413433024072912e-06	0.0254237288135593
SLC9A1	antineoplastic agents/therapeutic use	0.0007987709474506	0	1	0.6431935215825413	0.0014133663133358	0.0991023393127429
SLC9A1	glutathione disulfide/deficiency	8.4546925016582e-10	0	1	0.6431935215825413	2.953384699683184e-09	0.0254237288135593
SLC9A1	carcinoma renal cell/drug therapy	2.871899050016502e-05	0	1	0.6431935215825413	6.100594625427382e-05	0.0504128639721861
SLC9A1	amino acid transport system y+/metabolism	0.0002120713226091	0	1	0.6431935215825413	0.0004133694220297	0.0504128639721861
SLC9A1	cystine/antagonists & inhibitors	9.73918094393511e-07	0	1	0.6431935215825413	2.3413433024072912e-06	0.0254237288135593
SLC9A1	glutamine/antagonists & inhibitors	9.73918094393511e-07	0	1	0.6431935215825413	2.3413433024072912e-06	0.0254237288135593
SLC9A1	piperazines/therapeutic use	9.73918094393511e-07	0	1	0.6431935215825413	2.3413433024072912e-06	0.0254237288135593
SLC9A1	amino acid transport system y+/antagonists & inhibitors	9.73918094393511e-07	0	1	0.6431935215825413	2.3413433024072912e-06	0.0254237288135593
SLC9A1	sorafenib/therapeutic use	9.73918094393511e-07	0	1	0.6431935215825413	2.3413433024072912e-06	0.0254237288135593
SLC9A1	cystine/metabolism	8.4546925016582e-10	0	1	0.6431935215825413	2.953384699683184e-09	0.0254237288135593
SLC9A1	gamma-glutamyltransferase/metabolism	8.4546925016582e-10	0	1	0.6431935215825413	2.953384699683184e-09	0.0254237288135593
SLC9A1	sulfasalazine/therapeutic use	9.73918094393511e-07	0	1	0.6431935215825413	2.3413433024072912e-06	0.0254237288135593
SLC9A1	glucose/antagonists & inhibitors	9.73918094393511e-07	0	1	0.6431935215825413	2.3413433024072912e-06	0.0254237288135593
SLC9A1	GGT1	8.4546925016582e-10	0	1	0.6431935215825413	2.953384699683184e-09	0.0254237288135593
SLC9A1	SLC7A11	0.0062139744816632	0	2	0.3223370757289844	0.0095042993249043	0.0186575551859012
imidazoles/chemistry	zeolites/chemistry	5.145583958920952e-11	0	1	0.6431935215825413	2.0107803233217158e-10	0.0169491525423728
imidazoles/chemistry	gallic acid/chemistry	5.145583958920952e-11	0	1	0.6431935215825413	2.0107803233217158e-10	0.0169491525423728
imidazoles/chemistry	azo compounds/chemistry	5.145583958920952e-11	0	1	0.6431935215825413	2.0107803233217158e-10	0.0169491525423728
imidazoles/chemistry	ferric compounds/chemistry	4.157156320294675e-07	0	1	0.6431935215825413	1.0523544285088806e-06	0.0337534405331015
imidazoles/chemistry	tumor hypoxia/drug effects	5.145583958920952e-11	0	1	0.6431935215825413	2.0107803233217158e-10	0.0169491525423728
imidazoles/chemistry	glucose oxidase/chemistry	5.145583958920952e-11	0	1	0.6431935215825413	2.0107803233217158e-10	0.0169491525423728
imidazoles/chemistry	metal-organic frameworks/pharmacology	2.032680913588436e-07	0	1	0.6431935215825413	5.371612848110873e-07	0.0337534405331015
imidazoles/chemistry	mcf-7 cells	2.462782872525437e-06	0	1	0.6431935215825413	5.792056437170105e-06	0.0504128639721861
imidazoles/chemistry	tumor microenvironment/drug effects	9.74542915177512e-06	0	1	0.6431935215825413	2.1724371572095223e-05	0.0337534405331015
epithelial-mesenchymal transition/drug effects	sesquiterpenes/administration & dosage	0.0002828096196491	0	1	0.6431935215825413	0.0005335390153116	0.0169491525423728
epithelial-mesenchymal transition/drug effects	erbb receptors/antagonists & inhibitors	0.0002828096196491	0	1	0.6431935215825413	0.0005335390153116	0.0169491525423728
epithelial-mesenchymal transition/drug effects	cetuximab/administration & dosage	0.0002828096196491	0	1	0.6431935215825413	0.0005335390153116	0.0169491525423728
epithelial-mesenchymal transition/drug effects	cell proliferation	0.0022098042998848	0	1	0.6431935215825413	0.0036318301360332	0.0337534405331015
epithelial-mesenchymal transition/drug effects	mutation	0.0042997702476603	0	1	0.6431935215825413	0.0067048897333916	0.0337534405331015
epithelial-mesenchymal transition/drug effects	proto-oncogene proteins p21(ras)/genetics	0.0002828096196491	0	1	0.6431935215825413	0.0005335390153116	0.0169491525423728
epithelial-mesenchymal transition/drug effects	amino acid transport system y+/genetics	0.0036954739372909	0	1	0.6431935215825413	0.0058600860710767	0.0337534405331015
epithelial-mesenchymal transition/drug effects	CDH1	0.0002828096196491	0	1	0.6431935215825413	0.0005335390153116	0.0169491525423728
epithelial-mesenchymal transition/drug effects	CDH2	0.0002828096196491	0	1	0.6431935215825413	0.0005335390153116	0.0169491525423728
epithelial-mesenchymal transition/drug effects	GLS	0.0002828096196491	0	1	0.6431935215825413	0.0005335390153116	0.0169491525423728
epithelial-mesenchymal transition/drug effects	MMP9	0.0002828096196491	0	1	0.6431935215825413	0.0005335390153116	0.0169491525423728
epithelial-mesenchymal transition/drug effects	SLC40A1	0.0002828096196491	0	1	0.6431935215825413	0.0005335390153116	0.0169491525423728
epithelial-mesenchymal transition/drug effects	VIM	0.0002828096196491	0	1	0.6431935215825413	0.0005335390153116	0.0169491525423728
phospholipid hydroperoxide glutathione peroxidase/genetics	rna long noncoding/physiology	0.0006355939282138	0	1	0.6431935215825413	0.0011303829241555	0.0423728813559322
phospholipid hydroperoxide glutathione peroxidase/genetics	endometrium/cytology	0.0006355939282138	0	1	0.6431935215825413	0.0011303829241555	0.0423728813559322
phospholipid hydroperoxide glutathione peroxidase/genetics	coenzyme a ligases/genetics	4.833836817375037e-06	0	1	0.6431935215825413	1.1110984344843656e-05	0.0423728813559322
phospholipid hydroperoxide glutathione peroxidase/genetics	everolimus/administration & dosage	4.630460946586368e-05	0	1	0.6431935215825413	9.659347685237744e-05	0.0423728813559322
phospholipid hydroperoxide glutathione peroxidase/genetics	micrornas/genetics	0.0006355939282138	0	1	0.6431935215825413	0.0011303829241555	0.0423728813559322
phospholipid hydroperoxide glutathione peroxidase/genetics	cell movement/genetics	0.0006355939282138	0	1	0.6431935215825413	0.0011303829241555	0.0423728813559322
phospholipid hydroperoxide glutathione peroxidase/genetics	biomarkers tumor	0.0028023171301814	0	1	0.6431935215825413	0.0045187595550542	0.0832971171954223
phospholipid hydroperoxide glutathione peroxidase/genetics	stromal cells/physiology	0.0006355939282138	0	1	0.6431935215825413	0.0011303829241555	0.0423728813559322
phospholipid hydroperoxide glutathione peroxidase/genetics	tumor suppressor protein p53/genetics	0.0009891637291119	0	1	0.6431935215825413	0.0017141517965727	0.0423728813559322
phospholipid hydroperoxide glutathione peroxidase/genetics	carcinoma renal cell/drug therapy	0.0036954739372909	0	1	0.6431935215825413	0.0058600860710767	0.0832971171954223
phospholipid hydroperoxide glutathione peroxidase/genetics	anthelmintics/pharmacology	0.0009891637291119	0	1	0.6431935215825413	0.0017141517965727	0.0423728813559322
phospholipid hydroperoxide glutathione peroxidase/genetics	breast neoplasms/diagnosis	4.833836817375037e-06	0	1	0.6431935215825413	1.1110984344843656e-05	0.0423728813559322
phospholipid hydroperoxide glutathione peroxidase/genetics	amino acid transport system y+/genetics	1.2825174311781318e-05	0	2	0.3223370757289844	2.805075153559711e-05	0.0014486455164421
phospholipid hydroperoxide glutathione peroxidase/genetics	ferroptosis/genetics	0.000229905751035	0	2	0.3223370757289844	0.0004398628679992	0.0083941080307303
phospholipid hydroperoxide glutathione peroxidase/genetics	ADAMTS9-AS1	0.0006355939282138	0	1	0.6431935215825413	0.0011303829241555	0.0423728813559322
phospholipid hydroperoxide glutathione peroxidase/genetics	GPX4	0.00085607296178	0	5	0.0123899221684959	0.0014968222256024	0.0001505114457113
phospholipid hydroperoxide glutathione peroxidase/genetics	MIR6516	0.0006355939282138	0	1	0.6431935215825413	0.0011303829241555	0.0832971171954222
phospholipid hydroperoxide glutathione peroxidase/genetics	TP53	0.0009891637291119	0	1	0.6431935215825413	0.0017141517965727	0.0423728813559322
phospholipid hydroperoxide glutathione peroxidase/genetics	carbolines/administration & dosage	0.0028023171301814	0	1	0.6431935215825413	0.0045187595550542	0.0832971171954223
phospholipid hydroperoxide glutathione peroxidase/genetics	adamts9 protein/physiology	0.0006355939282138	0	1	0.6431935215825413	0.0011303829241555	0.0423728813559322
phospholipid hydroperoxide glutathione peroxidase/genetics	endometriosis/genetics	0.0006355939282138	0	1	0.6431935215825413	0.0011303829241555	0.0423728813559322
phospholipid hydroperoxide glutathione peroxidase/genetics	cell cycle/drug effects	0.0009891637291119	0	1	0.6431935215825413	0.0017141517965727	0.0423728813559322
phospholipid hydroperoxide glutathione peroxidase/genetics	mebendazole/analogs & derivatives	0.0009891637291119	0	1	0.6431935215825413	0.0017141517965727	0.0423728813559322
amino acid transport system y+/genetics	prostatic neoplasms castration-resistant/drug therapy	0.0002880744925515	0	1	0.6431935215825413	0.000541375627537	0.0337534405331015
amino acid transport system y+/genetics	tumor suppressor protein p53/genetics	2.286392930761494e-06	0	1	0.6431935215825413	5.411166950753161e-06	0.0169491525423728
amino acid transport system y+/genetics	anthelmintics/pharmacology	2.286392930761494e-06	0	1	0.6431935215825413	5.411166950753161e-06	0.0169491525423728
amino acid transport system y+/genetics	fluorouracil/pharmacology	0.0006355939282138	0	1	0.6431935215825413	0.0011303829241555	0.0337534405331015
amino acid transport system y+/genetics	cell cycle/drug effects	2.286392930761494e-06	0	1	0.6431935215825413	5.411166950753161e-06	0.0169491525423728
amino acid transport system y+/genetics	mebendazole/analogs & derivatives	2.286392930761494e-06	0	1	0.6431935215825413	5.411166950753161e-06	0.0169491525423728
amino acid transport system y+/genetics	SLC7A11	0.0062139744816632	0	2	0.3223370757289844	0.0095042993249043	0.0065189048239895
amino acid transport system y+/genetics	TP53	2.286392930761494e-06	0	1	0.6431935215825413	5.411166950753161e-06	0.0169491525423728
gene expression regulation neoplastic	receptors transferrin/genetics	0.0064529191659207	0	1	0.6431935215825413	0.009811255880041	0.0423728813559322
gene expression regulation neoplastic	coenzyme a ligases/genetics	1.691390996205744e-05	0	1	0.6431935215825413	3.6453552961126e-05	0.0423728813559322
gene expression regulation neoplastic	species specificity	0.0064529191659207	0	1	0.6431935215825413	0.009811255880041	0.0423728813559322
gene expression regulation neoplastic	histones/genetics	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.0423728813559322
gene expression regulation neoplastic	homozygote	0.0064529191659207	0	1	0.6431935215825413	0.009811255880041	0.0423728813559322
gene expression regulation neoplastic	glutathione/antagonists & inhibitors	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.0423728813559322
gene expression regulation neoplastic	n-acetylgalactosaminyltransferases/metabolism	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.0423728813559322
gene expression regulation neoplastic	sirolimus/analogs & derivatives	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.0423728813559322
gene expression regulation neoplastic	nitrilotriacetic acid/adverse effects	0.0064529191659207	0	1	0.6431935215825413	0.009811255880041	0.0423728813559322
gene expression regulation neoplastic	biomarkers tumor	0.005033230398565	0	1	0.6431935215825413	0.0077494255078065	0.0832971171954223
gene expression regulation neoplastic	cyclin-dependent kinase inhibitor p15/genetics	0.0064529191659207	0	1	0.6431935215825413	0.009811255880041	0.0423728813559322
gene expression regulation neoplastic	carcinoma renal cell/chemically induced	0.0064529191659207	0	1	0.6431935215825413	0.009811255880041	0.0423728813559322
gene expression regulation neoplastic	ferric compounds/adverse effects	0.0064529191659207	0	1	0.6431935215825413	0.009811255880041	0.0423728813559322
gene expression regulation neoplastic	cystine/antagonists & inhibitors	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.0423728813559322
gene expression regulation neoplastic	cationic amino acid transporter 1/genetics	0.0064529191659207	0	1	0.6431935215825413	0.009811255880041	0.0423728813559322
gene expression regulation neoplastic	gene regulatory networks	0.0064529191659207	0	1	0.6431935215825413	0.009811255880041	0.0423728813559322
gene expression regulation neoplastic	glutamine/antagonists & inhibitors	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.0423728813559322
gene expression regulation neoplastic	piperazines/therapeutic use	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.0423728813559322
gene expression regulation neoplastic	breast neoplasms/diagnosis	1.691390996205744e-05	0	1	0.6431935215825413	3.6453552961126e-05	0.0423728813559322
gene expression regulation neoplastic	amino acid transport system y+/antagonists & inhibitors	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.0423728813559322
gene expression regulation neoplastic	sorafenib/therapeutic use	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.0423728813559322
gene expression regulation neoplastic	erbb receptors/metabolism	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.0423728813559322
gene expression regulation neoplastic	ovary/pathology	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.0423728813559322
gene expression regulation neoplastic	ferritins/genetics	0.0064529191659207	0	1	0.6431935215825413	0.009811255880041	0.0423728813559322
gene expression regulation neoplastic	sequence deletion	0.0064529191659207	0	1	0.6431935215825413	0.009811255880041	0.0423728813559322
gene expression regulation neoplastic	CDKN2A	0.0064529191659207	0	1	0.6431935215825413	0.009811255880041	0.0423728813559322
gene expression regulation neoplastic	GALNT14	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.0423728813559322
gene expression regulation neoplastic	LCN2	0.0064529191659207	0	1	0.6431935215825413	0.009811255880041	0.0423728813559322
gene expression regulation neoplastic	sulfasalazine/therapeutic use	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.0423728813559322
gene expression regulation neoplastic	glucose/antagonists & inhibitors	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.0423728813559322
gene expression regulation neoplastic	cyclin-dependent kinase inhibitor p16/genetics	0.0064529191659207	0	1	0.6431935215825413	0.009811255880041	0.0423728813559322
gene expression regulation neoplastic	lipocalin-2/genetics	0.0064529191659207	0	1	0.6431935215825413	0.009811255880041	0.0423728813559322
neoplasms/drug therapy	nih 3t3 cells	0.001526960680637	0	1	0.6431935215825413	0.0025711400818052	0.1694915254237277
neoplasms/drug therapy	antineoplastic agents/therapeutic use	2.4712288054784537e-06	0	3	0.1299847034619319	5.80911624172528e-06	0.0151899278522407
neoplasms/drug therapy	cell differentiation	0.0006690670921051	0	1	0.6431935215825413	0.0011868816672108	0.1694915254237277
neoplasms/drug therapy	hydrogen peroxide/pharmacology	0.0006690670921051	0	1	0.6431935215825413	0.0011868816672108	0.1694915254237277
neoplasms/drug therapy	chlorophyllides	0.0021817849062482	0	2	0.3223370757289844	0.0035918371108606	0.0740307812195596
neoplasms/drug therapy	chlorophyllides/administration & dosage	0.001526960680637	0	1	0.6431935215825413	0.0025711400818052	0.1694915254237277
neoplasms/drug therapy	neoplastic stem cells/drug effects	0.0006690670921051	0	1	0.6431935215825413	0.0011868816672108	0.1694915254237277
neoplasms/drug therapy	doxorubicin/pharmacology	1.305057858447256e-07	0	1	0.6431935215825413	3.500025836110885e-07	0.1694915254237277
neoplasms/drug therapy	reactive oxygen species	0.0026933873087507	0	2	0.3223370757289844	0.0043691332741486	0.1328716345868785
neoplasms/drug therapy	lipid metabolism/drug effects	0.001526960680637	0	1	0.6431935215825413	0.0025711400818052	0.3114587860350568
neoplasms/drug therapy	oxidants/chemistry	0.0002250279626806	0	1	0.6431935215825413	0.0004312077318689	0.1694915254237277
neoplasms/drug therapy	carbonic anhydrase ix/metabolism	1.305057858447256e-07	0	1	0.6431935215825413	3.500025836110885e-07	0.1694915254237277
neoplasms/drug therapy	porphyrins	0.001526960680637	0	1	0.6431935215825413	0.0025711400818052	0.1694915254237277
neoplasms/drug therapy	doxorubicin/therapeutic use	1.305057858447256e-07	0	1	0.6431935215825413	3.500025836110885e-07	0.1694915254237282
neoplasms/drug therapy	oxygen	0.0005895052212623	0	2	0.3223370757289844	0.0010619811250319	0.0740307812195599
neoplasms/drug therapy	reactive oxygen species/chemistry	0.0002250279626806	0	1	0.6431935215825413	0.0004312077318689	0.1694915254237282
neoplasms/drug therapy	erythrocytes	4.968492005319458e-05	0	1	0.6431935215825413	0.0001033353032092	0.1694915254237282
neoplasms/drug therapy	iron overload/drug therapy	0.0002250279626806	0	1	0.6431935215825413	0.0004312077318689	0.1694915254237282
neoplasms/drug therapy	metal-organic frameworks/pharmacology	8.165033196616545e-05	0	2	0.3223370757289844	0.000166477852582	0.0275242648124004
neoplasms/drug therapy	antineoplastic agents/adverse effects	0.0029186400071936	0	1	0.6431935215825413	0.0046970055333734	0.311458786035057
neoplasms/drug therapy	sorafenib	0.001526960680637	0	1	0.6431935215825413	0.0025711400818052	0.1694915254237282
autophagy/drug effects	apoptosis/drug effects	0.0002170187311111	0	3	0.1299847034619319	0.0004170079955459	0.0017162214199288
autophagy/drug effects	artesunate/administration & dosage	0.0004445101169019	0	1	0.6431935215825413	0.0008134051068956	0.0669274228596264
autophagy/drug effects	plant leaves/chemistry	0.0002880744925515	0	1	0.6431935215825413	0.000541375627537	0.0338983050847457
autophagy/drug effects	carcinoma non-small-cell lung/drug therapy	0.0002880744925515	0	1	0.6431935215825413	0.000541375627537	0.0338983050847457
autophagy/drug effects	cisplatin/administration & dosage	0.0002880744925515	0	1	0.6431935215825413	0.000541375627537	0.0338983050847457
autophagy/drug effects	membrane potential mitochondrial/drug effects	0.0002880744925515	0	1	0.6431935215825413	0.000541375627537	0.0338983050847457
autophagy/drug effects	a549 cells	0.0002880744925515	0	1	0.6431935215825413	0.000541375627537	0.0338983050847457
autophagy/drug effects	biflavonoids/administration & dosage	0.0002880744925515	0	1	0.6431935215825413	0.000541375627537	0.0338983050847457
autophagy/drug effects	heme oxygenase-1/genetics	0.0002880744925515	0	1	0.6431935215825413	0.000541375627537	0.0338983050847457
autophagy/drug effects	erbb receptors/genetics	0.0002880744925515	0	1	0.6431935215825413	0.000541375627537	0.0338983050847457
autophagy/drug effects	antineoplastic agents	0.0042335216098199	0	1	0.6431935215825413	0.0066036974406698	0.0669274228596264
autophagy/drug effects	cyclin-dependent kinase inhibitor p21/antagonists & inhibitors	1.0524513804011091e-05	0	1	0.6431935215825413	2.340755626058697e-05	0.0338983050847457
autophagy/drug effects	cytosol/metabolism	0.0001010832823041	0	1	0.6431935215825413	0.0002030415641666	0.0338983050847457
autophagy/drug effects	alcohol oxidoreductases/genetics	0.0001010832823041	0	1	0.6431935215825413	0.0002030415641666	0.0338983050847457
autophagy/drug effects	endoplasmic reticulum stress/drug effects	1.0524513804011091e-05	0	1	0.6431935215825413	2.340755626058697e-05	0.0338983050847457
autophagy/drug effects	niacinamide/administration & dosage	1.0524513804011091e-05	0	1	0.6431935215825413	2.340755626058697e-05	0.0338983050847457
autophagy/drug effects	phenylurea compounds/administration & dosage	1.0524513804011091e-05	0	1	0.6431935215825413	2.340755626058697e-05	0.0338983050847457
autophagy/drug effects	deoxycytidine/analogs & derivatives	0.0001010832823041	0	1	0.6431935215825413	0.0002030415641666	0.0338983050847457
autophagy/drug effects	flavonoids/pharmacology	0.0001010832823041	0	1	0.6431935215825413	0.0002030415641666	0.0338983050847457
autophagy/drug effects	pancreatic neoplasms	0.0001010832823041	0	1	0.6431935215825413	0.0002030415641666	0.0338983050847457
autophagy/drug effects	neuroendocrine tumors/drug therapy	1.0524513804011091e-05	0	1	0.6431935215825413	2.340755626058697e-05	0.0338983050847457
autophagy/drug effects	CBR1	0.0001010832823041	0	1	0.6431935215825413	0.0002030415641666	0.0338983050847457
autophagy/drug effects	EIF2S1	0.0027768736118364	0	1	0.6431935215825413	0.0045000682110006	0.0669274228596264
apoptosis/drug effects	metal-organic frameworks/chemistry	0.0012608286884825	0	1	0.6431935215825413	0.0021580675092994	0.0847457627118643
apoptosis/drug effects	cell line tumor/drug effects	0.0005988108866488	0	1	0.6431935215825413	0.0010731906769546	0.0847457627118643
apoptosis/drug effects	cerebrovascular disorders/drug therapy	6.604701641632627e-05	0	1	0.6431935215825413	0.0001359725859724	0.0847457627118643
apoptosis/drug effects	cyclin-dependent kinase inhibitor p21/antagonists & inhibitors	0.0037717988488256	0	1	0.6431935215825413	0.0059578527683394	0.0847457627118643
apoptosis/drug effects	mammary neoplasms animal/drug therapy	0.0012608286884825	0	1	0.6431935215825413	0.0021580675092994	0.0847457627118643
apoptosis/drug effects	proanthocyanidins/metabolism	0.0057173262133574	0	1	0.6431935215825413	0.0087529156888754	0.0847457627118643
apoptosis/drug effects	reactive oxygen species/antagonists & inhibitors	0.0057173262133574	0	1	0.6431935215825413	0.0087529156888754	0.1629726205997385
apoptosis/drug effects	endoplasmic reticulum stress/drug effects	0.0037717988488256	0	1	0.6431935215825413	0.0059578527683394	0.0847457627118643
apoptosis/drug effects	lung neoplasms/drug therapy	0.0005988108866488	0	1	0.6431935215825413	0.0010731906769546	0.0847457627118643
apoptosis/drug effects	phenylurea compounds/administration & dosage	0.0037717988488256	0	1	0.6431935215825413	0.0059578527683394	0.0847457627118641
apoptosis/drug effects	chlorophyllides/metabolism	0.0005988108866488	0	1	0.6431935215825413	0.0010731906769546	0.0847457627118641
apoptosis/drug effects	organoids/drug effects	0.0057173262133574	0	1	0.6431935215825413	0.0087529156888754	0.0847457627118641
apoptosis/drug effects	diterpenes/pharmacology	0.0057173262133574	0	1	0.6431935215825413	0.0087529156888754	0.0847457627118641
apoptosis/drug effects	neuroendocrine tumors/drug therapy	0.0037717988488256	0	1	0.6431935215825413	0.0059578527683394	0.0847457627118641
apoptosis/drug effects	BLVRB	6.604701641632627e-05	0	1	0.6431935215825413	0.0001359725859724	0.0847457627118641
apoptosis/drug effects	niacinamide/administration & dosage	0.0037717988488256	0	1	0.6431935215825413	0.0059578527683394	0.0847457627118643
apoptosis/drug effects	neuroprotective agents/administration & dosage	6.604701641632627e-05	0	1	0.6431935215825413	0.0001359725859724	0.0847457627118643
nih 3t3 cells	chlorophyllides	7.49900141983062e-12	0	1	0.6431935215825413	3.1233020443448376e-11	0.0254237288135593
nih 3t3 cells	porphyrins	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
nih 3t3 cells	hypoxia/drug therapy	3.1553648582871574e-12	0	1	0.6431935215825413	1.4106507297645243e-11	0.0254237288135593
antineoplastic agents/therapeutic use	melanoma/drug therapy	0.0009701044822025	0	1	0.6431935215825413	0.0016871231769354	0.0991023393127429
antineoplastic agents/therapeutic use	homeostasis	9.634910654232608e-05	0	1	0.6431935215825413	0.000194494281765	0.0991023393127427
antineoplastic agents/therapeutic use	reactive oxygen species	0.0005216203689482	0	1	0.6431935215825413	0.0009466875448359	0.1304379101192554
antineoplastic agents/therapeutic use	skin neoplasms/drug therapy	5.996304603850256e-06	0	1	0.6431935215825413	1.3603348386667735e-05	0.0669274228596261
antineoplastic agents/therapeutic use	histones/genetics	2.601095426824074e-07	0	1	0.6431935215825413	6.832958498605774e-07	0.0338983050847457
antineoplastic agents/therapeutic use	glutathione/antagonists & inhibitors	2.601095426824074e-07	0	1	0.6431935215825413	6.832958498605774e-07	0.0338983050847457
antineoplastic agents/therapeutic use	neoplastic stem cells/drug effects	2.3581137043038325e-13	0	1	0.6431935215825413	1.1221765704172437e-12	0.0338983050847457
antineoplastic agents/therapeutic use	cystine/antagonists & inhibitors	2.601095426824074e-07	0	1	0.6431935215825413	6.832958498605774e-07	0.0338983050847457
antineoplastic agents/therapeutic use	piperazines/therapeutic use	2.601095426824074e-07	0	1	0.6431935215825413	6.832958498605774e-07	0.0338983050847457
antineoplastic agents/therapeutic use	sulfasalazine/therapeutic use	2.601095426824074e-07	0	1	0.6431935215825413	6.832958498605774e-07	0.0338983050847457
antineoplastic agents/therapeutic use	glutamine/antagonists & inhibitors	2.601095426824074e-07	0	1	0.6431935215825413	6.832958498605774e-07	0.0338983050847457
antineoplastic agents/therapeutic use	amino acid transport system y+/antagonists & inhibitors	2.601095426824074e-07	0	1	0.6431935215825413	6.832958498605774e-07	0.0338983050847457
antineoplastic agents/therapeutic use	cell differentiation	2.3581137043038325e-13	0	1	0.6431935215825413	1.1221765704172437e-12	0.0338983050847457
antineoplastic agents/therapeutic use	sorafenib/therapeutic use	2.601095426824074e-07	0	1	0.6431935215825413	6.832958498605774e-07	0.0338983050847457
antineoplastic agents/therapeutic use	glucose/antagonists & inhibitors	2.601095426824074e-07	0	1	0.6431935215825413	6.832958498605774e-07	0.0338983050847457
cell differentiation	reactive oxygen species/metabolism	0.0023324532785861	0	1	0.6431935215825413	0.0038000818544132	0.144067796610169
cell differentiation	homeostasis	7.771561172376097e-16	0	1	0.6431935215825413	5.694859788419355e-15	0.0254237288135593
cell differentiation	neoplastic stem cells/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hydrogen peroxide/pharmacology	tumor microenvironment	1.4421568432787524e-05	0	1	0.6431935215825413	3.147169859962992e-05	0.1101694915254238
hydrogen peroxide/pharmacology	oxygen	7.771561172376097e-16	0	1	0.6431935215825413	5.694859788419355e-15	0.0254237288135593
hydrogen peroxide/pharmacology	photosensitizing agents	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
hydrogen peroxide/pharmacology	metal-organic frameworks/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
chlorophyllides	glutathione/metabolism	4.86782468833713e-06	0	2	0.3223370757289844	1.118383295910742e-05	0.0063690449429783
chlorophyllides	metal-organic frameworks/chemistry	1.1128253873948779e-10	0	1	0.6431935215825413	4.1112950058947987e-10	0.0254237288135593
chlorophyllides	mammary neoplasms animal/drug therapy	1.1128253873948779e-10	0	1	0.6431935215825413	4.1112950058947987e-10	0.0254237288135593
chlorophyllides	hemin/chemistry	2.512418173505893e-08	0	1	0.6431935215825413	7.75856385265793e-08	0.0254237288135593
chlorophyllides	hydroxyl radical/metabolism	2.512418173505893e-08	0	1	0.6431935215825413	7.75856385265793e-08	0.0254237288135593
chlorophyllides	photosensitizing agents/administration & dosage	0.0002455556069622	0	1	0.6431935215825413	0.0004654190870194	0.0749711519729055
chlorophyllides	human umbilical vein endothelial cells	2.512418173505893e-08	0	1	0.6431935215825413	7.75856385265793e-08	0.0254237288135593
chlorophyllides	porphyrins	7.49900141983062e-12	0	1	0.6431935215825413	3.1233020443448376e-11	0.0254237288135593
chlorophyllides	hypoxia/drug therapy	0.0003211920873409	0	1	0.6431935215825413	0.0005996816251388	0.0749711519729055
chlorophyllides	porphyrins/administration & dosage	1.072699773496666e-05	0	1	0.6431935215825413	2.384701640624659e-05	0.0504128639721861
chlorophyllides	oxygen/metabolism	2.512418173505893e-08	0	1	0.6431935215825413	7.75856385265793e-08	0.0254237288135593
chlorophyllides	PEBP1	2.512418173505893e-08	0	1	0.6431935215825413	7.75856385265793e-08	0.0254237288135593
chlorophyllides	XAB2	2.512418173505893e-08	0	1	0.6431935215825413	7.75856385265793e-08	0.0254237288135593
chlorophyllides/administration & dosage	photosensitizing agents/administration & dosage	1.2460033005368132e-12	0	1	0.6431935215825413	5.627223432359491e-12	0.0254237288135593
chlorophyllides/administration & dosage	reactive oxygen species	1.683175820943461e-11	0	1	0.6431935215825413	6.818051351169979e-11	0.0338983050847457
chlorophyllides/administration & dosage	carbolines/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
chlorophyllides/administration & dosage	piperazines/administration & dosage	3.1553648582871574e-12	0	1	0.6431935215825413	1.4106507297645243e-11	0.0254237288135593
chlorophyllides/administration & dosage	sorafenib	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
neoplastic stem cells/drug effects	reactive oxygen species/metabolism	0.0023324532785861	0	1	0.6431935215825413	0.0038000818544132	0.144067796610169
neoplastic stem cells/drug effects	homeostasis	7.771561172376097e-16	0	1	0.6431935215825413	5.694859788419355e-15	0.0254237288135593
doxorubicin/pharmacology	tumor microenvironment	2.248556896233822e-11	0	1	0.6431935215825413	9.063041981263369e-11	0.1101694915254237
reactive oxygen species	gene expression regulation neoplastic/drug effects	0.0022985782424915	0	1	0.6431935215825413	0.0037688330335334	0.0991023393127429
reactive oxygen species	photosensitizing agents/administration & dosage	0.0003154877109791	0	1	0.6431935215825413	0.0005892570393258	0.0991023393127429
reactive oxygen species	antineoplastic agents	0.0001765303011255	0	1	0.6431935215825413	0.0003450590282329	0.0669274228596261
reactive oxygen species	cytosol/metabolism	4.157156320294675e-07	0	1	0.6431935215825413	1.0523544285088806e-06	0.0338983050847457
reactive oxygen species	alcohol oxidoreductases/genetics	4.157156320294675e-07	0	1	0.6431935215825413	1.0523544285088806e-06	0.0338983050847457
reactive oxygen species	carbolines/administration & dosage	8.665466092794283e-06	0	1	0.6431935215825413	1.940570600651955e-05	0.0669274228596264
reactive oxygen species	deoxycytidine/analogs & derivatives	4.157156320294675e-07	0	1	0.6431935215825413	1.0523544285088806e-06	0.0338983050847457
reactive oxygen species	piperazines/administration & dosage	0.0004092087658349	0	1	0.6431935215825413	0.0007499339285121	0.0991023393127429
reactive oxygen species	flavonoids/pharmacology	4.157156320294675e-07	0	1	0.6431935215825413	1.0523544285088806e-06	0.0338983050847457
reactive oxygen species	pancreatic neoplasms	4.157156320294675e-07	0	1	0.6431935215825413	1.0523544285088806e-06	0.0338983050847457
reactive oxygen species	sorafenib	1.683175820943461e-11	0	1	0.6431935215825413	6.818051351169979e-11	0.0338983050847457
reactive oxygen species	CBR1	4.157156320294675e-07	0	1	0.6431935215825413	1.0523544285088806e-06	0.0338983050847457
lipid metabolism/drug effects	reactive oxygen species/antagonists & inhibitors	0.0	0	1	0.6431935215825413	0.0	0.0337534405331015
lipid metabolism/drug effects	antineoplastic agents/administration & dosage	8.4546925016582e-10	0	1	0.6431935215825413	2.953384699683184e-09	0.0832971171954223
lipid metabolism/drug effects	pyroptosis/drug effects	1.5576429035490946e-13	0	1	0.6431935215825413	7.470860107278287e-13	0.0504128639721861
lipid metabolism/drug effects	drug resistance neoplasm/drug effects	7.141548729572289e-05	0	1	0.6431935215825413	0.0001462831734308	0.1156019122120817
oxidants/chemistry	photosensitizing agents/chemistry	8.4546925016582e-10	0	1	0.6431935215825413	2.953384699683184e-09	0.0423728813559322
oxidants/chemistry	reactive oxygen species/chemistry	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
porphyrins	hypoxia/drug therapy	3.1553648582871574e-12	0	1	0.6431935215825413	1.4106507297645243e-11	0.0254237288135593
doxorubicin/therapeutic use	tumor microenvironment	2.248556896233822e-11	0	1	0.6431935215825413	9.063041981263369e-11	0.1101694915254237
oxygen	photosensitizing agents/chemistry	0.0028023171301814	0	1	0.6431935215825413	0.0045187595550542	0.122810172488723
oxygen	hypoxia/drug therapy	7.141548729572289e-05	0	1	0.6431935215825413	0.0001462831734308	0.0749711519729055
oxygen	dna catalytic	8.4546925016582e-10	0	1	0.6431935215825413	2.953384699683184e-09	0.0254237288135593
oxygen	catalase	8.4546925016582e-10	0	1	0.6431935215825413	2.953384699683184e-09	0.0254237288135593
oxygen	hypoxia-inducible factor 1 alpha subunit	8.4546925016582e-10	0	1	0.6431935215825413	2.953384699683184e-09	0.0254237288135593
oxygen	hydrogen peroxide	8.4546925016582e-10	0	1	0.6431935215825413	2.953384699683184e-09	0.0254237288135593
oxygen	photosensitizing agents	1.422558737473878e-10	0	1	0.6431935215825413	5.251612672507733e-10	0.0504128639721861
oxygen	erythrocytes	0.0	0	1	0.6431935215825413	0.0	0.0254237288135593
oxygen	metal-organic frameworks/pharmacology	1.2188883344865786e-06	0	1	0.6431935215825413	2.9158776897167883e-06	0.0504128639721861
oxygen	hemin	8.4546925016582e-10	0	1	0.6431935215825413	2.953384699683184e-09	0.0254237288135593
oxygen	HIF1A	8.4546925016582e-10	0	1	0.6431935215825413	2.953384699683184e-09	0.0254237288135593
oxygen	NCL	8.4546925016582e-10	0	1	0.6431935215825413	2.953384699683184e-09	0.0254237288135593
reactive oxygen species/chemistry	photosensitizing agents/chemistry	8.4546925016582e-10	0	1	0.6431935215825413	2.953384699683184e-09	0.0423728813559322
iron overload/drug therapy	TF	1.2234853324355475e-05	0	1	0.6431935215825413	2.6965373247211323e-05	0.059322033898305
iron overload/drug therapy	antineoplastic agents/administration & dosage	1.2460033005368132e-12	0	1	0.6431935215825413	5.627223432359491e-12	0.0423728813559322
iron overload/drug therapy	TFRC	0.0	0	1	0.6431935215825413	0.0	0.0254237288135593
metal-organic frameworks/pharmacology	photosensitizing agents	5.215827769688985e-13	0	1	0.6431935215825413	2.4322228441812848e-12	0.0337534405331015
metal-organic frameworks/pharmacology	tumor microenvironment/drug effects	3.209811953563957e-06	0	1	0.6431935215825413	7.483929975941226e-06	0.0337534405331015
metal-organic frameworks/pharmacology	ferric compounds/chemistry	9.950676027603579e-08	0	1	0.6431935215825413	2.6760289339134786e-07	0.0337534405331015
metal-organic frameworks/pharmacology	gallic acid/chemistry	4.9010795422077535e-12	0	1	0.6431935215825413	2.066000052697092e-11	0.0169491525423728
metal-organic frameworks/pharmacology	zeolites/chemistry	4.9010795422077535e-12	0	1	0.6431935215825413	2.066000052697092e-11	0.0169491525423728
metal-organic frameworks/pharmacology	tumor hypoxia/drug effects	4.9010795422077535e-12	0	1	0.6431935215825413	2.066000052697092e-11	0.0169491525423728
metal-organic frameworks/pharmacology	azo compounds/chemistry	4.9010795422077535e-12	0	1	0.6431935215825413	2.066000052697092e-11	0.0169491525423728
metal-organic frameworks/pharmacology	glucose oxidase/chemistry	4.9010795422077535e-12	0	1	0.6431935215825413	2.066000052697092e-11	0.0169491525423728
metal-organic frameworks/pharmacology	mcf-7 cells	7.060305533546085e-07	0	1	0.6431935215825413	1.7679788728144949e-06	0.0504128639721861
antineoplastic agents/adverse effects	pyroptosis/drug effects	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0504128639721861
antineoplastic agents/adverse effects	breast neoplasms/drug therapy	1.1128253873948779e-10	0	1	0.6431935215825413	4.1112950058947987e-10	0.0669274228596264
antineoplastic agents/adverse effects	necroptosis/drug effects	7.507579002918874e-09	0	1	0.6431935215825413	2.432475563911148e-08	0.0669274228596264
antineoplastic agents/adverse effects	intracellular signaling peptides and proteins/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
sorafenib	photosensitizing agents/administration & dosage	1.2460033005368132e-12	0	1	0.6431935215825413	5.627223432359491e-12	0.0254237288135593
sorafenib	carbolines/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
sorafenib	piperazines/administration & dosage	3.1553648582871574e-12	0	1	0.6431935215825413	1.4106507297645243e-11	0.0254237288135593
colitis/drug therapy	gastritis	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
FTH1	folic acid/analogs & derivatives	0.0005722347310298	0	1	0.6431935215825413	0.0010320132658432	0.0338983050847457
FTH1	quassins/chemistry	0.0005722347310298	0	1	0.6431935215825413	0.0010320132658432	0.0338983050847457
FTH1	sesquiterpenes/administration & dosage	0.0055414834654826	0	1	0.6431935215825413	0.0085024083524234	0.0338983050847457
FTH1	erbb receptors/antagonists & inhibitors	0.0055414834654826	0	1	0.6431935215825413	0.0085024083524234	0.0338983050847457
FTH1	cetuximab/administration & dosage	0.0055414834654826	0	1	0.6431935215825413	0.0085024083524234	0.0338983050847457
FTH1	alcohol oxidoreductases/genetics	0.0005722347310298	0	1	0.6431935215825413	0.0010320132658432	0.0338983050847457
FTH1	pancreatic neoplasms/drug therapy	0.0005722347310298	0	1	0.6431935215825413	0.0010320132658432	0.0338983050847457
FTH1	cytosol/metabolism	0.0005722347310298	0	1	0.6431935215825413	0.0010320132658432	0.0338983050847457
FTH1	indoles/chemistry	0.0005722347310298	0	1	0.6431935215825413	0.0010320132658432	0.0338983050847457
FTH1	chlorophyllides/chemistry	0.0005722347310298	0	1	0.6431935215825413	0.0010320132658432	0.0338983050847457
FTH1	deoxycytidine/analogs & derivatives	0.0005722347310298	0	1	0.6431935215825413	0.0010320132658432	0.0338983050847457
FTH1	pancreatic neoplasms	0.0005722347310298	0	1	0.6431935215825413	0.0010320132658432	0.0338983050847457
FTH1	nf-e2-related factor 2/antagonists & inhibitors	0.0005722347310298	0	1	0.6431935215825413	0.0010320132658432	0.0338983050847457
FTH1	CBR1	0.0005722347310298	0	1	0.6431935215825413	0.0010320132658432	0.0338983050847457
FTH1	flavonoids/pharmacology	0.0005722347310298	0	1	0.6431935215825413	0.0010320132658432	0.0338983050847457
FTH1	CDH1	0.0055414834654826	0	1	0.6431935215825413	0.0085024083524234	0.0338983050847457
FTH1	CDH2	0.0055414834654826	0	1	0.6431935215825413	0.0085024083524234	0.0338983050847457
FTH1	GLS	0.0055414834654826	0	1	0.6431935215825413	0.0085024083524234	0.0338983050847457
FTH1	MMP9	0.0055414834654826	0	1	0.6431935215825413	0.0085024083524234	0.0338983050847457
FTH1	SLC40A1	0.0055414834654826	0	1	0.6431935215825413	0.0085024083524234	0.0338983050847457
FTH1	VIM	0.0055414834654826	0	1	0.6431935215825413	0.0085024083524234	0.0338983050847457
FTH1	proto-oncogene proteins p21(ras)/genetics	0.0055414834654826	0	1	0.6431935215825413	0.0085024083524234	0.0338983050847457
piperazines/pharmacology	tumor necrosis factor inhibitors/pharmacology	1.691390996205744e-05	0	1	0.6431935215825413	3.6453552961126e-05	0.0338983050847457
piperazines/pharmacology	fibroblasts/cytology	1.691390996205744e-05	0	1	0.6431935215825413	3.6453552961126e-05	0.0338983050847457
piperazines/pharmacology	fusion regulatory protein 1 heavy chain/metabolism	0.0001274847587391	0	1	0.6431935215825413	0.0002516132966123	0.0338983050847457
piperazines/pharmacology	protein isoforms/genetics	2.286392930761494e-06	0	1	0.6431935215825413	5.411166950753161e-06	0.0338983050847457
piperazines/pharmacology	imidazoles/pharmacology	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.0669274228596261
piperazines/pharmacology	prostatic neoplasms castration-resistant/drug therapy	0.0034576698058652	0	1	0.6431935215825413	0.0055062826679677	0.0669274228596261
piperazines/pharmacology	etanercept/pharmacology	1.691390996205744e-05	0	1	0.6431935215825413	3.6453552961126e-05	0.0338983050847457
piperazines/pharmacology	androstenes/pharmacology	0.0001274847587391	0	1	0.6431935215825413	0.0002516132966123	0.0338983050847457
piperazines/pharmacology	amino acid transport system y+/metabolism	0.0028023171301814	0	1	0.6431935215825413	0.0045187595550542	0.0669274228596264
piperazines/pharmacology	arthritis rheumatoid/genetics	1.691390996205744e-05	0	1	0.6431935215825413	3.6453552961126e-05	0.0338983050847457
piperazines/pharmacology	receptors androgen/genetics	2.286392930761494e-06	0	1	0.6431935215825413	5.411166950753161e-06	0.0338983050847457
piperazines/pharmacology	docetaxel/pharmacology	2.286392930761494e-06	0	1	0.6431935215825413	5.411166950753161e-06	0.0338983050847457
piperazines/pharmacology	prostatic neoplasms castration-resistant/diagnosis	0.0001274847587391	0	1	0.6431935215825413	0.0002516132966123	0.0338983050847457
piperazines/pharmacology	phenylthiohydantoin/pharmacology	0.0001274847587391	0	1	0.6431935215825413	0.0002516132966123	0.0338983050847457
piperazines/pharmacology	carbolines/pharmacology	0.0001274847587391	0	1	0.6431935215825413	0.0002516132966123	0.0338983050847457
piperazines/pharmacology	prostate/pathology	0.0001274847587391	0	1	0.6431935215825413	0.0002516132966123	0.0338983050847457
piperazines/pharmacology	nitriles/pharmacology	0.0001274847587391	0	1	0.6431935215825413	0.0002516132966123	0.0338983050847457
piperazines/pharmacology	androgen antagonists/pharmacology	0.0001274847587391	0	1	0.6431935215825413	0.0002516132966123	0.0338983050847457
piperazines/pharmacology	benzamides/pharmacology	0.0001274847587391	0	1	0.6431935215825413	0.0002516132966123	0.0338983050847457
piperazines/pharmacology	ketones/pharmacology	1.691390996205744e-05	0	1	0.6431935215825413	3.6453552961126e-05	0.0338983050847457
piperazines/pharmacology	synovial membrane/cytology	1.691390996205744e-05	0	1	0.6431935215825413	3.6453552961126e-05	0.0338983050847457
piperazines/pharmacology	SLC3A2	0.0001274847587391	0	1	0.6431935215825413	0.0002516132966123	0.0338983050847457
piperazines/pharmacology	TNF	0.0042006311134247	0	1	0.6431935215825413	0.0065544910072746	0.0669274228596264
tumor necrosis factor inhibitors/pharmacology	glutathione/metabolism	0.0002385648205763	0	1	0.6431935215825413	0.000452520969509	0.0508474576271186
tumor necrosis factor inhibitors/pharmacology	cells cultured	8.679791325683084e-07	0	1	0.6431935215825413	2.104309608460381e-06	0.0254237288135593
tumor necrosis factor inhibitors/pharmacology	fibroblasts/cytology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
tumor necrosis factor inhibitors/pharmacology	imidazoles/pharmacology	5.145583958920952e-11	0	1	0.6431935215825413	2.0107803233217158e-10	0.0169491525423728
tumor necrosis factor inhibitors/pharmacology	etanercept/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
tumor necrosis factor inhibitors/pharmacology	arthritis rheumatoid/genetics	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
tumor necrosis factor inhibitors/pharmacology	ketones/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
tumor necrosis factor inhibitors/pharmacology	synovial membrane/cytology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
tumor necrosis factor inhibitors/pharmacology	TNF	3.831546191435109e-09	0	1	0.6431935215825413	1.2649813408443961e-08	0.0169491525423728
fibroblasts/cytology	glutathione/metabolism	0.0002385648205763	0	1	0.6431935215825413	0.000452520969509	0.0508474576271186
fibroblasts/cytology	cells cultured	8.679791325683084e-07	0	1	0.6431935215825413	2.104309608460381e-06	0.0254237288135593
fibroblasts/cytology	imidazoles/pharmacology	5.145583958920952e-11	0	1	0.6431935215825413	2.0107803233217158e-10	0.0169491525423728
fibroblasts/cytology	etanercept/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
fibroblasts/cytology	arthritis rheumatoid/genetics	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
fibroblasts/cytology	ketones/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
fibroblasts/cytology	synovial membrane/cytology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
fibroblasts/cytology	TNF	3.831546191435109e-09	0	1	0.6431935215825413	1.2649813408443961e-08	0.0169491525423728
fusion regulatory protein 1 heavy chain/metabolism	phospholipid hydroperoxide glutathione peroxidase/metabolism	1.1568873169554015e-05	0	1	0.6431935215825413	2.5509103599654628e-05	0.0338983050847457
fusion regulatory protein 1 heavy chain/metabolism	amino acid transport system y+/metabolism	4.3302904817466015e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0169491525423728
fusion regulatory protein 1 heavy chain/metabolism	drug resistance neoplasm/drug effects	0.004400314041403	0	1	0.6431935215825413	0.0068050556406718	0.0593220338983051
fusion regulatory protein 1 heavy chain/metabolism	androstenes/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
fusion regulatory protein 1 heavy chain/metabolism	prostatic neoplasms castration-resistant/diagnosis	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
fusion regulatory protein 1 heavy chain/metabolism	phenylthiohydantoin/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
fusion regulatory protein 1 heavy chain/metabolism	carbolines/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
fusion regulatory protein 1 heavy chain/metabolism	prostate/pathology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
fusion regulatory protein 1 heavy chain/metabolism	nitriles/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
fusion regulatory protein 1 heavy chain/metabolism	androgen antagonists/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
fusion regulatory protein 1 heavy chain/metabolism	benzamides/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
fusion regulatory protein 1 heavy chain/metabolism	SLC3A2	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
protein isoforms/genetics	cell survival/drug effects	0.0001765303011255	0	1	0.6431935215825413	0.0003450590282329	0.0593220338983051
protein isoforms/genetics	gene expression regulation neoplastic/drug effects	6.637322425007143e-08	0	1	0.6431935215825413	1.822178714200552e-07	0.0254237288135593
protein isoforms/genetics	prostatic neoplasms castration-resistant/drug therapy	4.3028025586977485e-11	0	1	0.6431935215825413	1.7116372953905412e-10	0.0169491525423728
protein isoforms/genetics	receptors androgen/genetics	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
protein isoforms/genetics	docetaxel/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
imidazoles/pharmacology	glutathione/metabolism	0.0063896485175681	0	1	0.6431935215825413	0.0097607389423541	0.099521946979574
imidazoles/pharmacology	cells cultured	0.0002317229095878	0	1	0.6431935215825413	0.0004428179366358	0.0504128639721861
imidazoles/pharmacology	myocardial infarction/metabolism	3.0420110874729296e-14	0	1	0.6431935215825413	1.9764960039007447e-13	0.0169491525423728
imidazoles/pharmacology	cell line	0.0028407588071802	0	1	0.6431935215825413	0.0045792317788254	0.0832971171954222
imidazoles/pharmacology	myocytes cardiac/drug effects	3.0420110874729296e-14	0	1	0.6431935215825413	1.9764960039007447e-13	0.0169491525423728
imidazoles/pharmacology	etanercept/pharmacology	5.145583958920952e-11	0	1	0.6431935215825413	2.0107803233217158e-10	0.0169491525423728
imidazoles/pharmacology	deferoxamine/pharmacology	3.0420110874729296e-14	0	1	0.6431935215825413	1.9764960039007447e-13	0.0169491525423728
imidazoles/pharmacology	myocardial reperfusion injury/metabolism	3.0420110874729296e-14	0	1	0.6431935215825413	1.9764960039007447e-13	0.0169491525423728
imidazoles/pharmacology	arthritis rheumatoid/genetics	5.145583958920952e-11	0	1	0.6431935215825413	2.0107803233217158e-10	0.0169491525423728
imidazoles/pharmacology	pyridazines/pharmacology	3.0420110874729296e-14	0	1	0.6431935215825413	1.9764960039007447e-13	0.0169491525423728
imidazoles/pharmacology	necroptosis/drug effects	0.0001878376937263	0	1	0.6431935215825413	0.0003670140663706	0.0669274228596261
imidazoles/pharmacology	ketones/pharmacology	5.145583958920952e-11	0	1	0.6431935215825413	2.0107803233217158e-10	0.0169491525423728
imidazoles/pharmacology	synovial membrane/cytology	5.145583958920952e-11	0	1	0.6431935215825413	2.0107803233217158e-10	0.0169491525423728
imidazoles/pharmacology	TNF	9.74542915177512e-06	0	1	0.6431935215825413	2.1724371572095223e-05	0.0337534405331015
prostatic neoplasms castration-resistant/drug therapy	cell survival/drug effects	4.562312156286552e-06	0	2	0.3223370757289844	1.050172278582162e-05	0.0030421555845284
prostatic neoplasms castration-resistant/drug therapy	gene expression regulation neoplastic/drug effects	0.0007823483151576	0	1	0.6431935215825413	0.0013853137135767	0.0504128639721861
prostatic neoplasms castration-resistant/drug therapy	tumor suppressor protein p53/genetics	8.148486618786421e-08	0	1	0.6431935215825413	2.213354252694885e-07	0.0169491525423728
prostatic neoplasms castration-resistant/drug therapy	receptors androgen/genetics	4.3028025586977485e-11	0	1	0.6431935215825413	1.7116372953905412e-10	0.0169491525423728
prostatic neoplasms castration-resistant/drug therapy	docetaxel/pharmacology	4.3028025586977485e-11	0	1	0.6431935215825413	1.7116372953905412e-10	0.0169491525423728
prostatic neoplasms castration-resistant/drug therapy	anthelmintics/pharmacology	8.148486618786421e-08	0	1	0.6431935215825413	2.213354252694885e-07	0.0169491525423728
prostatic neoplasms castration-resistant/drug therapy	cell cycle/drug effects	8.148486618786421e-08	0	1	0.6431935215825413	2.213354252694885e-07	0.0169491525423728
prostatic neoplasms castration-resistant/drug therapy	mebendazole/analogs & derivatives	8.148486618786421e-08	0	1	0.6431935215825413	2.213354252694885e-07	0.0169491525423728
prostatic neoplasms castration-resistant/drug therapy	fluorouracil/pharmacology	0.0001010832823041	0	1	0.6431935215825413	0.0002030415641666	0.0337534405331015
prostatic neoplasms castration-resistant/drug therapy	TP53	8.148486618786421e-08	0	1	0.6431935215825413	2.213354252694885e-07	0.0169491525423728
etanercept/pharmacology	glutathione/metabolism	0.0002385648205763	0	1	0.6431935215825413	0.000452520969509	0.0508474576271186
etanercept/pharmacology	cells cultured	8.679791325683084e-07	0	1	0.6431935215825413	2.104309608460381e-06	0.0254237288135593
etanercept/pharmacology	arthritis rheumatoid/genetics	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
etanercept/pharmacology	ketones/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
etanercept/pharmacology	synovial membrane/cytology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
etanercept/pharmacology	TNF	3.831546191435109e-09	0	1	0.6431935215825413	1.2649813408443961e-08	0.0169491525423728
androstenes/pharmacology	phospholipid hydroperoxide glutathione peroxidase/metabolism	1.1568873169554015e-05	0	1	0.6431935215825413	2.5509103599654628e-05	0.0338983050847457
androstenes/pharmacology	amino acid transport system y+/metabolism	4.3302904817466015e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0169491525423728
androstenes/pharmacology	drug resistance neoplasm/drug effects	0.004400314041403	0	1	0.6431935215825413	0.0068050556406718	0.0593220338983051
androstenes/pharmacology	prostatic neoplasms castration-resistant/diagnosis	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
androstenes/pharmacology	phenylthiohydantoin/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
androstenes/pharmacology	carbolines/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
androstenes/pharmacology	prostate/pathology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
androstenes/pharmacology	nitriles/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
androstenes/pharmacology	androgen antagonists/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
androstenes/pharmacology	benzamides/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
androstenes/pharmacology	SLC3A2	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
amino acid transport system y+/metabolism	phospholipid hydroperoxide glutathione peroxidase/metabolism	0.0005988108866488	0	1	0.6431935215825413	0.0010731906769546	0.0669274228596261
amino acid transport system y+/metabolism	biological transport	1.2460033005368132e-12	0	1	0.6431935215825413	5.627223432359491e-12	0.0169491525423728
amino acid transport system y+/metabolism	glutathione disulfide/deficiency	1.2460033005368132e-12	0	1	0.6431935215825413	5.627223432359491e-12	0.0169491525423728
amino acid transport system y+/metabolism	carcinoma renal cell/drug therapy	1.2188883344865786e-06	0	1	0.6431935215825413	2.9158776897167883e-06	0.0337534405331015
amino acid transport system y+/metabolism	prostatic neoplasms castration-resistant/diagnosis	4.3302904817466015e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0169491525423728
amino acid transport system y+/metabolism	phenylthiohydantoin/pharmacology	4.3302904817466015e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0169491525423728
amino acid transport system y+/metabolism	carbolines/pharmacology	4.3302904817466015e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0169491525423728
amino acid transport system y+/metabolism	cystine/metabolism	1.2460033005368132e-12	0	1	0.6431935215825413	5.627223432359491e-12	0.0169491525423728
amino acid transport system y+/metabolism	prostate/pathology	4.3302904817466015e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0169491525423728
amino acid transport system y+/metabolism	nitriles/pharmacology	4.3302904817466015e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0169491525423728
amino acid transport system y+/metabolism	androgen antagonists/pharmacology	4.3302904817466015e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0169491525423728
amino acid transport system y+/metabolism	gamma-glutamyltransferase/metabolism	1.2460033005368132e-12	0	1	0.6431935215825413	5.627223432359491e-12	0.0169491525423728
amino acid transport system y+/metabolism	benzamides/pharmacology	4.3302904817466015e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0169491525423728
amino acid transport system y+/metabolism	GGT1	1.2460033005368132e-12	0	1	0.6431935215825413	5.627223432359491e-12	0.0169491525423728
amino acid transport system y+/metabolism	SLC3A2	4.3302904817466015e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0169491525423728
arthritis rheumatoid/genetics	glutathione/metabolism	0.0002385648205763	0	1	0.6431935215825413	0.000452520969509	0.0508474576271186
arthritis rheumatoid/genetics	cells cultured	8.679791325683084e-07	0	1	0.6431935215825413	2.104309608460381e-06	0.0254237288135593
arthritis rheumatoid/genetics	ketones/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
arthritis rheumatoid/genetics	synovial membrane/cytology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
arthritis rheumatoid/genetics	TNF	3.831546191435109e-09	0	1	0.6431935215825413	1.2649813408443961e-08	0.0169491525423728
receptors androgen/genetics	cell survival/drug effects	0.0001765303011255	0	1	0.6431935215825413	0.0003450590282329	0.0593220338983051
receptors androgen/genetics	gene expression regulation neoplastic/drug effects	6.637322425007143e-08	0	1	0.6431935215825413	1.822178714200552e-07	0.0254237288135593
receptors androgen/genetics	docetaxel/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
docetaxel/pharmacology	cell survival/drug effects	0.0001765303011255	0	1	0.6431935215825413	0.0003450590282329	0.0593220338983051
docetaxel/pharmacology	gene expression regulation neoplastic/drug effects	6.637322425007143e-08	0	1	0.6431935215825413	1.822178714200552e-07	0.0254237288135593
prostatic neoplasms castration-resistant/diagnosis	phospholipid hydroperoxide glutathione peroxidase/metabolism	1.1568873169554015e-05	0	1	0.6431935215825413	2.5509103599654628e-05	0.0338983050847457
prostatic neoplasms castration-resistant/diagnosis	drug resistance neoplasm/drug effects	0.004400314041403	0	1	0.6431935215825413	0.0068050556406718	0.0593220338983051
prostatic neoplasms castration-resistant/diagnosis	phenylthiohydantoin/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
prostatic neoplasms castration-resistant/diagnosis	carbolines/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
prostatic neoplasms castration-resistant/diagnosis	prostate/pathology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
prostatic neoplasms castration-resistant/diagnosis	nitriles/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
prostatic neoplasms castration-resistant/diagnosis	androgen antagonists/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
prostatic neoplasms castration-resistant/diagnosis	benzamides/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
prostatic neoplasms castration-resistant/diagnosis	SLC3A2	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
phenylthiohydantoin/pharmacology	phospholipid hydroperoxide glutathione peroxidase/metabolism	1.1568873169554015e-05	0	1	0.6431935215825413	2.5509103599654628e-05	0.0338983050847457
phenylthiohydantoin/pharmacology	drug resistance neoplasm/drug effects	0.004400314041403	0	1	0.6431935215825413	0.0068050556406718	0.0593220338983051
phenylthiohydantoin/pharmacology	carbolines/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
phenylthiohydantoin/pharmacology	prostate/pathology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
phenylthiohydantoin/pharmacology	nitriles/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
phenylthiohydantoin/pharmacology	androgen antagonists/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
phenylthiohydantoin/pharmacology	benzamides/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
phenylthiohydantoin/pharmacology	SLC3A2	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
carbolines/pharmacology	phospholipid hydroperoxide glutathione peroxidase/metabolism	1.1568873169554015e-05	0	1	0.6431935215825413	2.5509103599654628e-05	0.0338983050847457
carbolines/pharmacology	drug resistance neoplasm/drug effects	0.004400314041403	0	1	0.6431935215825413	0.0068050556406718	0.0593220338983051
carbolines/pharmacology	prostate/pathology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
carbolines/pharmacology	nitriles/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
carbolines/pharmacology	androgen antagonists/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
carbolines/pharmacology	benzamides/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
carbolines/pharmacology	SLC3A2	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
prostate/pathology	phospholipid hydroperoxide glutathione peroxidase/metabolism	1.1568873169554015e-05	0	1	0.6431935215825413	2.5509103599654628e-05	0.0338983050847457
prostate/pathology	drug resistance neoplasm/drug effects	0.004400314041403	0	1	0.6431935215825413	0.0068050556406718	0.0593220338983051
prostate/pathology	nitriles/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
prostate/pathology	androgen antagonists/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
prostate/pathology	benzamides/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
prostate/pathology	SLC3A2	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
nitriles/pharmacology	phospholipid hydroperoxide glutathione peroxidase/metabolism	1.1568873169554015e-05	0	1	0.6431935215825413	2.5509103599654628e-05	0.0338983050847457
nitriles/pharmacology	drug resistance neoplasm/drug effects	0.004400314041403	0	1	0.6431935215825413	0.0068050556406718	0.0593220338983051
nitriles/pharmacology	androgen antagonists/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
nitriles/pharmacology	benzamides/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
nitriles/pharmacology	SLC3A2	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
androgen antagonists/pharmacology	phospholipid hydroperoxide glutathione peroxidase/metabolism	1.1568873169554015e-05	0	1	0.6431935215825413	2.5509103599654628e-05	0.0338983050847457
androgen antagonists/pharmacology	drug resistance neoplasm/drug effects	0.004400314041403	0	1	0.6431935215825413	0.0068050556406718	0.0593220338983051
androgen antagonists/pharmacology	benzamides/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
androgen antagonists/pharmacology	SLC3A2	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
benzamides/pharmacology	phospholipid hydroperoxide glutathione peroxidase/metabolism	1.1568873169554015e-05	0	1	0.6431935215825413	2.5509103599654628e-05	0.0338983050847457
benzamides/pharmacology	drug resistance neoplasm/drug effects	0.004400314041403	0	1	0.6431935215825413	0.0068050556406718	0.0593220338983051
benzamides/pharmacology	SLC3A2	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
ketones/pharmacology	glutathione/metabolism	0.0002385648205763	0	1	0.6431935215825413	0.000452520969509	0.0508474576271186
ketones/pharmacology	cells cultured	8.679791325683084e-07	0	1	0.6431935215825413	2.104309608460381e-06	0.0254237288135593
ketones/pharmacology	synovial membrane/cytology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
ketones/pharmacology	TNF	3.831546191435109e-09	0	1	0.6431935215825413	1.2649813408443961e-08	0.0169491525423728
synovial membrane/cytology	glutathione/metabolism	0.0002385648205763	0	1	0.6431935215825413	0.000452520969509	0.0508474576271186
synovial membrane/cytology	cells cultured	8.679791325683084e-07	0	1	0.6431935215825413	2.104309608460381e-06	0.0254237288135593
synovial membrane/cytology	TNF	3.831546191435109e-09	0	1	0.6431935215825413	1.2649813408443961e-08	0.0169491525423728
SLC3A2	phospholipid hydroperoxide glutathione peroxidase/metabolism	1.1568873169554015e-05	0	1	0.6431935215825413	2.5509103599654628e-05	0.0338983050847457
SLC3A2	drug resistance neoplasm/drug effects	0.004400314041403	0	1	0.6431935215825413	0.0068050556406718	0.0593220338983051
TNF	oxidative stress/drug effects	0.0010020122946788	0	1	0.6431935215825413	0.0017314914581454	0.0669274228596264
TNF	cells cultured	0.0010020122946788	0	1	0.6431935215825413	0.0017314914581454	0.0504128639721861
TNF	phenylenediamines/administration & dosage	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
TNF	adenine/administration & dosage	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
TNF	cyclohexylamines/administration & dosage	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
TNF	bronchi/cytology	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
TNF	asthma/chemically induced	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
TNF	ovalbumin/adverse effects	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
TNF	interleukin-13/pharmacology	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
TNF	IL13	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
TNF	epithelial cells/drug effects	0.0001393995799914	0	1	0.6431935215825413	0.0002739089327815	0.0337534405331015
TNF	IL1B	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
TNF	IL6	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
dna catalytic	glutathione/metabolism	0.0002385648205763	0	1	0.6431935215825413	0.000452520969509	0.0508474576271186
dna catalytic	photosensitizing agents/chemistry	1.691390996205744e-05	0	1	0.6431935215825413	3.6453552961126e-05	0.0423728813559322
dna catalytic	hypoxia/drug therapy	1.4029182482389048e-08	0	1	0.6431935215825413	4.416292392550505e-08	0.0254237288135593
dna catalytic	catalase	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
dna catalytic	hypoxia-inducible factor 1 alpha subunit	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
dna catalytic	hydrogen peroxide	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
dna catalytic	hemin	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
dna catalytic	HIF1A	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
dna catalytic	NCL	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cd8-positive t-lymphocytes/metabolism	tumor microenvironment	0.0010679811251681	0	1	0.6431935215825413	0.0018409168811264	0.1101694915254238
cd8-positive t-lymphocytes/metabolism	CD274	2.286392930761494e-06	0	1	0.6431935215825413	5.411166950753161e-06	0.0338983050847457
cd8-positive t-lymphocytes/metabolism	chlorophyll	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cd8-positive t-lymphocytes/metabolism	urinary bladder neoplasms/drug therapy	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cd8-positive t-lymphocytes/metabolism	IDO1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cd8-positive t-lymphocytes/metabolism	NOC2L	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
deferoxamine	hemorrhage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
deferoxamine	stroke/prevention & control	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hydrogen peroxide	glutathione/metabolism	0.0002385648205763	0	1	0.6431935215825413	0.000452520969509	0.0508474576271186
hydrogen peroxide	photosensitizing agents/chemistry	1.691390996205744e-05	0	1	0.6431935215825413	3.6453552961126e-05	0.0423728813559322
hydrogen peroxide	hypoxia/drug therapy	1.4029182482389048e-08	0	1	0.6431935215825413	4.416292392550505e-08	0.0254237288135593
hydrogen peroxide	catalase	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hydrogen peroxide	hypoxia-inducible factor 1 alpha subunit	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hydrogen peroxide	hemin	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hydrogen peroxide	HIF1A	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hydrogen peroxide	NCL	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hemorrhage	stroke/prevention & control	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hypoxia/drug therapy	photosensitizing agents/chemistry	0.0059567918621721	0	1	0.6431935215825413	0.0091166604096623	0.122810172488723
hypoxia/drug therapy	catalase	1.4029182482389048e-08	0	1	0.6431935215825413	4.416292392550505e-08	0.0254237288135593
hypoxia/drug therapy	hypoxia-inducible factor 1 alpha subunit	1.4029182482389048e-08	0	1	0.6431935215825413	4.416292392550505e-08	0.0254237288135593
hypoxia/drug therapy	chlorophyllides/pharmacology	3.1553648582871574e-12	0	1	0.6431935215825413	1.4106507297645243e-11	0.0254237288135593
hypoxia/drug therapy	hemin	1.4029182482389048e-08	0	1	0.6431935215825413	4.416292392550505e-08	0.0254237288135593
hypoxia/drug therapy	oxygen/pharmacology	3.1553648582871574e-12	0	1	0.6431935215825413	1.4106507297645243e-11	0.0254237288135593
hypoxia/drug therapy	CD47	7.379537600549213e-06	0	1	0.6431935215825413	1.6579293097038412e-05	0.0504128639721861
hypoxia/drug therapy	HIF1A	1.4029182482389048e-08	0	1	0.6431935215825413	4.416292392550505e-08	0.0254237288135593
hypoxia/drug therapy	NCL	1.4029182482389048e-08	0	1	0.6431935215825413	4.416292392550505e-08	0.0254237288135593
hemin	glutathione/metabolism	0.0002385648205763	0	1	0.6431935215825413	0.000452520969509	0.0508474576271186
hemin	photosensitizing agents/chemistry	1.691390996205744e-05	0	1	0.6431935215825413	3.6453552961126e-05	0.0423728813559322
hemin	catalase	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hemin	hypoxia-inducible factor 1 alpha subunit	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hemin	HIF1A	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hemin	NCL	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
CD274	tumor microenvironment	0.0008250285131184	0	2	0.3223370757289844	0.0014545455660008	0.0595041462319685
CD274	hep g2 cells	0.0034576698058652	0	1	0.6431935215825413	0.0055062826679677	0.0991023393127427
CD274	b7-h1 antigen/metabolism	4.3302904817466015e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0338983050847457
CD274	kidney	4.3302904817466015e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0338983050847457
CD274	iron/chemistry	4.630460946586368e-05	0	1	0.6431935215825413	9.659347685237744e-05	0.0669274228596261
CD274	skin neoplasms/drug therapy	0.0001274847587391	0	1	0.6431935215825413	0.0002516132966123	0.0669274228596261
CD274	urinary bladder neoplasms/drug therapy	2.286392930761494e-06	0	1	0.6431935215825413	5.411166950753161e-06	0.0338983050847457
CD274	chlorophyll	2.286392930761494e-06	0	1	0.6431935215825413	5.411166950753161e-06	0.0338983050847457
CD274	tumor microenvironment/drug effects	0.001596705919183	0	1	0.6431935215825413	0.0026830165324754	0.0669274228596261
CD274	glioblastoma/drug therapy	4.630460946586368e-05	0	1	0.6431935215825413	9.659347685237744e-05	0.0669274228596261
CD274	hyaluronic acid/chemistry	1.269586845653592e-05	0	1	0.6431935215825413	2.7780407269285823e-05	0.0338983050847457
CD274	immunologic memory	1.269586845653592e-05	0	1	0.6431935215825413	2.7780407269285823e-05	0.0338983050847457
CD274	t-lymphocytes cytotoxic/drug effects	1.269586845653592e-05	0	1	0.6431935215825413	2.7780407269285823e-05	0.0338983050847457
CD274	cell line tumor/transplantation	1.269586845653592e-05	0	1	0.6431935215825413	2.7780407269285823e-05	0.0338983050847457
CD274	tumor escape/drug effects	1.269586845653592e-05	0	1	0.6431935215825413	2.7780407269285823e-05	0.0338983050847457
CD274	pharmaceutical preparations	1.5576429035490946e-13	0	1	0.6431935215825413	7.470860107278287e-13	0.0338983050847457
CD274	aniline compounds/pharmacology	1.269586845653592e-05	0	1	0.6431935215825413	2.7780407269285823e-05	0.0338983050847457
CD274	benzylidene compounds/pharmacology	1.269586845653592e-05	0	1	0.6431935215825413	2.7780407269285823e-05	0.0338983050847457
CD274	exosomes/drug effects	1.269586845653592e-05	0	1	0.6431935215825413	2.7780407269285823e-05	0.0338983050847457
CD274	b7-h1 antigen/antagonists & inhibitors	1.269586845653592e-05	0	1	0.6431935215825413	2.7780407269285823e-05	0.0338983050847457
CD274	IDO1	2.286392930761494e-06	0	1	0.6431935215825413	5.411166950753161e-06	0.0338983050847457
CD274	IFNG	0.0007555044762606	0	1	0.6431935215825413	0.0013397282797736	0.0991023393127429
CD274	NOC2L	2.286392930761494e-06	0	1	0.6431935215825413	5.411166950753161e-06	0.0338983050847457
CD274	PDCD1	1.5576429035490946e-13	0	1	0.6431935215825413	7.470860107278287e-13	0.0338983050847457
CD274	immune checkpoint inhibitors/pharmacology	1.269586845653592e-05	0	1	0.6431935215825413	2.7780407269285823e-05	0.0338983050847457
HIF1A	glutathione/metabolism	0.0002385648205763	0	1	0.6431935215825413	0.000452520969509	0.0508474576271186
HIF1A	photosensitizing agents/chemistry	1.691390996205744e-05	0	1	0.6431935215825413	3.6453552961126e-05	0.0423728813559322
HIF1A	catalase	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
HIF1A	hypoxia-inducible factor 1 alpha subunit	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
HIF1A	NCL	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
IDO1	tumor microenvironment	0.0010679811251681	0	1	0.6431935215825413	0.0018409168811264	0.1101694915254237
IDO1	chlorophyll	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
IDO1	urinary bladder neoplasms/drug therapy	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
IDO1	NOC2L	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
NCL	glutathione/metabolism	0.0002385648205763	0	1	0.6431935215825413	0.000452520969509	0.0508474576271186
NCL	photosensitizing agents/chemistry	1.691390996205744e-05	0	1	0.6431935215825413	3.6453552961126e-05	0.0423728813559322
NCL	catalase	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
NCL	hypoxia-inducible factor 1 alpha subunit	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
NOC2L	tumor microenvironment	0.0010679811251681	0	1	0.6431935215825413	0.0018409168811264	0.1101694915254237
NOC2L	chlorophyll	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
NOC2L	urinary bladder neoplasms/drug therapy	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
catalase	glutathione/metabolism	0.0002385648205763	0	1	0.6431935215825413	0.000452520969509	0.0508474576271186
catalase	photosensitizing agents/chemistry	1.691390996205744e-05	0	1	0.6431935215825413	3.6453552961126e-05	0.0423728813559322
catalase	hypoxia-inducible factor 1 alpha subunit	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hypoxia-inducible factor 1 alpha subunit	glutathione/metabolism	0.0002385648205763	0	1	0.6431935215825413	0.000452520969509	0.0508474576271186
hypoxia-inducible factor 1 alpha subunit	photosensitizing agents/chemistry	1.691390996205744e-05	0	1	0.6431935215825413	3.6453552961126e-05	0.0423728813559322
chlorophyll	tumor microenvironment	0.0010679811251681	0	1	0.6431935215825413	0.0018409168811264	0.1101694915254238
chlorophyll	urinary bladder neoplasms/drug therapy	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
urinary bladder neoplasms/drug therapy	tumor microenvironment	0.0010679811251681	0	1	0.6431935215825413	0.0018409168811264	0.1101694915254238
sesquiterpenes/administration & dosage	mutation	9.291170156455753e-05	0	1	0.6431935215825413	0.0001877109128209	0.0169491525423728
sesquiterpenes/administration & dosage	EGFR	0.0018869183339988	0	1	0.6431935215825413	0.0031243469390338	0.0254237288135593
sesquiterpenes/administration & dosage	cell proliferation	2.917252330836284e-05	0	1	0.6431935215825413	6.170039326460595e-05	0.0169491525423728
sesquiterpenes/administration & dosage	cetuximab/administration & dosage	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
sesquiterpenes/administration & dosage	colorectal neoplasms/drug therapy	0.0023324532785861	0	1	0.6431935215825413	0.0038000818544132	0.0338983050847457
sesquiterpenes/administration & dosage	proto-oncogene proteins p21(ras)/genetics	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
sesquiterpenes/administration & dosage	CDH1	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
sesquiterpenes/administration & dosage	CDH2	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
sesquiterpenes/administration & dosage	GLS	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
sesquiterpenes/administration & dosage	MMP9	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
sesquiterpenes/administration & dosage	SLC40A1	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
sesquiterpenes/administration & dosage	VIM	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
sesquiterpenes/administration & dosage	erbb receptors/antagonists & inhibitors	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
erbb receptors/antagonists & inhibitors	mutation	9.291170156455753e-05	0	1	0.6431935215825413	0.0001877109128209	0.0169491525423728
erbb receptors/antagonists & inhibitors	EGFR	0.0018869183339988	0	1	0.6431935215825413	0.0031243469390338	0.0254237288135593
erbb receptors/antagonists & inhibitors	cell proliferation	2.917252330836284e-05	0	1	0.6431935215825413	6.170039326460595e-05	0.0169491525423728
erbb receptors/antagonists & inhibitors	cetuximab/administration & dosage	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
erbb receptors/antagonists & inhibitors	colorectal neoplasms/drug therapy	0.0023324532785861	0	1	0.6431935215825413	0.0038000818544132	0.0338983050847457
erbb receptors/antagonists & inhibitors	proto-oncogene proteins p21(ras)/genetics	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
erbb receptors/antagonists & inhibitors	CDH1	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
erbb receptors/antagonists & inhibitors	CDH2	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
erbb receptors/antagonists & inhibitors	GLS	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
erbb receptors/antagonists & inhibitors	MMP9	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
erbb receptors/antagonists & inhibitors	SLC40A1	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
erbb receptors/antagonists & inhibitors	VIM	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
cetuximab/administration & dosage	mutation	9.291170156455753e-05	0	1	0.6431935215825413	0.0001877109128209	0.0169491525423728
cetuximab/administration & dosage	EGFR	0.0018869183339988	0	1	0.6431935215825413	0.0031243469390338	0.0254237288135593
cetuximab/administration & dosage	cell proliferation	2.917252330836284e-05	0	1	0.6431935215825413	6.170039326460595e-05	0.0169491525423728
cetuximab/administration & dosage	colorectal neoplasms/drug therapy	0.0023324532785861	0	1	0.6431935215825413	0.0038000818544132	0.0338983050847457
cetuximab/administration & dosage	proto-oncogene proteins p21(ras)/genetics	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
cetuximab/administration & dosage	CDH1	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
cetuximab/administration & dosage	CDH2	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
cetuximab/administration & dosage	GLS	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
cetuximab/administration & dosage	MMP9	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
cetuximab/administration & dosage	SLC40A1	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
cetuximab/administration & dosage	VIM	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
cell proliferation	mutation	0.0009701044822025	0	1	0.6431935215825413	0.0016871231769354	0.0337534405331015
cell proliferation	neoplasm metastasis	7.49900141983062e-12	0	1	0.6431935215825413	3.1233020443448376e-11	0.0169491525423728
cell proliferation	homeostasis	9.634910654232608e-05	0	1	0.6431935215825413	0.000194494281765	0.0504128639721861
cell proliferation	proto-oncogene proteins p21(ras)/genetics	2.917252330836284e-05	0	1	0.6431935215825413	6.170039326460595e-05	0.0169491525423728
cell proliferation	mitochondria/metabolism	7.49900141983062e-12	0	1	0.6431935215825413	3.1233020443448376e-11	0.0169491525423728
cell proliferation	neoplastic stem cells/metabolism	7.49900141983062e-12	0	1	0.6431935215825413	3.1233020443448376e-11	0.0169491525423728
cell proliferation	CDH1	2.917252330836284e-05	0	1	0.6431935215825413	6.170039326460595e-05	0.0169491525423728
cell proliferation	CDH2	2.917252330836284e-05	0	1	0.6431935215825413	6.170039326460595e-05	0.0169491525423728
cell proliferation	GLS	2.917252330836284e-05	0	1	0.6431935215825413	6.170039326460595e-05	0.0169491525423728
cell proliferation	MMP9	2.917252330836284e-05	0	1	0.6431935215825413	6.170039326460595e-05	0.0169491525423728
cell proliferation	SLC40A1	2.917252330836284e-05	0	1	0.6431935215825413	6.170039326460595e-05	0.0169491525423728
cell proliferation	VIM	2.917252330836284e-05	0	1	0.6431935215825413	6.170039326460595e-05	0.0169491525423728
mutation	proto-oncogene proteins p21(ras)/genetics	9.291170156455753e-05	0	1	0.6431935215825413	0.0001877109128209	0.0169491525423728
mutation	CDH1	9.291170156455753e-05	0	1	0.6431935215825413	0.0001877109128209	0.0169491525423728
mutation	CDH2	9.291170156455753e-05	0	1	0.6431935215825413	0.0001877109128209	0.0169491525423728
mutation	GLS	9.291170156455753e-05	0	1	0.6431935215825413	0.0001877109128209	0.0169491525423728
mutation	MMP9	9.291170156455753e-05	0	1	0.6431935215825413	0.0001877109128209	0.0169491525423728
mutation	SLC40A1	9.291170156455753e-05	0	1	0.6431935215825413	0.0001877109128209	0.0169491525423728
mutation	TF	0.0005516067043375	0	2	0.3223370757289844	0.0010003645218595	0.0030421555845284
mutation	VIM	9.291170156455753e-05	0	1	0.6431935215825413	0.0001877109128209	0.0169491525423728
proto-oncogene proteins p21(ras)/genetics	EGFR	0.0018869183339988	0	1	0.6431935215825413	0.0031243469390338	0.0254237288135593
proto-oncogene proteins p21(ras)/genetics	colorectal neoplasms/drug therapy	0.0023324532785861	0	1	0.6431935215825413	0.0038000818544132	0.0338983050847457
proto-oncogene proteins p21(ras)/genetics	CDH1	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
proto-oncogene proteins p21(ras)/genetics	CDH2	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
proto-oncogene proteins p21(ras)/genetics	GLS	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
proto-oncogene proteins p21(ras)/genetics	MMP9	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
proto-oncogene proteins p21(ras)/genetics	SLC40A1	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
proto-oncogene proteins p21(ras)/genetics	VIM	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
CDH1	EGFR	0.0018869183339988	0	1	0.6431935215825413	0.0031243469390338	0.0254237288135593
CDH1	colorectal neoplasms/drug therapy	0.0023324532785861	0	1	0.6431935215825413	0.0038000818544132	0.0338983050847457
CDH1	CDH2	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
CDH1	GLS	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
CDH1	MMP9	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
CDH1	SLC40A1	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
CDH1	VIM	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
CDH2	EGFR	0.0018869183339988	0	1	0.6431935215825413	0.0031243469390338	0.0254237288135593
CDH2	colorectal neoplasms/drug therapy	0.0023324532785861	0	1	0.6431935215825413	0.0038000818544132	0.0338983050847457
CDH2	GLS	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
CDH2	MMP9	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
CDH2	SLC40A1	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
CDH2	VIM	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
GLS	EGFR	0.0018869183339988	0	1	0.6431935215825413	0.0031243469390338	0.0254237288135593
GLS	colorectal neoplasms/drug therapy	0.0023324532785861	0	1	0.6431935215825413	0.0038000818544132	0.0338983050847457
GLS	MMP9	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
GLS	SLC40A1	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
GLS	VIM	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
MMP9	EGFR	0.0018869183339988	0	1	0.6431935215825413	0.0031243469390338	0.0254237288135593
MMP9	colorectal neoplasms/drug therapy	0.0023324532785861	0	1	0.6431935215825413	0.0038000818544132	0.0338983050847457
MMP9	SLC40A1	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
MMP9	VIM	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
SLC40A1	EGFR	0.0018869183339988	0	1	0.6431935215825413	0.0031243469390338	0.0254237288135593
SLC40A1	colorectal neoplasms/drug therapy	0.0023324532785861	0	1	0.6431935215825413	0.0038000818544132	0.0338983050847457
SLC40A1	VIM	7.950874323370272e-07	0	1	0.6431935215825413	1.942085743247285e-06	0.0084745762711864
VIM	EGFR	0.0018869183339988	0	1	0.6431935215825413	0.0031243469390338	0.0254237288135593
VIM	colorectal neoplasms/drug therapy	0.0023324532785861	0	1	0.6431935215825413	0.0038000818544132	0.0338983050847457
glutathione/metabolism	metal-organic frameworks/chemistry	1.974209448174502e-05	0	1	0.6431935215825413	4.243635924549779e-05	0.0508474576271186
glutathione/metabolism	mammary neoplasms animal/drug therapy	1.974209448174502e-05	0	1	0.6431935215825413	4.243635924549779e-05	0.0508474576271186
glutathione/metabolism	sorafenib/analogs & derivatives	1.974209448174502e-05	0	1	0.6431935215825413	4.243635924549779e-05	0.0508474576271186
glutathione/metabolism	hemin/chemistry	0.0002385648205763	0	1	0.6431935215825413	0.000452520969509	0.0508474576271186
glutathione/metabolism	hydroxyl radical/metabolism	0.0002385648205763	0	1	0.6431935215825413	0.000452520969509	0.0508474576271186
glutathione/metabolism	photosensitizing agents/chemistry	0.0006247844548458	0	2	0.3223370757289844	0.001115228808961	0.0202602671765057
glutathione/metabolism	human umbilical vein endothelial cells	0.0002385648205763	0	1	0.6431935215825413	0.000452520969509	0.0508474576271186
glutathione/metabolism	chlorides/chemistry	1.974209448174502e-05	0	1	0.6431935215825413	4.243635924549779e-05	0.0508474576271186
glutathione/metabolism	porphyrins/administration & dosage	0.003990633117329	0	1	0.6431935215825413	0.0062388049986347	0.0995219469795744
glutathione/metabolism	oxygen/metabolism	0.0002385648205763	0	1	0.6431935215825413	0.000452520969509	0.0508474576271186
glutathione/metabolism	PEBP1	0.0002385648205763	0	1	0.6431935215825413	0.000452520969509	0.0508474576271186
glutathione/metabolism	XAB2	0.0002385648205763	0	1	0.6431935215825413	0.000452520969509	0.0508474576271186
metal-organic frameworks/chemistry	mammary neoplasms animal/drug therapy	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
metal-organic frameworks/chemistry	photosensitizing agents/administration & dosage	2.248556896233822e-11	0	1	0.6431935215825413	9.063041981263369e-11	0.0254237288135593
metal-organic frameworks/chemistry	porphyrins/administration & dosage	1.3322676295501878e-15	0	1	0.6431935215825413	9.287754161370623e-15	0.0169491525423728
mammary neoplasms animal/drug therapy	photosensitizing agents/administration & dosage	2.248556896233822e-11	0	1	0.6431935215825413	9.063041981263369e-11	0.0254237288135593
mammary neoplasms animal/drug therapy	porphyrins/administration & dosage	1.3322676295501878e-15	0	1	0.6431935215825413	9.287754161370623e-15	0.0169491525423728
sorafenib/analogs & derivatives	manganese compounds/chemistry	4.0234482412415673e-13	0	1	0.6431935215825413	1.894324954547841e-12	0.0169491525423728
sorafenib/analogs & derivatives	phospholipid hydroperoxide glutathione peroxidase/metabolism	1.2049213626852406e-08	0	1	0.6431935215825413	3.8451747219156376e-08	0.0338983050847457
sorafenib/analogs & derivatives	silicon dioxide/chemistry	4.0234482412415673e-13	0	1	0.6431935215825413	1.894324954547841e-12	0.0169491525423728
sorafenib/analogs & derivatives	hep g2 cells	2.287315892246511e-10	0	1	0.6431935215825413	8.330411317576418e-10	0.0254237288135593
sorafenib/analogs & derivatives	chlorides/chemistry	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hemin/chemistry	photosensitizing agents/chemistry	1.691390996205744e-05	0	1	0.6431935215825413	3.6453552961126e-05	0.0423728813559322
hemin/chemistry	hydroxyl radical/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hemin/chemistry	human umbilical vein endothelial cells	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hemin/chemistry	oxygen/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hemin/chemistry	PEBP1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hemin/chemistry	XAB2	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hydroxyl radical/metabolism	photosensitizing agents/chemistry	1.691390996205744e-05	0	1	0.6431935215825413	3.6453552961126e-05	0.0423728813559322
hydroxyl radical/metabolism	human umbilical vein endothelial cells	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hydroxyl radical/metabolism	oxygen/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hydroxyl radical/metabolism	PEBP1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hydroxyl radical/metabolism	XAB2	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
photosensitizing agents/chemistry	manganese compounds/chemistry	0.0022317857690734	0	1	0.6431935215825413	0.0036630151743667	0.0832971171954223
photosensitizing agents/chemistry	silicon dioxide/chemistry	0.0022317857690734	0	1	0.6431935215825413	0.0036630151743667	0.0832971171954222
photosensitizing agents/chemistry	folic acid/analogs & derivatives	7.141548729572289e-05	0	1	0.6431935215825413	0.0001462831734308	0.0423728813559322
photosensitizing agents/chemistry	quassins/chemistry	7.141548729572289e-05	0	1	0.6431935215825413	0.0001462831734308	0.0423728813559322
photosensitizing agents/chemistry	pancreatic neoplasms/drug therapy	7.141548729572289e-05	0	1	0.6431935215825413	0.0001462831734308	0.0423728813559322
photosensitizing agents/chemistry	indoles/chemistry	7.141548729572289e-05	0	1	0.6431935215825413	0.0001462831734308	0.0423728813559322
photosensitizing agents/chemistry	human umbilical vein endothelial cells	1.691390996205744e-05	0	1	0.6431935215825413	3.6453552961126e-05	0.0423728813559322
photosensitizing agents/chemistry	chlorophyllides/chemistry	7.141548729572289e-05	0	1	0.6431935215825413	0.0001462831734308	0.0423728813559322
photosensitizing agents/chemistry	nf-e2-related factor 2/antagonists & inhibitors	7.141548729572289e-05	0	1	0.6431935215825413	0.0001462831734308	0.0423728813559322
photosensitizing agents/chemistry	oxygen/metabolism	1.691390996205744e-05	0	1	0.6431935215825413	3.6453552961126e-05	0.0423728813559322
photosensitizing agents/chemistry	PEBP1	1.691390996205744e-05	0	1	0.6431935215825413	3.6453552961126e-05	0.0423728813559322
photosensitizing agents/chemistry	XAB2	1.691390996205744e-05	0	1	0.6431935215825413	3.6453552961126e-05	0.0423728813559322
human umbilical vein endothelial cells	oxygen/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
human umbilical vein endothelial cells	PEBP1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
human umbilical vein endothelial cells	XAB2	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
chlorides/chemistry	manganese compounds/chemistry	4.0234482412415673e-13	0	1	0.6431935215825413	1.894324954547841e-12	0.0169491525423728
chlorides/chemistry	phospholipid hydroperoxide glutathione peroxidase/metabolism	1.2049213626852406e-08	0	1	0.6431935215825413	3.8451747219156376e-08	0.0338983050847457
chlorides/chemistry	silicon dioxide/chemistry	4.0234482412415673e-13	0	1	0.6431935215825413	1.894324954547841e-12	0.0169491525423728
chlorides/chemistry	hep g2 cells	2.287315892246511e-10	0	1	0.6431935215825413	8.330411317576418e-10	0.0254237288135593
porphyrins/administration & dosage	photosensitizing agents/administration & dosage	0.0	0	2	0.3223370757289844	0.0	0.0004345936549326
porphyrins/administration & dosage	tongue neoplasms/drug therapy	3.5638159090467525e-14	0	1	0.6431935215825413	2.3001953542761363e-13	0.0169491525423728
porphyrins/administration & dosage	antineoplastic agents/administration & dosage	8.316309313394221e-05	0	1	0.6431935215825413	0.0001694204652348	0.0832971171954222
porphyrins/administration & dosage	amino acid transport system y+/analysis	3.5638159090467525e-14	0	1	0.6431935215825413	2.3001953542761363e-13	0.0169491525423728
porphyrins/administration & dosage	macromolecular substances/administration & dosage	3.5638159090467525e-14	0	1	0.6431935215825413	2.3001953542761363e-13	0.0169491525423728
porphyrins/administration & dosage	piperazines/administration & dosage	7.379537600549213e-06	0	1	0.6431935215825413	1.6579293097038412e-05	0.0504128639721861
porphyrins/administration & dosage	carcinoma squamous cell/drug therapy	3.5638159090467525e-14	0	1	0.6431935215825413	2.3001953542761363e-13	0.0169491525423728
oxygen/metabolism	PEBP1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
oxygen/metabolism	XAB2	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
PEBP1	XAB2	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cell line	oxidative stress/drug effects	2.8272495455894383e-11	0	3	0.1299847034619319	1.137670275446518e-10	0.0001479051869111
cell line	myocardial infarction/metabolism	3.286172911454166e-06	0	1	0.6431935215825413	7.64003845301343e-06	0.0423728813559322
cell line	myocytes cardiac/drug effects	3.286172911454166e-06	0	1	0.6431935215825413	7.64003845301343e-06	0.0423728813559322
cell line	deferoxamine/pharmacology	3.286172911454166e-06	0	1	0.6431935215825413	7.64003845301343e-06	0.0423728813559322
cell line	phenylenediamines/administration & dosage	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0423728813559322
cell line	myocardial reperfusion injury/metabolism	3.286172911454166e-06	0	1	0.6431935215825413	7.64003845301343e-06	0.0423728813559322
cell line	tumor suppressor protein p53/genetics	0.0003601294793559	0	1	0.6431935215825413	0.000663231652646	0.0423728813559322
cell line	adenine/administration & dosage	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0423728813559322
cell line	retinal pigment epithelium/cytology	1.0320496013349612e-08	0	1	0.6431935215825413	3.2978214474132894e-08	0.0423728813559322
cell line	cyclohexylamines/administration & dosage	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0423728813559322
cell line	pyridazines/pharmacology	3.286172911454166e-06	0	1	0.6431935215825413	7.64003845301343e-06	0.0423728813559322
cell line	ovalbumin/adverse effects	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0423728813559322
cell line	ferrocyanides/administration & dosage	1.0320496013349612e-08	0	1	0.6431935215825413	3.2978214474132894e-08	0.0423728813559322
cell line	anthelmintics/pharmacology	0.0003601294793559	0	1	0.6431935215825413	0.000663231652646	0.0423728813559322
cell line	bronchi/cytology	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0423728813559322
cell line	asthma/chemically induced	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0423728813559322
cell line	cell cycle/drug effects	0.0003601294793559	0	1	0.6431935215825413	0.000663231652646	0.0423728813559322
cell line	mebendazole/analogs & derivatives	0.0003601294793559	0	1	0.6431935215825413	0.000663231652646	0.0423728813559322
cell line	iodates/adverse effects	1.0320496013349612e-08	0	1	0.6431935215825413	3.2978214474132894e-08	0.0423728813559322
cell line	macular degeneration/chemically induced	1.0320496013349612e-08	0	1	0.6431935215825413	3.2978214474132894e-08	0.0423728813559322
cell line	interleukin-13/pharmacology	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0423728813559322
cell line	IL13	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0423728813559322
cell line	IL1B	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0423728813559322
cell line	IL6	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0423728813559322
cell line	TP53	0.0003601294793559	0	1	0.6431935215825413	0.000663231652646	0.0423728813559322
oxidative stress/drug effects	phenylenediamines/administration & dosage	5.506449314074402e-06	0	1	0.6431935215825413	1.2503694085500728e-05	0.0338983050847457
oxidative stress/drug effects	sorafenib/administration & dosage	2.51687559682523e-12	0	1	0.6431935215825413	1.131433098093113e-11	0.0338983050847457
oxidative stress/drug effects	adenine/administration & dosage	5.506449314074402e-06	0	1	0.6431935215825413	1.2503694085500728e-05	0.0338983050847457
oxidative stress/drug effects	artesunate/administration & dosage	3.950338465419368e-05	0	1	0.6431935215825413	8.293838579055828e-05	0.0669274228596261
oxidative stress/drug effects	retinal pigment epithelium/cytology	2.51687559682523e-12	0	1	0.6431935215825413	1.131433098093113e-11	0.0338983050847457
oxidative stress/drug effects	bronchi/cytology	5.506449314074402e-06	0	1	0.6431935215825413	1.2503694085500728e-05	0.0338983050847457
oxidative stress/drug effects	asthma/chemically induced	5.506449314074402e-06	0	1	0.6431935215825413	1.2503694085500728e-05	0.0338983050847457
oxidative stress/drug effects	iodates/adverse effects	2.51687559682523e-12	0	1	0.6431935215825413	1.131433098093113e-11	0.0338983050847457
oxidative stress/drug effects	macular degeneration/chemically induced	2.51687559682523e-12	0	1	0.6431935215825413	1.131433098093113e-11	0.0338983050847457
oxidative stress/drug effects	interleukin-13/pharmacology	5.506449314074402e-06	0	1	0.6431935215825413	1.2503694085500728e-05	0.0338983050847457
oxidative stress/drug effects	epithelial cells/drug effects	0.0015615735142621	0	1	0.6431935215825413	0.0026248871110725	0.0669274228596264
oxidative stress/drug effects	IL13	5.506449314074402e-06	0	1	0.6431935215825413	1.2503694085500728e-05	0.0338983050847457
oxidative stress/drug effects	IL1B	5.506449314074402e-06	0	1	0.6431935215825413	1.2503694085500728e-05	0.0338983050847457
oxidative stress/drug effects	IL6	5.506449314074402e-06	0	1	0.6431935215825413	1.2503694085500728e-05	0.0338983050847457
oxidative stress/drug effects	cyclohexylamines/administration & dosage	5.506449314074402e-06	0	1	0.6431935215825413	1.2503694085500728e-05	0.0338983050847457
oxidative stress/drug effects	ovalbumin/adverse effects	5.506449314074402e-06	0	1	0.6431935215825413	1.2503694085500728e-05	0.0338983050847457
oxidative stress/drug effects	ferrocyanides/administration & dosage	2.51687559682523e-12	0	1	0.6431935215825413	1.131433098093113e-11	0.0338983050847457
TF	cation transport proteins	0.0003990265556311	0	1	0.6431935215825413	0.0007332037728471	0.059322033898305
TF	cyclooxygenase 2	0.0003990265556311	0	1	0.6431935215825413	0.0007332037728471	0.059322033898305
TF	biomarkers/metabolism	0.0008098522057113	0	1	0.6431935215825413	0.0014293407455384	0.059322033898305
TF	golgi apparatus/metabolism	0.0008098522057113	0	1	0.6431935215825413	0.0014293407455384	0.059322033898305
TF	cell membrane/drug effects	0.0008098522057113	0	1	0.6431935215825413	0.0014293407455384	0.059322033898305
TF	antibodies monoclonal/metabolism	0.0008098522057113	0	1	0.6431935215825413	0.0014293407455384	0.059322033898305
TF	piperazine/pharmacology	0.0008098522057113	0	1	0.6431935215825413	0.0014293407455384	0.059322033898305
TF	ethanol	0.0003990265556311	0	1	0.6431935215825413	0.0007332037728471	0.059322033898305
TF	receptors transferrin/metabolism	0.0008098522057113	0	1	0.6431935215825413	0.0014293407455384	0.059322033898305
TF	antigens/metabolism	0.0008098522057113	0	1	0.6431935215825413	0.0014293407455384	0.059322033898305
TF	SLC39A14	0.0003990265556311	0	1	0.6431935215825413	0.0007332037728471	0.059322033898305
TF	TFRC	6.274738506562015e-10	0	3	0.1299847034619319	2.233513567748481e-09	0.0001311273958848
TF	VDAC1	0.0003990265556311	0	1	0.6431935215825413	0.0007332037728471	0.0593220338983051
homeostasis/drug effects	ATF4	0.0004445101169019	0	1	0.6431935215825413	0.0008134051068956	0.0504128639721861
homeostasis/drug effects	nf-e2-related factor 2/metabolism	0.0009389048097199	0	1	0.6431935215825413	0.0016398864293065	0.0504128639721861
homeostasis/drug effects	artesunate/pharmacology	7.824340964024401e-08	0	1	0.6431935215825413	2.1312472620285585e-07	0.0254237288135593
homeostasis/drug effects	carcinogenesis/drug effects	0.0017238034337688	0	1	0.6431935215825413	0.0028718270539335	0.0749711519729055
homeostasis/drug effects	lysosomes/drug effects	7.90928279311709e-05	0	1	0.6431935215825413	0.0001613308290115	0.0504128639721861
homeostasis/drug effects	antineoplastic agents	0.0004445101169019	0	1	0.6431935215825413	0.0008134051068956	0.0504128639721861
homeostasis/drug effects	antimalarials/pharmacology	7.824340964024401e-08	0	1	0.6431935215825413	2.1312472620285585e-07	0.0254237288135593
homeostasis/drug effects	activating transcription factor 4/metabolism	2.786690866951602e-07	0	1	0.6431935215825413	7.200182711906234e-07	0.0254237288135593
homeostasis/drug effects	glioblastoma/drug therapy	9.373898991138496e-06	0	1	0.6431935215825413	2.0915297520063137e-05	0.0504128639721861
homeostasis/drug effects	stress physiological/drug effects	2.786690866951602e-07	0	1	0.6431935215825413	7.200182711906234e-07	0.0254237288135593
homeostasis/drug effects	lipids/toxicity	2.786690866951602e-07	0	1	0.6431935215825413	7.200182711906234e-07	0.0254237288135593
homeostasis/drug effects	endocytosis/drug effects	2.786690866951602e-07	0	1	0.6431935215825413	7.200182711906234e-07	0.0254237288135593
homeostasis/drug effects	EIF2S1	0.0002432086850959	0	1	0.6431935215825413	0.0004611501643862	0.0504128639721861
homeostasis/drug effects	MAPK1	7.824340964024401e-08	0	1	0.6431935215825413	2.1312472620285585e-07	0.0254237288135593
alcohol oxidoreductases/genetics	gene expression regulation neoplastic/drug effects	5.506449314074402e-06	0	1	0.6431935215825413	1.2503694085500728e-05	0.0254237288135593
alcohol oxidoreductases/genetics	oxidative stress	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0338983050847457
alcohol oxidoreductases/genetics	antineoplastic agents	2.7580701722484946e-08	0	1	0.6431935215825413	8.431666216666824e-08	0.0169491525423728
alcohol oxidoreductases/genetics	cytosol/metabolism	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
alcohol oxidoreductases/genetics	deoxycytidine/analogs & derivatives	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
alcohol oxidoreductases/genetics	flavonoids/pharmacology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
alcohol oxidoreductases/genetics	pancreatic neoplasms	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
alcohol oxidoreductases/genetics	CBR1	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
cytosol/metabolism	gene expression regulation neoplastic/drug effects	5.506449314074402e-06	0	1	0.6431935215825413	1.2503694085500728e-05	0.0254237288135593
cytosol/metabolism	oxidative stress	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0338983050847457
cytosol/metabolism	antineoplastic agents	2.7580701722484946e-08	0	1	0.6431935215825413	8.431666216666824e-08	0.0169491525423728
cytosol/metabolism	deoxycytidine/analogs & derivatives	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
cytosol/metabolism	flavonoids/pharmacology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
cytosol/metabolism	pancreatic neoplasms	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
cytosol/metabolism	CBR1	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
deoxycytidine/analogs & derivatives	gene expression regulation neoplastic/drug effects	5.506449314074402e-06	0	1	0.6431935215825413	1.2503694085500728e-05	0.0254237288135593
deoxycytidine/analogs & derivatives	oxidative stress	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0338983050847457
deoxycytidine/analogs & derivatives	antineoplastic agents	2.7580701722484946e-08	0	1	0.6431935215825413	8.431666216666824e-08	0.0169491525423728
deoxycytidine/analogs & derivatives	flavonoids/pharmacology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
deoxycytidine/analogs & derivatives	pancreatic neoplasms	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
deoxycytidine/analogs & derivatives	CBR1	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
flavonoids/pharmacology	gene expression regulation neoplastic/drug effects	5.506449314074402e-06	0	1	0.6431935215825413	1.2503694085500728e-05	0.0254237288135593
flavonoids/pharmacology	oxidative stress	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0338983050847457
flavonoids/pharmacology	antineoplastic agents	2.7580701722484946e-08	0	1	0.6431935215825413	8.431666216666824e-08	0.0169491525423728
flavonoids/pharmacology	pancreatic neoplasms	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
flavonoids/pharmacology	CBR1	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
pancreatic neoplasms	gene expression regulation neoplastic/drug effects	5.506449314074402e-06	0	1	0.6431935215825413	1.2503694085500728e-05	0.0254237288135593
pancreatic neoplasms	oxidative stress	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0338983050847457
pancreatic neoplasms	antineoplastic agents	2.7580701722484946e-08	0	1	0.6431935215825413	8.431666216666824e-08	0.0169491525423728
pancreatic neoplasms	CBR1	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
CBR1	gene expression regulation neoplastic/drug effects	5.506449314074402e-06	0	1	0.6431935215825413	1.2503694085500728e-05	0.0254237288135593
CBR1	oxidative stress	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0338983050847457
CBR1	antineoplastic agents	2.7580701722484946e-08	0	1	0.6431935215825413	8.431666216666824e-08	0.0169491525423728
b7-h1 antigen/metabolism	tumor microenvironment	0.0001409462894507	0	1	0.6431935215825413	0.0002767249268708	0.1101694915254238
b7-h1 antigen/metabolism	cell survival/drug effects	7.422353092412237e-05	0	1	0.6431935215825413	0.0001517798011721	0.059322033898305
b7-h1 antigen/metabolism	hep g2 cells	2.287315892246511e-10	0	1	0.6431935215825413	8.330411317576418e-10	0.0254237288135593
b7-h1 antigen/metabolism	kidney	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
b7-h1 antigen/metabolism	iron/chemistry	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
manganese compounds/chemistry	folic acid/analogs & derivatives	6.734482749237713e-09	0	1	0.6431935215825413	2.1907299357166475e-08	0.0169491525423728
manganese compounds/chemistry	quassins/chemistry	6.734482749237713e-09	0	1	0.6431935215825413	2.1907299357166475e-08	0.0169491525423728
manganese compounds/chemistry	pancreatic neoplasms/drug therapy	6.734482749237713e-09	0	1	0.6431935215825413	2.1907299357166475e-08	0.0169491525423728
manganese compounds/chemistry	indoles/chemistry	6.734482749237713e-09	0	1	0.6431935215825413	2.1907299357166475e-08	0.0169491525423728
manganese compounds/chemistry	chlorophyllides/chemistry	6.734482749237713e-09	0	1	0.6431935215825413	2.1907299357166475e-08	0.0169491525423728
manganese compounds/chemistry	phospholipid hydroperoxide glutathione peroxidase/metabolism	0.0004481571619056	0	1	0.6431935215825413	0.0008191559827329	0.0669274228596261
manganese compounds/chemistry	nf-e2-related factor 2/antagonists & inhibitors	6.734482749237713e-09	0	1	0.6431935215825413	2.1907299357166475e-08	0.0169491525423728
manganese compounds/chemistry	silicon dioxide/chemistry	0.0	0	2	0.3223370757289844	0.0	0.0001448645516442
manganese compounds/chemistry	hep g2 cells	8.956939430038169e-05	0	1	0.6431935215825413	0.0001817117645402	0.0504128639721861
kidney	tumor microenvironment	0.0001409462894507	0	1	0.6431935215825413	0.0002767249268708	0.1101694915254238
kidney	cell survival/drug effects	7.422353092412237e-05	0	1	0.6431935215825413	0.0001517798011721	0.0593220338983051
kidney	hep g2 cells	2.287315892246511e-10	0	1	0.6431935215825413	8.330411317576418e-10	0.0254237288135593
kidney	iron/chemistry	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
iron/chemistry	tumor microenvironment	0.005033230398565	0	1	0.6431935215825413	0.0077494255078065	0.2090395480225988
iron/chemistry	cell survival/drug effects	4.9700118465167975e-09	0	2	0.3223370757289844	1.6375164116346423e-08	0.0030421555845284
iron/chemistry	reactive oxygen species/metabolism	0.0001153388864491	0	2	0.3223370757289844	0.0002297818453256	0.0197015790236128
iron/chemistry	hep g2 cells	2.286392930761494e-06	0	1	0.6431935215825413	5.411166950753161e-06	0.0504128639721861
iron/chemistry	EDN3	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
iron/chemistry	EDNRB	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
iron/chemistry	receptor endothelin b/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
silicon dioxide/chemistry	phospholipid hydroperoxide glutathione peroxidase/metabolism	0.0004481571619056	0	1	0.6431935215825413	0.0008191559827329	0.0669274228596264
silicon dioxide/chemistry	folic acid/analogs & derivatives	6.734482749237713e-09	0	1	0.6431935215825413	2.1907299357166475e-08	0.0169491525423728
silicon dioxide/chemistry	quassins/chemistry	6.734482749237713e-09	0	1	0.6431935215825413	2.1907299357166475e-08	0.0169491525423728
silicon dioxide/chemistry	pancreatic neoplasms/drug therapy	6.734482749237713e-09	0	1	0.6431935215825413	2.1907299357166475e-08	0.0169491525423728
silicon dioxide/chemistry	indoles/chemistry	6.734482749237713e-09	0	1	0.6431935215825413	2.1907299357166475e-08	0.0169491525423728
silicon dioxide/chemistry	chlorophyllides/chemistry	6.734482749237713e-09	0	1	0.6431935215825413	2.1907299357166475e-08	0.0169491525423728
silicon dioxide/chemistry	nf-e2-related factor 2/antagonists & inhibitors	6.734482749237713e-09	0	1	0.6431935215825413	2.1907299357166475e-08	0.0169491525423728
silicon dioxide/chemistry	hep g2 cells	8.956939430038169e-05	0	1	0.6431935215825413	0.0001817117645402	0.0504128639721861
hep g2 cells	phospholipid hydroperoxide glutathione peroxidase/metabolism	0.0022985782424915	0	1	0.6431935215825413	0.0037688330335334	0.0991023393127429
hep g2 cells	liver neoplasms/drug therapy	4.3302904817466015e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0254237288135593
hep g2 cells	depression chemical	4.3302904817466015e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0254237288135593
hep g2 cells	GCLC	0.0022985782424915	0	1	0.6431935215825413	0.0037688330335334	0.0749711519729055
hep g2 cells	energy metabolism/drug effects	4.3302904817466015e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0254237288135593
drug resistance neoplasm/drug effects	reactive oxygen species/antagonists & inhibitors	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.1156019122120817
drug resistance neoplasm/drug effects	n-acetylgalactosaminyltransferases/metabolism	0.0031191982834976	0	1	0.6431935215825413	0.0049950224237541	0.0593220338983051
drug resistance neoplasm/drug effects	beta catenin/antagonists & inhibitors	0.0021020040079506	0	1	0.6431935215825413	0.0034616645930191	0.0593220338983051
drug resistance neoplasm/drug effects	sirolimus/analogs & derivatives	0.0031191982834976	0	1	0.6431935215825413	0.0049950224237541	0.0593220338983051
drug resistance neoplasm/drug effects	hyaluronic acid/chemistry	0.0031191982834976	0	1	0.6431935215825413	0.0049950224237541	0.0593220338983051
drug resistance neoplasm/drug effects	crispr-cas systems	0.0004092087658349	0	1	0.6431935215825413	0.0007499339285121	0.0593220338983051
drug resistance neoplasm/drug effects	immunologic memory	0.0031191982834976	0	1	0.6431935215825413	0.0049950224237541	0.0593220338983051
drug resistance neoplasm/drug effects	carcinoma hepatocellular/diagnosis	0.0004092087658349	0	1	0.6431935215825413	0.0007499339285121	0.0593220338983051
drug resistance neoplasm/drug effects	exosomes/drug effects	0.0031191982834976	0	1	0.6431935215825413	0.0049950224237541	0.0593220338983051
drug resistance neoplasm/drug effects	cell line tumor/transplantation	0.0031191982834976	0	1	0.6431935215825413	0.0049950224237541	0.0593220338983051
drug resistance neoplasm/drug effects	erbb receptors/metabolism	0.0031191982834976	0	1	0.6431935215825413	0.0049950224237541	0.0593220338983051
drug resistance neoplasm/drug effects	b7-h1 antigen/antagonists & inhibitors	0.0031191982834976	0	1	0.6431935215825413	0.0049950224237541	0.0593220338983051
drug resistance neoplasm/drug effects	aniline compounds/pharmacology	0.0031191982834976	0	1	0.6431935215825413	0.0049950224237541	0.0593220338983051
drug resistance neoplasm/drug effects	ovary/pathology	0.0031191982834976	0	1	0.6431935215825413	0.0049950224237541	0.0593220338983051
drug resistance neoplasm/drug effects	antimetabolites antineoplastic/pharmacology	0.0021020040079506	0	1	0.6431935215825413	0.0034616645930191	0.0593220338983051
drug resistance neoplasm/drug effects	phosphotransferases (alcohol group acceptor)/antagonists & inhibitors	0.0004092087658349	0	1	0.6431935215825413	0.0007499339285121	0.0593220338983051
drug resistance neoplasm/drug effects	immune checkpoint inhibitors/pharmacology	0.0031191982834976	0	1	0.6431935215825413	0.0049950224237541	0.0593220338983051
drug resistance neoplasm/drug effects	t-lymphocytes cytotoxic/drug effects	0.0031191982834976	0	1	0.6431935215825413	0.0049950224237541	0.0593220338983051
drug resistance neoplasm/drug effects	tumor escape/drug effects	0.0031191982834976	0	1	0.6431935215825413	0.0049950224237541	0.0593220338983051
drug resistance neoplasm/drug effects	benzylidene compounds/pharmacology	0.0031191982834976	0	1	0.6431935215825413	0.0049950224237541	0.0593220338983051
drug resistance neoplasm/drug effects	CASP9	0.0021020040079506	0	1	0.6431935215825413	0.0034616645930191	0.0593220338983051
drug resistance neoplasm/drug effects	CTNNB1	0.0021020040079506	0	1	0.6431935215825413	0.0034616645930191	0.0593220338983051
drug resistance neoplasm/drug effects	GALNT14	0.0031191982834976	0	1	0.6431935215825413	0.0049950224237541	0.0593220338983051
drug resistance neoplasm/drug effects	PSTK	0.0004092087658349	0	1	0.6431935215825413	0.0007499339285121	0.0593220338983051
drug resistance neoplasm/drug effects	TCF7L2	0.0021020040079506	0	1	0.6431935215825413	0.0034616645930191	0.0593220338983051
artesunate/pharmacology	carcinogenesis/drug effects	1.7972456856085728e-08	0	1	0.6431935215825413	5.6430272074552674e-08	0.0254237288135593
artesunate/pharmacology	antineoplastic agents	3.3450886505193006e-10	0	1	0.6431935215825413	1.2128435263378387e-09	0.0169491525423728
artesunate/pharmacology	antimalarials/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
artesunate/pharmacology	glioblastoma/drug therapy	3.4416913763379853e-15	0	1	0.6431935215825413	2.3522246952166904e-14	0.0169491525423728
artesunate/pharmacology	MAPK1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
neoplasm metastasis	tumor microenvironment	5.1804063198046535e-05	0	1	0.6431935215825413	0.0001071482173022	0.1101694915254238
neoplasm metastasis	homeostasis	4.8405723873656825e-14	0	1	0.6431935215825413	3.071368391098044e-13	0.0254237288135593
neoplasm metastasis	mitochondria/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
neoplasm metastasis	neoplastic stem cells/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
lysosomes/metabolism	doxorubicin/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
lysosomes/metabolism	starch/analogs & derivatives	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
lysosomes/metabolism	antineoplastic agents/administration & dosage	8.4546925016582e-10	0	1	0.6431935215825413	2.953384699683184e-09	0.0423728813559322
lysosomes/metabolism	hemolysis	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
lysosomes/metabolism	maleic anhydrides/chemistry	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
maleic anhydrides/chemistry	doxorubicin/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
maleic anhydrides/chemistry	starch/analogs & derivatives	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
maleic anhydrides/chemistry	antineoplastic agents/administration & dosage	8.4546925016582e-10	0	1	0.6431935215825413	2.953384699683184e-09	0.0423728813559322
maleic anhydrides/chemistry	hemolysis	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
lung diseases/drug therapy	reactive oxygen species/metabolism	0.0009513001672776	0	1	0.6431935215825413	0.0016561935388152	0.144067796610169
lung diseases/drug therapy	autophagy	0.0	0	1	0.6431935215825413	0.0	0.0254237288135593
lung diseases/drug therapy	necrosis	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
lung diseases/drug therapy	pyroptosis	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
homeostasis	ferroptosis/physiology	1.0932638977112497e-05	0	1	0.6431935215825413	2.422680751954033e-05	0.0749711519729055
homeostasis	biomarkers/chemistry	1.2460033005368132e-12	0	1	0.6431935215825413	5.627223432359491e-12	0.0254237288135593
homeostasis	covid-19/metabolism	1.2460033005368132e-12	0	1	0.6431935215825413	5.627223432359491e-12	0.0254237288135593
homeostasis	mitochondria/metabolism	4.8405723873656825e-14	0	1	0.6431935215825413	3.071368391098044e-13	0.0254237288135593
homeostasis	ceruloplasmin/metabolism	1.2460033005368132e-12	0	1	0.6431935215825413	5.627223432359491e-12	0.0254237288135593
homeostasis	inflammation/metabolism	1.2460033005368132e-12	0	1	0.6431935215825413	5.627223432359491e-12	0.0254237288135593
homeostasis	ferritins/chemistry	1.2460033005368132e-12	0	1	0.6431935215825413	5.627223432359491e-12	0.0254237288135593
homeostasis	neoplastic stem cells/metabolism	4.8405723873656825e-14	0	1	0.6431935215825413	3.071368391098044e-13	0.0254237288135593
homeostasis	neoplasms/diagnosis	1.2460033005368132e-12	0	1	0.6431935215825413	5.627223432359491e-12	0.0254237288135593
starch/analogs & derivatives	doxorubicin/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
starch/analogs & derivatives	antineoplastic agents/administration & dosage	8.4546925016582e-10	0	1	0.6431935215825413	2.953384699683184e-09	0.0423728813559322
starch/analogs & derivatives	hemolysis	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
antimalarials/pharmacology	carcinogenesis/drug effects	1.7972456856085728e-08	0	1	0.6431935215825413	5.6430272074552674e-08	0.0254237288135593
antimalarials/pharmacology	antineoplastic agents	3.3450886505193006e-10	0	1	0.6431935215825413	1.2128435263378387e-09	0.0169491525423728
antimalarials/pharmacology	glioblastoma/drug therapy	3.4416913763379853e-15	0	1	0.6431935215825413	2.3522246952166904e-14	0.0169491525423728
antimalarials/pharmacology	MAPK1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
ceruloplasmin/metabolism	ferroptosis/physiology	4.0234482412415673e-13	0	1	0.6431935215825413	1.894324954547841e-12	0.0254237288135593
ceruloplasmin/metabolism	biomarkers/chemistry	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
ceruloplasmin/metabolism	covid-19/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
ceruloplasmin/metabolism	inflammation/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
ceruloplasmin/metabolism	ferritins/chemistry	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
ceruloplasmin/metabolism	neoplasms/diagnosis	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
inflammation/metabolism	ferroptosis/physiology	4.0234482412415673e-13	0	1	0.6431935215825413	1.894324954547841e-12	0.0254237288135593
inflammation/metabolism	biomarkers/chemistry	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
inflammation/metabolism	covid-19/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
inflammation/metabolism	ferritins/chemistry	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
inflammation/metabolism	neoplasms/diagnosis	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
autophagy	neoplastic stem cells/pathology	0.0	0	1	0.6431935215825413	0.0	0.0254237288135593
autophagy	necrosis	0.0	0	1	0.6431935215825413	0.0	0.0254237288135593
autophagy	pyroptosis	0.0	0	1	0.6431935215825413	0.0	0.0254237288135593
ferritins/chemistry	ferroptosis/physiology	4.0234482412415673e-13	0	1	0.6431935215825413	1.894324954547841e-12	0.0254237288135593
ferritins/chemistry	biomarkers/chemistry	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
ferritins/chemistry	covid-19/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
ferritins/chemistry	neoplasms/diagnosis	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hemolysis	doxorubicin/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
hemolysis	antineoplastic agents/administration & dosage	8.4546925016582e-10	0	1	0.6431935215825413	2.953384699683184e-09	0.0423728813559322
neoplastic stem cells/metabolism	tumor microenvironment	5.1804063198046535e-05	0	1	0.6431935215825413	0.0001071482173022	0.1101694915254237
neoplastic stem cells/metabolism	mitochondria/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
neoplasms/diagnosis	ferroptosis/physiology	4.0234482412415673e-13	0	1	0.6431935215825413	1.894324954547841e-12	0.0254237288135593
neoplasms/diagnosis	biomarkers/chemistry	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
neoplasms/diagnosis	covid-19/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
pyroptosis	reactive oxygen species/metabolism	0.0009513001672776	0	1	0.6431935215825413	0.0016561935388152	0.1440677966101693
pyroptosis	necrosis	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
MAPK1	carcinogenesis/drug effects	1.7972456856085728e-08	0	1	0.6431935215825413	5.6430272074552674e-08	0.0254237288135593
MAPK1	antineoplastic agents	3.3450886505193006e-10	0	1	0.6431935215825413	1.2128435263378387e-09	0.0169491525423728
MAPK1	glioblastoma/drug therapy	3.4416913763379853e-15	0	1	0.6431935215825413	2.3522246952166904e-14	0.0169491525423728
biomarkers/chemistry	ferroptosis/physiology	4.0234482412415673e-13	0	1	0.6431935215825413	1.894324954547841e-12	0.0254237288135593
biomarkers/chemistry	covid-19/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
necrosis	reactive oxygen species/metabolism	0.0009513001672776	0	1	0.6431935215825413	0.0016561935388152	0.144067796610169
antineoplastic agents/administration & dosage	photosensitizing agents/administration & dosage	0.0010679811251681	0	1	0.6431935215825413	0.0018409168811264	0.1228101724887232
antineoplastic agents/administration & dosage	cerebrovascular disorders/drug therapy	1.2460033005368132e-12	0	1	0.6431935215825413	5.627223432359491e-12	0.0423728813559322
antineoplastic agents/administration & dosage	reactive oxygen species/antagonists & inhibitors	0.0	0	2	0.3223370757289844	0.0	0.0014486455164421
antineoplastic agents/administration & dosage	neuroprotective agents/administration & dosage	1.2460033005368132e-12	0	1	0.6431935215825413	5.627223432359491e-12	0.0423728813559322
antineoplastic agents/administration & dosage	doxorubicin/administration & dosage	4.043901339345624e-06	0	1	0.6431935215825413	9.334879785235064e-06	0.0832971171954223
antineoplastic agents/administration & dosage	pyroptosis/drug effects	0.0006545726870674	0	1	0.6431935215825413	0.001162439032099	0.1228101724887232
antineoplastic agents/administration & dosage	tongue neoplasms/drug therapy	4.3302904817466015e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0423728813559322
antineoplastic agents/administration & dosage	carcinoma squamous cell/drug therapy	4.3302904817466015e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0423728813559322
antineoplastic agents/administration & dosage	macromolecular substances/administration & dosage	4.3302904817466015e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0423728813559322
antineoplastic agents/administration & dosage	piperazines/administration & dosage	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.122810172488723
antineoplastic agents/administration & dosage	amino acid transport system y+/analysis	4.3302904817466015e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0423728813559322
antineoplastic agents/administration & dosage	BLVRB	1.2460033005368132e-12	0	1	0.6431935215825413	5.627223432359491e-12	0.0423728813559322
antineoplastic agents/administration & dosage	TFRC	0.0006545726870674	0	1	0.6431935215825413	0.001162439032099	0.122810172488723
covid-19/metabolism	ferroptosis/physiology	4.0234482412415673e-13	0	1	0.6431935215825413	1.894324954547841e-12	0.0254237288135593
mitochondria/metabolism	tumor microenvironment	5.1804063198046535e-05	0	1	0.6431935215825413	0.0001071482173022	0.1101694915254237
amyotrophic lateral sclerosis/drug therapy	motor neurons/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
amyotrophic lateral sclerosis/drug therapy	edaravone/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
amyotrophic lateral sclerosis/drug therapy	neuroprotective agents/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
amyotrophic lateral sclerosis/drug therapy	antioxidants/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0254237288135593
motor neurons/drug effects	edaravone/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
motor neurons/drug effects	antioxidants/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0254237288135593
motor neurons/drug effects	neuroprotective agents/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
edaravone/pharmacology	antioxidants/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0254237288135593
edaravone/pharmacology	neuroprotective agents/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
neuroprotective agents/pharmacology	antioxidants/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0254237288135593
antioxidants/pharmacology	necroptosis/drug effects	0.0006545726870674	0	1	0.6431935215825413	0.001162439032099	0.0991023393127427
antioxidants/pharmacology	carcinogenesis/drug effects	1.6986412276764898e-13	0	2	0.3223370757289844	8.139113768404655e-13	0.0012962879707473
antioxidants/pharmacology	proanthocyanidins/metabolism	1.8543679924931662e-09	0	1	0.6431935215825413	6.288333491593041e-09	0.0254237288135593
antioxidants/pharmacology	lysosomes/drug effects	3.6909999207024313e-06	0	1	0.6431935215825413	8.568957891178154e-06	0.0504128639721861
antioxidants/pharmacology	colorectal neoplasms/drug therapy	0.005580281586772	0	1	0.6431935215825413	0.0085592421064967	0.0991023393127427
antioxidants/pharmacology	plant extracts/pharmacology	3.723574202307845e-05	0	1	0.6431935215825413	7.824483435897424e-05	0.0504128639721861
antioxidants/pharmacology	methylene blue/pharmacology	1.5576429035490946e-13	0	1	0.6431935215825413	7.470860107278287e-13	0.0254237288135593
antioxidants/pharmacology	lipids/chemistry	1.5576429035490946e-13	0	1	0.6431935215825413	7.470860107278287e-13	0.0254237288135593
antioxidants/pharmacology	organoids/drug effects	1.8543679924931662e-09	0	1	0.6431935215825413	6.288333491593041e-09	0.0254237288135593
antioxidants/pharmacology	triple negative breast neoplasms/pathology	1.5576429035490946e-13	0	1	0.6431935215825413	7.470860107278287e-13	0.0254237288135593
antioxidants/pharmacology	diterpenes/pharmacology	1.8543679924931662e-09	0	1	0.6431935215825413	6.288333491593041e-09	0.0254237288135593
antioxidants/pharmacology	GCLC	0.0007823483151576	0	1	0.6431935215825413	0.0013853137135767	0.0749711519729055
antioxidants/pharmacology	GCLM	3.723574202307845e-05	0	1	0.6431935215825413	7.824483435897424e-05	0.0504128639721861
cell line tumor/drug effects	phospholipid hydroperoxide glutathione peroxidase/metabolism	1.4372473211565762e-09	0	1	0.6431935215825413	4.9321874619690124e-09	0.0338983050847457
cell line tumor/drug effects	lung neoplasms/drug therapy	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cell line tumor/drug effects	chlorophyllides/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cerebrovascular disorders/drug therapy	reactive oxygen species/antagonists & inhibitors	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
cerebrovascular disorders/drug therapy	neuroprotective agents/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cerebrovascular disorders/drug therapy	BLVRB	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cyclin-dependent kinase inhibitor p21/antagonists & inhibitors	antineoplastic agents/pharmacology	0.0001059938397611	0	1	0.6431935215825413	0.0002121182674152	0.0423728813559322
cyclin-dependent kinase inhibitor p21/antagonists & inhibitors	artesunate/administration & dosage	2.220446049250313e-14	0	1	0.6431935215825413	1.464172340730281e-13	0.0169491525423728
cyclin-dependent kinase inhibitor p21/antagonists & inhibitors	endoplasmic reticulum stress/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cyclin-dependent kinase inhibitor p21/antagonists & inhibitors	niacinamide/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cyclin-dependent kinase inhibitor p21/antagonists & inhibitors	phenylurea compounds/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cyclin-dependent kinase inhibitor p21/antagonists & inhibitors	neuroendocrine tumors/drug therapy	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cyclin-dependent kinase inhibitor p21/antagonists & inhibitors	EIF2S1	5.6210813781376594e-11	0	1	0.6431935215825413	2.175657629520637e-10	0.0169491525423728
proanthocyanidins/metabolism	HMOX1	0.0005988108866488	0	1	0.6431935215825413	0.0010731906769546	0.0423728813559322
proanthocyanidins/metabolism	carcinogenesis/drug effects	7.209571695199203e-08	0	1	0.6431935215825413	1.9726132998711802e-07	0.0254237288135593
proanthocyanidins/metabolism	colorectal neoplasms/drug therapy	4.3732695386156095e-05	0	1	0.6431935215825413	9.150254384574438e-05	0.0338983050847457
proanthocyanidins/metabolism	plant extracts/pharmacology	1.8543679924931662e-09	0	1	0.6431935215825413	6.288333491593041e-09	0.0169491525423728
proanthocyanidins/metabolism	organoids/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
proanthocyanidins/metabolism	diterpenes/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
proanthocyanidins/metabolism	GCLC	8.679791325683084e-07	0	1	0.6431935215825413	2.104309608460381e-06	0.0254237288135593
proanthocyanidins/metabolism	GCLM	1.8543679924931662e-09	0	1	0.6431935215825413	6.288333491593041e-09	0.0169491525423728
reactive oxygen species/antagonists & inhibitors	pyroptosis/drug effects	1.8543679924931662e-09	0	1	0.6431935215825413	6.288333491593041e-09	0.0504128639721861
reactive oxygen species/antagonists & inhibitors	neuroprotective agents/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
reactive oxygen species/antagonists & inhibitors	BLVRB	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
endoplasmic reticulum stress/drug effects	antineoplastic agents/pharmacology	0.0001059938397611	0	1	0.6431935215825413	0.0002121182674152	0.0423728813559322
endoplasmic reticulum stress/drug effects	artesunate/administration & dosage	2.220446049250313e-14	0	1	0.6431935215825413	1.464172340730281e-13	0.0169491525423728
endoplasmic reticulum stress/drug effects	niacinamide/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
endoplasmic reticulum stress/drug effects	phenylurea compounds/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
endoplasmic reticulum stress/drug effects	neuroendocrine tumors/drug therapy	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
endoplasmic reticulum stress/drug effects	EIF2S1	5.6210813781376594e-11	0	1	0.6431935215825413	2.175657629520637e-10	0.0169491525423728
lung neoplasms/drug therapy	phospholipid hydroperoxide glutathione peroxidase/metabolism	1.4372473211565762e-09	0	1	0.6431935215825413	4.9321874619690124e-09	0.0338983050847457
lung neoplasms/drug therapy	chlorophyllides/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
phenylurea compounds/administration & dosage	antineoplastic agents/pharmacology	0.0001059938397611	0	1	0.6431935215825413	0.0002121182674152	0.0423728813559322
phenylurea compounds/administration & dosage	artesunate/administration & dosage	2.220446049250313e-14	0	1	0.6431935215825413	1.464172340730281e-13	0.0169491525423728
phenylurea compounds/administration & dosage	niacinamide/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
phenylurea compounds/administration & dosage	neuroendocrine tumors/drug therapy	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
phenylurea compounds/administration & dosage	EIF2S1	5.6210813781376594e-11	0	1	0.6431935215825413	2.175657629520637e-10	0.0169491525423728
chlorophyllides/metabolism	phospholipid hydroperoxide glutathione peroxidase/metabolism	1.4372473211565762e-09	0	1	0.6431935215825413	4.9321874619690124e-09	0.0338983050847457
organoids/drug effects	HMOX1	0.0005988108866488	0	1	0.6431935215825413	0.0010731906769546	0.0423728813559322
organoids/drug effects	carcinogenesis/drug effects	7.209571695199203e-08	0	1	0.6431935215825413	1.9726132998711802e-07	0.0254237288135593
organoids/drug effects	colorectal neoplasms/drug therapy	4.3732695386156095e-05	0	1	0.6431935215825413	9.150254384574438e-05	0.0338983050847457
organoids/drug effects	plant extracts/pharmacology	1.8543679924931662e-09	0	1	0.6431935215825413	6.288333491593041e-09	0.0169491525423728
organoids/drug effects	diterpenes/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
organoids/drug effects	GCLC	8.679791325683084e-07	0	1	0.6431935215825413	2.104309608460381e-06	0.0254237288135593
organoids/drug effects	GCLM	1.8543679924931662e-09	0	1	0.6431935215825413	6.288333491593041e-09	0.0169491525423728
diterpenes/pharmacology	HMOX1	0.0005988108866488	0	1	0.6431935215825413	0.0010731906769546	0.0423728813559322
diterpenes/pharmacology	carcinogenesis/drug effects	7.209571695199203e-08	0	1	0.6431935215825413	1.9726132998711802e-07	0.0254237288135593
diterpenes/pharmacology	colorectal neoplasms/drug therapy	4.3732695386156095e-05	0	1	0.6431935215825413	9.150254384574438e-05	0.0338983050847457
diterpenes/pharmacology	plant extracts/pharmacology	1.8543679924931662e-09	0	1	0.6431935215825413	6.288333491593041e-09	0.0169491525423728
diterpenes/pharmacology	GCLC	8.679791325683084e-07	0	1	0.6431935215825413	2.104309608460381e-06	0.0254237288135593
diterpenes/pharmacology	GCLM	1.8543679924931662e-09	0	1	0.6431935215825413	6.288333491593041e-09	0.0169491525423728
neuroendocrine tumors/drug therapy	antineoplastic agents/pharmacology	0.0001059938397611	0	1	0.6431935215825413	0.0002121182674152	0.0423728813559322
neuroendocrine tumors/drug therapy	artesunate/administration & dosage	2.220446049250313e-14	0	1	0.6431935215825413	1.464172340730281e-13	0.0169491525423728
neuroendocrine tumors/drug therapy	niacinamide/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
neuroendocrine tumors/drug therapy	EIF2S1	5.6210813781376594e-11	0	1	0.6431935215825413	2.175657629520637e-10	0.0169491525423728
BLVRB	neuroprotective agents/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
niacinamide/administration & dosage	antineoplastic agents/pharmacology	0.0001059938397611	0	1	0.6431935215825413	0.0002121182674152	0.0423728813559322
niacinamide/administration & dosage	artesunate/administration & dosage	2.220446049250313e-14	0	1	0.6431935215825413	1.464172340730281e-13	0.0169491525423728
niacinamide/administration & dosage	EIF2S1	5.6210813781376594e-11	0	1	0.6431935215825413	2.175657629520637e-10	0.0169491525423728
tumor microenvironment	metal-organic frameworks/therapeutic use	2.6503952971213e-06	0	1	0.6431935215825413	6.212302204363682e-06	0.1101694915254238
tumor microenvironment	photosensitizing agents	0.0006124224873796	0	1	0.6431935215825413	0.0010939643625371	0.2090395480225995
tumor microenvironment	glypicans/therapeutic use	1.4421568432787524e-05	0	1	0.6431935215825413	3.147169859962992e-05	0.1101694915254238
tumor microenvironment	chlorophyllides/pharmacology	5.1804063198046535e-05	0	1	0.6431935215825413	0.0001071482173022	0.1101694915254237
tumor microenvironment	hydrogen peroxide/therapeutic use	2.6503952971213e-06	0	1	0.6431935215825413	6.212302204363682e-06	0.1101694915254237
tumor microenvironment	cell membrane	2.6503952971213e-06	0	1	0.6431935215825413	6.212302204363682e-06	0.1101694915254237
tumor microenvironment	carcinoma hepatocellular/diagnostic imaging	1.4421568432787524e-05	0	1	0.6431935215825413	3.147169859962992e-05	0.1101694915254237
tumor microenvironment	lipid peroxides	1.4421568432787524e-05	0	1	0.6431935215825413	3.147169859962992e-05	0.1101694915254237
tumor microenvironment	oxygen/pharmacology	5.1804063198046535e-05	0	1	0.6431935215825413	0.0001071482173022	0.1101694915254237
metal-organic frameworks/therapeutic use	breast neoplasms/drug therapy	2.3314683517128287e-15	0	1	0.6431935215825413	1.6184110082473813e-14	0.0338983050847457
metal-organic frameworks/therapeutic use	hydrogen peroxide/therapeutic use	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
metal-organic frameworks/therapeutic use	cell membrane	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
photosensitizing agents	singlet oxygen	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
photosensitizing agents	neoplasms	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
photosensitizing agents	PCLAF	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
glypicans/therapeutic use	carcinoma hepatocellular/diagnostic imaging	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
glypicans/therapeutic use	lipid peroxides	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
chlorophyllides/pharmacology	oxygen/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
chlorophyllides/pharmacology	CD47	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
hydrogen peroxide/therapeutic use	breast neoplasms/drug therapy	2.3314683517128287e-15	0	1	0.6431935215825413	1.6184110082473813e-14	0.0338983050847457
hydrogen peroxide/therapeutic use	cell membrane	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cell membrane	breast neoplasms/drug therapy	2.3314683517128287e-15	0	1	0.6431935215825413	1.6184110082473813e-14	0.0338983050847457
carcinoma hepatocellular/diagnostic imaging	lipid peroxides	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
oxygen/pharmacology	CD47	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
phenylenediamines/administration & dosage	epithelial cells/drug effects	1.574785828406533e-07	0	1	0.6431935215825413	4.175153069545722e-07	0.0169491525423728
phenylenediamines/administration & dosage	adenine/administration & dosage	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
phenylenediamines/administration & dosage	cyclohexylamines/administration & dosage	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
phenylenediamines/administration & dosage	ovalbumin/adverse effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
phenylenediamines/administration & dosage	bronchi/cytology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
phenylenediamines/administration & dosage	asthma/chemically induced	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
phenylenediamines/administration & dosage	interleukin-13/pharmacology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
phenylenediamines/administration & dosage	IL13	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
phenylenediamines/administration & dosage	IL1B	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
phenylenediamines/administration & dosage	IL6	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
sorafenib/administration & dosage	artesunate/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
adenine/administration & dosage	epithelial cells/drug effects	1.574785828406533e-07	0	1	0.6431935215825413	4.175153069545722e-07	0.0169491525423728
adenine/administration & dosage	cyclohexylamines/administration & dosage	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
adenine/administration & dosage	ovalbumin/adverse effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
adenine/administration & dosage	bronchi/cytology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
adenine/administration & dosage	asthma/chemically induced	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
adenine/administration & dosage	interleukin-13/pharmacology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
adenine/administration & dosage	IL13	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
adenine/administration & dosage	IL1B	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
adenine/administration & dosage	IL6	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
artesunate/administration & dosage	antineoplastic agents/pharmacology	0.0020598616168203	0	1	0.6431935215825413	0.0033980046238204	0.0832971171954222
artesunate/administration & dosage	EIF2S1	1.5172858669476597e-07	0	1	0.6431935215825413	4.066960412341004e-07	0.0337534405331015
retinal pigment epithelium/cytology	ferrocyanides/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
retinal pigment epithelium/cytology	iodates/adverse effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
retinal pigment epithelium/cytology	macular degeneration/chemically induced	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
bronchi/cytology	epithelial cells/drug effects	1.574785828406533e-07	0	1	0.6431935215825413	4.175153069545722e-07	0.0169491525423728
bronchi/cytology	cyclohexylamines/administration & dosage	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
bronchi/cytology	ovalbumin/adverse effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
bronchi/cytology	asthma/chemically induced	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
bronchi/cytology	interleukin-13/pharmacology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
bronchi/cytology	IL13	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
bronchi/cytology	IL1B	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
bronchi/cytology	IL6	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
asthma/chemically induced	epithelial cells/drug effects	1.574785828406533e-07	0	1	0.6431935215825413	4.175153069545722e-07	0.0169491525423728
asthma/chemically induced	cyclohexylamines/administration & dosage	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
asthma/chemically induced	ovalbumin/adverse effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
asthma/chemically induced	interleukin-13/pharmacology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
asthma/chemically induced	IL13	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
asthma/chemically induced	IL1B	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
asthma/chemically induced	IL6	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
iodates/adverse effects	ferrocyanides/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
iodates/adverse effects	macular degeneration/chemically induced	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
macular degeneration/chemically induced	ferrocyanides/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
interleukin-13/pharmacology	epithelial cells/drug effects	1.574785828406533e-07	0	1	0.6431935215825413	4.175153069545722e-07	0.0169491525423728
interleukin-13/pharmacology	cyclohexylamines/administration & dosage	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
interleukin-13/pharmacology	ovalbumin/adverse effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
interleukin-13/pharmacology	IL13	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
interleukin-13/pharmacology	IL1B	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
interleukin-13/pharmacology	IL6	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
epithelial cells/drug effects	pyroptosis/drug effects	0.0001010832823041	0	1	0.6431935215825413	0.0002030415641666	0.0504128639721861
epithelial cells/drug effects	retinal drusen/genetics	1.574785828406533e-07	0	1	0.6431935215825413	4.175153069545722e-07	0.0169491525423728
epithelial cells/drug effects	macular degeneration/genetics	1.574785828406533e-07	0	1	0.6431935215825413	4.175153069545722e-07	0.0169491525423728
epithelial cells/drug effects	bevacizumab/therapeutic use	1.574785828406533e-07	0	1	0.6431935215825413	4.175153069545722e-07	0.0169491525423728
epithelial cells/drug effects	vascular endothelial growth factor a/antagonists & inhibitors	1.574785828406533e-07	0	1	0.6431935215825413	4.175153069545722e-07	0.0169491525423728
epithelial cells/drug effects	verteporfin/therapeutic use	1.574785828406533e-07	0	1	0.6431935215825413	4.175153069545722e-07	0.0169491525423728
epithelial cells/drug effects	aging/genetics	1.574785828406533e-07	0	1	0.6431935215825413	4.175153069545722e-07	0.0169491525423728
epithelial cells/drug effects	ranibizumab/therapeutic use	1.574785828406533e-07	0	1	0.6431935215825413	4.175153069545722e-07	0.0169491525423728
epithelial cells/drug effects	necroptosis/drug effects	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.0669274228596264
epithelial cells/drug effects	retinal pigment epithelium/drug effects	1.574785828406533e-07	0	1	0.6431935215825413	4.175153069545722e-07	0.0169491525423728
epithelial cells/drug effects	cyclohexylamines/administration & dosage	1.574785828406533e-07	0	1	0.6431935215825413	4.175153069545722e-07	0.0169491525423728
epithelial cells/drug effects	ovalbumin/adverse effects	1.574785828406533e-07	0	1	0.6431935215825413	4.175153069545722e-07	0.0169491525423728
epithelial cells/drug effects	IL13	1.574785828406533e-07	0	1	0.6431935215825413	4.175153069545722e-07	0.0169491525423728
epithelial cells/drug effects	IL1B	1.574785828406533e-07	0	1	0.6431935215825413	4.175153069545722e-07	0.0169491525423728
epithelial cells/drug effects	IL6	1.574785828406533e-07	0	1	0.6431935215825413	4.175153069545722e-07	0.0169491525423728
epithelial cells/drug effects	RPE	1.574785828406533e-07	0	1	0.6431935215825413	4.175153069545722e-07	0.0169491525423728
IL13	cyclohexylamines/administration & dosage	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
IL13	ovalbumin/adverse effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
IL13	IL1B	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
IL13	IL6	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
IL1B	cyclohexylamines/administration & dosage	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
IL1B	ovalbumin/adverse effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
IL1B	IL6	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
IL6	cyclohexylamines/administration & dosage	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
IL6	ovalbumin/adverse effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
cyclohexylamines/administration & dosage	ovalbumin/adverse effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
antineoplastic agents	gene expression regulation neoplastic/drug effects	0.0007823483151576	0	1	0.6431935215825413	0.0013853137135767	0.0504128639721861
antineoplastic agents	carcinogenesis/drug effects	0.0002272434002398	0	1	0.6431935215825413	0.000434939940836	0.0504128639721861
antineoplastic agents	glioblastoma/drug therapy	2.106653107514234e-07	0	1	0.6431935215825413	5.56407620212296e-07	0.0337534405331015
glioblastoma/drug therapy	carcinogenesis/drug effects	3.3640379001331766e-06	0	1	0.6431935215825413	7.817337476084392e-06	0.0504128639721861
glioblastoma/drug therapy	pharmaceutical preparations	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
glioblastoma/drug therapy	IFNG	6.105088778962653e-08	0	1	0.6431935215825413	1.6788994142147298e-07	0.0504128639721861
glioblastoma/drug therapy	PDCD1	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
ferroptosis/physiology	disease/etiology	0.0	0	1	0.6431935215825413	0.0	0.0254237288135593
ferroptosis/physiology	mitochondria/pathology	3.6034164541121067e-10	0	1	0.6431935215825413	1.288294085171555e-09	0.0254237288135593
ferroptosis/physiology	cell movement/physiology	3.6034164541121067e-10	0	1	0.6431935215825413	1.288294085171555e-09	0.0254237288135593
ferroptosis/physiology	neoplasms/pathology	6.105088778962653e-08	0	1	0.6431935215825413	1.6788994142147298e-07	0.0504128639721861
ferroptosis/physiology	metabolism	0.0	0	1	0.6431935215825413	0.0	0.0254237288135593
ferroptosis/physiology	mitophagy/physiology	3.6034164541121067e-10	0	1	0.6431935215825413	1.288294085171555e-09	0.0254237288135593
ferroptosis/physiology	disease progression	3.6034164541121067e-10	0	1	0.6431935215825413	1.288294085171555e-09	0.0254237288135593
ferroptosis/physiology	DENR	3.6034164541121067e-10	0	1	0.6431935215825413	1.288294085171555e-09	0.0254237288135593
ferroptosis/physiology	DNM1L	3.6034164541121067e-10	0	1	0.6431935215825413	1.288294085171555e-09	0.0254237288135593
ferroptosis/physiology	FKBP8	3.6034164541121067e-10	0	1	0.6431935215825413	1.288294085171555e-09	0.0254237288135593
ferroptosis/physiology	FUNDC1	3.6034164541121067e-10	0	1	0.6431935215825413	1.288294085171555e-09	0.0254237288135593
ferroptosis/physiology	PINK1	3.6034164541121067e-10	0	1	0.6431935215825413	1.288294085171555e-09	0.0254237288135593
ferroptosis/physiology	UTRN	3.6034164541121067e-10	0	1	0.6431935215825413	1.288294085171555e-09	0.0254237288135593
breast neoplasms/pathology	phospholipid hydroperoxide glutathione peroxidase/metabolism	1.609823385706477e-14	0	1	0.6431935215825413	1.0790466793050429e-13	0.0338983050847457
breast neoplasms/pathology	adenosine triphosphate	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
breast neoplasms/pathology	biomarkers tumor/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
breast neoplasms/pathology	HDAC1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
porphyrins/therapeutic use	iron/therapeutic use	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cerebral hemorrhage	curcumin/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cerebral hemorrhage	P4HB	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cerebral hemorrhage	PADI1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cerebral hemorrhage	PDIA2	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
phospholipid hydroperoxide glutathione peroxidase	GPX4	0.0008210403085373	0	1	0.6431935215825413	0.0014480381554478	0.1864406779661013
phospholipid hydroperoxide glutathione peroxidase	ACSL4	0.0	0	1	0.6431935215825413	0.0	0.0423728813559322
phospholipid hydroperoxide glutathione peroxidase	MCU	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
curcumin/pharmacology	P4HB	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
curcumin/pharmacology	PADI1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
curcumin/pharmacology	PDIA2	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
adenosine triphosphate	phospholipid hydroperoxide glutathione peroxidase/metabolism	1.609823385706477e-14	0	1	0.6431935215825413	1.0790466793050429e-13	0.0338983050847457
adenosine triphosphate	biomarkers tumor/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
adenosine triphosphate	HDAC1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
immunogenic cell death	neoplasms/pathology	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
lipid peroxides/therapeutic use	mcf-7 cells	0.0	0	1	0.6431935215825413	0.0	0.0254237288135593
lipid peroxides/therapeutic use	breast neoplasms/therapy	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
lipid peroxides/therapeutic use	SERPINB6	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
singlet oxygen	neoplasms	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
singlet oxygen	PCLAF	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
neoplasms	PCLAF	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
biomarkers tumor/metabolism	phospholipid hydroperoxide glutathione peroxidase/metabolism	1.609823385706477e-14	0	1	0.6431935215825413	1.0790466793050429e-13	0.0338983050847457
biomarkers tumor/metabolism	HDAC1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
pharmaceutical preparations	IFNG	0.0	0	1	0.6431935215825413	0.0	0.0254237288135593
pharmaceutical preparations	PDCD1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
HDAC1	phospholipid hydroperoxide glutathione peroxidase/metabolism	1.609823385706477e-14	0	1	0.6431935215825413	1.0790466793050429e-13	0.0338983050847457
KEAP1	nf-e2-related factor 2/genetics	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
KEAP1	GABPA	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
KEAP1	NFE2L2	4.3302904817466015e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0508474576271186
KEAP1	covid-19	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
MCU	GPX4	0.0008210403085373	0	1	0.6431935215825413	0.0014480381554478	0.186440677966102
MCU	ACSL4	0.0	0	1	0.6431935215825413	0.0	0.0423728813559322
P4HB	PADI1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
P4HB	PDIA2	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
PADI1	PDIA2	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
PDCD1	IFNG	0.0	0	1	0.6431935215825413	0.0	0.0254237288135593
SERPINB6	mcf-7 cells	0.0	0	1	0.6431935215825413	0.0	0.0254237288135593
SERPINB6	breast neoplasms/therapy	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
breast neoplasms/therapy	mcf-7 cells	0.0	0	1	0.6431935215825413	0.0	0.0254237288135593
covid-19	nf-e2-related factor 2/genetics	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
covid-19	GABPA	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
covid-19	NFE2L2	4.3302904817466015e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0508474576271186
cell proliferation/genetics	rna long noncoding/physiology	9.192074035269117e-08	0	1	0.6431935215825413	2.4816053614330416e-07	0.0169491525423728
cell proliferation/genetics	endometrium/cytology	9.192074035269117e-08	0	1	0.6431935215825413	2.4816053614330416e-07	0.0169491525423728
cell proliferation/genetics	micrornas/genetics	9.192074035269117e-08	0	1	0.6431935215825413	2.4816053614330416e-07	0.0169491525423728
cell proliferation/genetics	cell movement/genetics	9.192074035269117e-08	0	1	0.6431935215825413	2.4816053614330416e-07	0.0169491525423728
cell proliferation/genetics	gene expression regulation neoplastic/drug effects	0.0012608286884825	0	1	0.6431935215825413	0.0021580675092994	0.0504128639721861
cell proliferation/genetics	stromal cells/physiology	9.192074035269117e-08	0	1	0.6431935215825413	2.4816053614330416e-07	0.0169491525423728
cell proliferation/genetics	homocysteine/genetics	2.8886264269445405e-08	0	1	0.6431935215825413	8.797672861562966e-08	0.0169491525423728
cell proliferation/genetics	activating transcription factor 4/genetics	2.8886264269445405e-08	0	1	0.6431935215825413	8.797672861562966e-08	0.0169491525423728
cell proliferation/genetics	nf-e2-related factor 2/genetics	2.6503952971213e-06	0	1	0.6431935215825413	6.212302204363682e-06	0.0337534405331015
cell proliferation/genetics	melanoma/drug therapy	0.0006124224873796	0	1	0.6431935215825413	0.0010939643625371	0.0504128639721861
cell proliferation/genetics	apoptosis/genetics	2.8886264269445405e-08	0	1	0.6431935215825413	8.797672861562966e-08	0.0169491525423728
cell proliferation/genetics	methionine/antagonists & inhibitors	2.8886264269445405e-08	0	1	0.6431935215825413	8.797672861562966e-08	0.0169491525423728
cell proliferation/genetics	endometriosis/genetics	9.192074035269117e-08	0	1	0.6431935215825413	2.4816053614330416e-07	0.0169491525423728
cell proliferation/genetics	adamts9 protein/physiology	9.192074035269117e-08	0	1	0.6431935215825413	2.4816053614330416e-07	0.0169491525423728
cell proliferation/genetics	cysteine/antagonists & inhibitors	2.8886264269445405e-08	0	1	0.6431935215825413	8.797672861562966e-08	0.0169491525423728
cell proliferation/genetics	cells cultured	0.0012608286884825	0	1	0.6431935215825413	0.0021580675092994	0.0504128639721861
cell proliferation/genetics	ferroptosis/genetics	2.639591101250005e-09	0	2	0.3223370757289844	8.932449608605052e-09	0.0008691873098652
cell proliferation/genetics	ADAMTS9-AS1	9.192074035269117e-08	0	1	0.6431935215825413	2.4816053614330416e-07	0.0169491525423728
cell proliferation/genetics	ATF4	7.422353092412237e-05	0	1	0.6431935215825413	0.0001517798011721	0.0337534405331015
cell proliferation/genetics	GABPA	2.6503952971213e-06	0	1	0.6431935215825413	6.212302204363682e-06	0.0337534405331015
cell proliferation/genetics	MIR6516	9.192074035269117e-08	0	1	0.6431935215825413	2.4816053614330416e-07	0.0337534405331015
cell proliferation/genetics	gene expression/genetics	2.293791829210967e-05	0	1	0.6431935215825413	4.91973925340891e-05	0.0337534405331015
rna long noncoding/physiology	endometrium/cytology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
rna long noncoding/physiology	micrornas/genetics	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
rna long noncoding/physiology	cell movement/genetics	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
rna long noncoding/physiology	stromal cells/physiology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
rna long noncoding/physiology	endometriosis/genetics	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
rna long noncoding/physiology	adamts9 protein/physiology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
rna long noncoding/physiology	cells cultured	5.506449314074402e-06	0	1	0.6431935215825413	1.2503694085500728e-05	0.0254237288135593
rna long noncoding/physiology	ferroptosis/genetics	2.6114209231042903e-05	0	1	0.6431935215825413	5.569126546296371e-05	0.0338983050847457
rna long noncoding/physiology	ADAMTS9-AS1	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
rna long noncoding/physiology	MIR6516	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0169491525423728
rna long noncoding/physiology	gene expression/genetics	3.026972561492869e-09	0	1	0.6431935215825413	1.0172715373899828e-08	0.0169491525423728
endometrium/cytology	micrornas/genetics	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
endometrium/cytology	cell movement/genetics	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
endometrium/cytology	stromal cells/physiology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
endometrium/cytology	gene expression/genetics	3.026972561492869e-09	0	1	0.6431935215825413	1.0172715373899828e-08	0.0169491525423728
endometrium/cytology	endometriosis/genetics	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
endometrium/cytology	adamts9 protein/physiology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
endometrium/cytology	cells cultured	5.506449314074402e-06	0	1	0.6431935215825413	1.2503694085500728e-05	0.0254237288135593
endometrium/cytology	ferroptosis/genetics	2.6114209231042903e-05	0	1	0.6431935215825413	5.569126546296371e-05	0.0338983050847457
endometrium/cytology	ADAMTS9-AS1	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
endometrium/cytology	MIR6516	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0169491525423728
micrornas/genetics	gene expression/genetics	3.026972561492869e-09	0	1	0.6431935215825413	1.0172715373899828e-08	0.0169491525423728
micrornas/genetics	cell movement/genetics	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
micrornas/genetics	stromal cells/physiology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
micrornas/genetics	endometriosis/genetics	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
micrornas/genetics	adamts9 protein/physiology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
micrornas/genetics	cells cultured	5.506449314074402e-06	0	1	0.6431935215825413	1.2503694085500728e-05	0.0254237288135593
micrornas/genetics	ferroptosis/genetics	2.6114209231042903e-05	0	1	0.6431935215825413	5.569126546296371e-05	0.0338983050847457
micrornas/genetics	ADAMTS9-AS1	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
micrornas/genetics	MIR6516	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0169491525423728
cell movement/genetics	gene expression/genetics	3.026972561492869e-09	0	1	0.6431935215825413	1.0172715373899828e-08	0.0169491525423728
cell movement/genetics	stromal cells/physiology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
cell movement/genetics	endometriosis/genetics	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
cell movement/genetics	adamts9 protein/physiology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
cell movement/genetics	cells cultured	5.506449314074402e-06	0	1	0.6431935215825413	1.2503694085500728e-05	0.0254237288135593
cell movement/genetics	ferroptosis/genetics	2.6114209231042903e-05	0	1	0.6431935215825413	5.569126546296371e-05	0.0338983050847457
cell movement/genetics	ADAMTS9-AS1	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
cell movement/genetics	MIR6516	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0169491525423728
gene expression regulation neoplastic/drug effects	homocysteine/genetics	2.343975940899412e-06	0	1	0.6431935215825413	5.520635456743758e-06	0.0254237288135593
gene expression regulation neoplastic/drug effects	activating transcription factor 4/genetics	2.343975940899412e-06	0	1	0.6431935215825413	5.520635456743758e-06	0.0254237288135593
gene expression regulation neoplastic/drug effects	nf-e2-related factor 2/genetics	6.604701641632627e-05	0	1	0.6431935215825413	0.0001359725859724	0.0504128639721861
gene expression regulation neoplastic/drug effects	melanoma/drug therapy	0.0037717988488256	0	1	0.6431935215825413	0.0059578527683394	0.0749711519729055
gene expression regulation neoplastic/drug effects	apoptosis/genetics	2.343975940899412e-06	0	1	0.6431935215825413	5.520635456743758e-06	0.0254237288135593
gene expression regulation neoplastic/drug effects	methionine/antagonists & inhibitors	2.343975940899412e-06	0	1	0.6431935215825413	5.520635456743758e-06	0.0254237288135593
gene expression regulation neoplastic/drug effects	cysteine/antagonists & inhibitors	2.343975940899412e-06	0	1	0.6431935215825413	5.520635456743758e-06	0.0254237288135593
gene expression regulation neoplastic/drug effects	ATF4	0.0007823483151576	0	1	0.6431935215825413	0.0013853137135767	0.0504128639721861
gene expression regulation neoplastic/drug effects	GABPA	6.604701641632627e-05	0	1	0.6431935215825413	0.0001359725859724	0.0504128639721861
stromal cells/physiology	gene expression/genetics	3.026972561492869e-09	0	1	0.6431935215825413	1.0172715373899828e-08	0.0169491525423728
stromal cells/physiology	endometriosis/genetics	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
stromal cells/physiology	adamts9 protein/physiology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
stromal cells/physiology	cells cultured	5.506449314074402e-06	0	1	0.6431935215825413	1.2503694085500728e-05	0.0254237288135593
stromal cells/physiology	ferroptosis/genetics	2.6114209231042903e-05	0	1	0.6431935215825413	5.569126546296371e-05	0.0338983050847457
stromal cells/physiology	ADAMTS9-AS1	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
stromal cells/physiology	MIR6516	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0169491525423728
homocysteine/genetics	activating transcription factor 4/genetics	8.881784197001252e-16	0	1	0.6431935215825413	6.3183845827718386e-15	0.0084745762711864
homocysteine/genetics	nf-e2-related factor 2/genetics	9.225953334635052e-12	0	1	0.6431935215825413	3.8100059830234406e-11	0.0169491525423728
homocysteine/genetics	melanoma/drug therapy	5.53103744915795e-07	0	1	0.6431935215825413	1.3965153103495694e-06	0.0254237288135593
homocysteine/genetics	apoptosis/genetics	8.881784197001252e-16	0	1	0.6431935215825413	6.3183845827718386e-15	0.0084745762711864
homocysteine/genetics	methionine/antagonists & inhibitors	8.881784197001252e-16	0	1	0.6431935215825413	6.3183845827718386e-15	0.0084745762711864
homocysteine/genetics	cysteine/antagonists & inhibitors	8.881784197001252e-16	0	1	0.6431935215825413	6.3183845827718386e-15	0.0084745762711864
homocysteine/genetics	ferroptosis/genetics	1.2463632624526433e-05	0	1	0.6431935215825413	2.740761813146088e-05	0.0338983050847457
homocysteine/genetics	ATF4	7.922876021915215e-09	0	1	0.6431935215825413	2.5416836639099963e-08	0.0169491525423728
homocysteine/genetics	GABPA	9.225953334635052e-12	0	1	0.6431935215825413	3.8100059830234406e-11	0.0169491525423728
homocysteine/genetics	NFE2L2	0.0008437390094017	0	1	0.6431935215825413	0.0014757861424316	0.0508474576271186
activating transcription factor 4/genetics	nf-e2-related factor 2/genetics	9.225953334635052e-12	0	1	0.6431935215825413	3.8100059830234406e-11	0.0169491525423728
activating transcription factor 4/genetics	melanoma/drug therapy	5.53103744915795e-07	0	1	0.6431935215825413	1.3965153103495694e-06	0.0254237288135593
activating transcription factor 4/genetics	apoptosis/genetics	8.881784197001252e-16	0	1	0.6431935215825413	6.3183845827718386e-15	0.0084745762711864
activating transcription factor 4/genetics	methionine/antagonists & inhibitors	8.881784197001252e-16	0	1	0.6431935215825413	6.3183845827718386e-15	0.0084745762711864
activating transcription factor 4/genetics	cysteine/antagonists & inhibitors	8.881784197001252e-16	0	1	0.6431935215825413	6.3183845827718386e-15	0.0084745762711864
activating transcription factor 4/genetics	ferroptosis/genetics	1.2463632624526433e-05	0	1	0.6431935215825413	2.740761813146088e-05	0.0338983050847457
activating transcription factor 4/genetics	ATF4	7.922876021915215e-09	0	1	0.6431935215825413	2.5416836639099963e-08	0.0169491525423728
activating transcription factor 4/genetics	GABPA	9.225953334635052e-12	0	1	0.6431935215825413	3.8100059830234406e-11	0.0169491525423728
activating transcription factor 4/genetics	NFE2L2	0.0008437390094017	0	1	0.6431935215825413	0.0014757861424316	0.0508474576271186
nf-e2-related factor 2/genetics	melanoma/drug therapy	2.293791829210967e-05	0	1	0.6431935215825413	4.91973925340891e-05	0.0504128639721861
nf-e2-related factor 2/genetics	apoptosis/genetics	9.225953334635052e-12	0	1	0.6431935215825413	3.8100059830234406e-11	0.0169491525423728
nf-e2-related factor 2/genetics	methionine/antagonists & inhibitors	9.225953334635052e-12	0	1	0.6431935215825413	3.8100059830234406e-11	0.0169491525423728
nf-e2-related factor 2/genetics	cysteine/antagonists & inhibitors	9.225953334635052e-12	0	1	0.6431935215825413	3.8100059830234406e-11	0.0169491525423728
nf-e2-related factor 2/genetics	ferroptosis/genetics	0.0002250279626806	0	1	0.6431935215825413	0.0004312077318689	0.0669274228596261
nf-e2-related factor 2/genetics	ATF4	1.0308646052337167e-06	0	1	0.6431935215825413	2.470931245107674e-06	0.0337534405331015
nf-e2-related factor 2/genetics	GABPA	0.0	0	2	0.3223370757289844	0.0	0.0001448645516442
nf-e2-related factor 2/genetics	NFE2L2	2.0098735120654965e-08	0	2	0.3223370757289844	6.278277964291772e-08	0.0021729682746631
melanoma/drug therapy	benzophenanthridines/pharmacology	6.797857805773688e-06	0	1	0.6431935215825413	1.529361084373739e-05	0.0254237288135593
melanoma/drug therapy	cation transport proteins/genetics	6.797857805773688e-06	0	1	0.6431935215825413	1.529361084373739e-05	0.0254237288135593
melanoma/drug therapy	diosgenin/analogs & derivatives	6.797857805773688e-06	0	1	0.6431935215825413	1.529361084373739e-05	0.0254237288135593
melanoma/drug therapy	phenylenediamines/pharmacology	0.0004742932395011	0	1	0.6431935215825413	0.0008662784692986	0.0504128639721861
melanoma/drug therapy	skin neoplasms/drug therapy	2.293791829210967e-05	0	1	0.6431935215825413	4.91973925340891e-05	0.0504128639721861
melanoma/drug therapy	transferrin/genetics	6.797857805773688e-06	0	1	0.6431935215825413	1.529361084373739e-05	0.0254237288135593
melanoma/drug therapy	apoptosis/genetics	5.53103744915795e-07	0	1	0.6431935215825413	1.3965153103495694e-06	0.0254237288135593
melanoma/drug therapy	methionine/antagonists & inhibitors	5.53103744915795e-07	0	1	0.6431935215825413	1.3965153103495694e-06	0.0254237288135593
melanoma/drug therapy	cysteine/antagonists & inhibitors	5.53103744915795e-07	0	1	0.6431935215825413	1.3965153103495694e-06	0.0254237288135593
melanoma/drug therapy	cyclohexylamines/pharmacology	0.0004742932395011	0	1	0.6431935215825413	0.0008662784692986	0.0504128639721861
melanoma/drug therapy	rna small interfering	6.797857805773688e-06	0	1	0.6431935215825413	1.529361084373739e-05	0.0254237288135593
melanoma/drug therapy	malondialdehyde/metabolism	6.797857805773688e-06	0	1	0.6431935215825413	1.529361084373739e-05	0.0254237288135593
melanoma/drug therapy	ATF4	0.0003601294793559	0	1	0.6431935215825413	0.000663231652646	0.0504128639721861
melanoma/drug therapy	GABPA	2.293791829210967e-05	0	1	0.6431935215825413	4.91973925340891e-05	0.0504128639721861
apoptosis/genetics	methionine/antagonists & inhibitors	8.881784197001252e-16	0	1	0.6431935215825413	6.3183845827718386e-15	0.0084745762711864
apoptosis/genetics	cysteine/antagonists & inhibitors	8.881784197001252e-16	0	1	0.6431935215825413	6.3183845827718386e-15	0.0084745762711864
apoptosis/genetics	ferroptosis/genetics	1.2463632624526433e-05	0	1	0.6431935215825413	2.740761813146088e-05	0.0338983050847457
apoptosis/genetics	ATF4	7.922876021915215e-09	0	1	0.6431935215825413	2.5416836639099963e-08	0.0169491525423728
apoptosis/genetics	GABPA	9.225953334635052e-12	0	1	0.6431935215825413	3.8100059830234406e-11	0.0169491525423728
apoptosis/genetics	NFE2L2	0.0008437390094017	0	1	0.6431935215825413	0.0014757861424316	0.0508474576271186
methionine/antagonists & inhibitors	cysteine/antagonists & inhibitors	8.881784197001252e-16	0	1	0.6431935215825413	6.3183845827718386e-15	0.0084745762711864
methionine/antagonists & inhibitors	ferroptosis/genetics	1.2463632624526433e-05	0	1	0.6431935215825413	2.740761813146088e-05	0.0338983050847457
methionine/antagonists & inhibitors	ATF4	7.922876021915215e-09	0	1	0.6431935215825413	2.5416836639099963e-08	0.0169491525423728
methionine/antagonists & inhibitors	GABPA	9.225953334635052e-12	0	1	0.6431935215825413	3.8100059830234406e-11	0.0169491525423728
methionine/antagonists & inhibitors	NFE2L2	0.0008437390094017	0	1	0.6431935215825413	0.0014757861424316	0.0508474576271186
endometriosis/genetics	gene expression/genetics	3.026972561492869e-09	0	1	0.6431935215825413	1.0172715373899828e-08	0.0169491525423728
endometriosis/genetics	adamts9 protein/physiology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
endometriosis/genetics	cells cultured	5.506449314074402e-06	0	1	0.6431935215825413	1.2503694085500728e-05	0.0254237288135593
endometriosis/genetics	ferroptosis/genetics	2.6114209231042903e-05	0	1	0.6431935215825413	5.569126546296371e-05	0.0338983050847457
endometriosis/genetics	ADAMTS9-AS1	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
endometriosis/genetics	MIR6516	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0169491525423728
adamts9 protein/physiology	gene expression/genetics	3.026972561492869e-09	0	1	0.6431935215825413	1.0172715373899828e-08	0.0169491525423728
adamts9 protein/physiology	cells cultured	5.506449314074402e-06	0	1	0.6431935215825413	1.2503694085500728e-05	0.0254237288135593
adamts9 protein/physiology	ferroptosis/genetics	2.6114209231042903e-05	0	1	0.6431935215825413	5.569126546296371e-05	0.0338983050847457
adamts9 protein/physiology	ADAMTS9-AS1	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
adamts9 protein/physiology	MIR6516	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0169491525423728
cysteine/antagonists & inhibitors	ferroptosis/genetics	1.2463632624526433e-05	0	1	0.6431935215825413	2.740761813146088e-05	0.0338983050847457
cysteine/antagonists & inhibitors	ATF4	7.922876021915215e-09	0	1	0.6431935215825413	2.5416836639099963e-08	0.0169491525423728
cysteine/antagonists & inhibitors	GABPA	9.225953334635052e-12	0	1	0.6431935215825413	3.8100059830234406e-11	0.0169491525423728
cysteine/antagonists & inhibitors	NFE2L2	0.0008437390094017	0	1	0.6431935215825413	0.0014757861424316	0.0508474576271186
cells cultured	hemoglobins/chemistry	2.6925185070414415e-07	0	1	0.6431935215825413	7.027660784581116e-07	0.0254237288135593
cells cultured	gene expression/genetics	0.0003269716938369	0	1	0.6431935215825413	0.0006081423908655	0.0504128639721861
cells cultured	antineoplastic agents/analysis	2.6925185070414415e-07	0	1	0.6431935215825413	7.027660784581116e-07	0.0254237288135593
cells cultured	oxygen/analysis	2.6925185070414415e-07	0	1	0.6431935215825413	7.027660784581116e-07	0.0254237288135593
cells cultured	breast neoplasms/drug therapy	0.001906750567958	0	1	0.6431935215825413	0.0031561126079007	0.0991023393127429
cells cultured	photosensitizing agents/analysis	2.6925185070414415e-07	0	1	0.6431935215825413	7.027660784581116e-07	0.0254237288135593
cells cultured	dose-response relationship drug	2.6925185070414415e-07	0	1	0.6431935215825413	7.027660784581116e-07	0.0254237288135593
cells cultured	ADAMTS9-AS1	5.506449314074402e-06	0	1	0.6431935215825413	1.2503694085500728e-05	0.0254237288135593
cells cultured	IFNG	0.0004481571619056	0	1	0.6431935215825413	0.0008191559827329	0.0749711519729055
cells cultured	MIR6516	5.506449314074402e-06	0	1	0.6431935215825413	1.2503694085500728e-05	0.0504128639721861
cells cultured	MMP2	2.6925185070414415e-07	0	1	0.6431935215825413	7.027660784581116e-07	0.0254237288135593
cells cultured	SRF	2.6925185070414415e-07	0	1	0.6431935215825413	7.027660784581116e-07	0.0254237288135593
ferroptosis/genetics	coenzyme a ligases/genetics	2.0781291465432616e-08	0	1	0.6431935215825413	6.458369471368187e-08	0.0338983050847457
ferroptosis/genetics	gene expression/genetics	3.197897502360547e-11	0	2	0.3223370757289844	1.2857553241751604e-10	0.0008691873098652
ferroptosis/genetics	brain neoplasms/genetics	2.0781291465432616e-08	0	1	0.6431935215825413	6.458369471368187e-08	0.0338983050847457
ferroptosis/genetics	biomarkers tumor	0.0002250279626806	0	1	0.6431935215825413	0.0004312077318689	0.0669274228596261
ferroptosis/genetics	piperazines	2.0781291465432616e-08	0	1	0.6431935215825413	6.458369471368187e-08	0.0338983050847457
ferroptosis/genetics	breast neoplasms/diagnosis	2.0781291465432616e-08	0	1	0.6431935215825413	6.458369471368187e-08	0.0338983050847457
ferroptosis/genetics	hsp27 heat-shock proteins/genetics	2.0781291465432616e-08	0	1	0.6431935215825413	6.458369471368187e-08	0.0338983050847457
ferroptosis/genetics	ADAMTS9-AS1	2.6114209231042903e-05	0	1	0.6431935215825413	5.569126546296371e-05	0.0338983050847457
ferroptosis/genetics	ATF4	0.0019267191784032	0	1	0.6431935215825413	0.0031880823620913	0.0669274228596264
ferroptosis/genetics	GABPA	0.0002250279626806	0	1	0.6431935215825413	0.0004312077318689	0.0669274228596264
ferroptosis/genetics	HSPB1	2.0781291465432616e-08	0	1	0.6431935215825413	6.458369471368187e-08	0.0338983050847457
ferroptosis/genetics	HSPB2	2.0781291465432616e-08	0	1	0.6431935215825413	6.458369471368187e-08	0.0338983050847457
ferroptosis/genetics	MIR6516	2.6114209231042903e-05	0	1	0.6431935215825413	5.569126546296371e-05	0.0669274228596264
ferroptosis/genetics	glioblastoma/genetics	2.0781291465432616e-08	0	1	0.6431935215825413	6.458369471368187e-08	0.0338983050847457
ADAMTS9-AS1	gene expression/genetics	3.026972561492869e-09	0	1	0.6431935215825413	1.0172715373899828e-08	0.0169491525423728
ADAMTS9-AS1	MIR6516	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0169491525423728
ATF4	lysosomes/drug effects	3.6909999207024313e-06	0	1	0.6431935215825413	8.568957891178154e-06	0.0337534405331015
ATF4	activating transcription factor 4/metabolism	1.8543679924931662e-09	0	1	0.6431935215825413	6.288333491593041e-09	0.0169491525423728
ATF4	nf-e2-related factor 2/metabolism	0.0001010832823041	0	1	0.6431935215825413	0.0002030415641666	0.0337534405331015
ATF4	stress physiological/drug effects	1.8543679924931662e-09	0	1	0.6431935215825413	6.288333491593041e-09	0.0169491525423728
ATF4	lipids/toxicity	1.8543679924931662e-09	0	1	0.6431935215825413	6.288333491593041e-09	0.0169491525423728
ATF4	endocytosis/drug effects	1.8543679924931662e-09	0	1	0.6431935215825413	6.288333491593041e-09	0.0169491525423728
ATF4	EIF2S1	1.6620964684799233e-05	0	1	0.6431935215825413	3.625513021890182e-05	0.0337534405331015
ATF4	GABPA	1.0308646052337167e-06	0	1	0.6431935215825413	2.470931245107674e-06	0.0337534405331015
ATF4	NFE2L2	2.743248641579044e-06	0	2	0.3223370757289844	6.426851264622442e-06	0.0021729682746631
GABPA	NFE2L2	2.0098735120654965e-08	0	2	0.3223370757289844	6.278277964291772e-08	0.0021729682746631
MIR6516	gene expression/genetics	3.026972561492869e-09	0	1	0.6431935215825413	1.0172715373899828e-08	0.0337534405331015
gene expression/genetics	brain neoplasms/genetics	3.4416913763379853e-15	0	1	0.6431935215825413	2.3522246952166904e-14	0.0169491525423728
gene expression/genetics	piperazines	3.4416913763379853e-15	0	1	0.6431935215825413	2.3522246952166904e-14	0.0169491525423728
gene expression/genetics	glioblastoma/genetics	3.4416913763379853e-15	0	1	0.6431935215825413	2.3522246952166904e-14	0.0169491525423728
gene expression/genetics	hsp27 heat-shock proteins/genetics	3.4416913763379853e-15	0	1	0.6431935215825413	2.3522246952166904e-14	0.0169491525423728
gene expression/genetics	HSPB1	3.4416913763379853e-15	0	1	0.6431935215825413	2.3522246952166904e-14	0.0169491525423728
gene expression/genetics	HSPB2	3.4416913763379853e-15	0	1	0.6431935215825413	2.3522246952166904e-14	0.0169491525423728
benzophenanthridines/pharmacology	cation transport proteins/genetics	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
benzophenanthridines/pharmacology	cell survival/drug effects	0.0034576698058652	0	1	0.6431935215825413	0.0055062826679677	0.059322033898305
benzophenanthridines/pharmacology	diosgenin/analogs & derivatives	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
benzophenanthridines/pharmacology	antineoplastic agents/pharmacology	0.0014592816657932	0	1	0.6431935215825413	0.0024614328686086	0.0423728813559322
benzophenanthridines/pharmacology	cyclohexylamines/pharmacology	3.647442603504914e-07	0	1	0.6431935215825413	9.344893694468688e-07	0.0169491525423728
benzophenanthridines/pharmacology	rna small interfering	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
benzophenanthridines/pharmacology	malondialdehyde/metabolism	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
benzophenanthridines/pharmacology	phenylenediamines/pharmacology	3.647442603504914e-07	0	1	0.6431935215825413	9.344893694468688e-07	0.0169491525423728
benzophenanthridines/pharmacology	transferrin/genetics	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
cation transport proteins/genetics	cell survival/drug effects	0.0034576698058652	0	1	0.6431935215825413	0.0055062826679677	0.059322033898305
cation transport proteins/genetics	diosgenin/analogs & derivatives	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
cation transport proteins/genetics	antineoplastic agents/pharmacology	0.0014592816657932	0	1	0.6431935215825413	0.0024614328686086	0.0423728813559322
cation transport proteins/genetics	cyclohexylamines/pharmacology	3.647442603504914e-07	0	1	0.6431935215825413	9.344893694468688e-07	0.0169491525423728
cation transport proteins/genetics	rna small interfering	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
cation transport proteins/genetics	malondialdehyde/metabolism	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
cation transport proteins/genetics	phenylenediamines/pharmacology	3.647442603504914e-07	0	1	0.6431935215825413	9.344893694468688e-07	0.0169491525423728
cation transport proteins/genetics	transferrin/genetics	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
cell survival/drug effects	phospholipid hydroperoxide glutathione peroxidase/biosynthesis	6.386755461718074e-06	0	1	0.6431935215825413	1.444206931088268e-05	0.059322033898305
cell survival/drug effects	hemoglobins/chemistry	0.0003601294793559	0	1	0.6431935215825413	0.000663231652646	0.059322033898305
cell survival/drug effects	diosgenin/analogs & derivatives	0.0034576698058652	0	1	0.6431935215825413	0.0055062826679677	0.0593220338983051
cell survival/drug effects	antineoplastic agents/analysis	0.0003601294793559	0	1	0.6431935215825413	0.000663231652646	0.0593220338983051
cell survival/drug effects	oxygen/analysis	0.0003601294793559	0	1	0.6431935215825413	0.000663231652646	0.0593220338983051
cell survival/drug effects	pc12 cells	0.004657838120425	0	1	0.6431935215825413	0.0071987456900829	0.1156019122120817
cell survival/drug effects	transferrin/genetics	0.0034576698058652	0	1	0.6431935215825413	0.0055062826679677	0.059322033898305
cell survival/drug effects	photosensitizing agents/analysis	0.0003601294793559	0	1	0.6431935215825413	0.000663231652646	0.0593220338983051
cell survival/drug effects	tumor suppressor protein p53/genetics	0.0024711672872856	0	1	0.6431935215825413	0.0040126618430333	0.0593220338983051
cell survival/drug effects	receptor endothelin b/metabolism	6.386755461718074e-06	0	1	0.6431935215825413	1.444206931088268e-05	0.0593220338983051
cell survival/drug effects	1-methyl-4-phenylpyridinium/toxicity	6.386755461718074e-06	0	1	0.6431935215825413	1.444206931088268e-05	0.0593220338983051
cell survival/drug effects	anthelmintics/pharmacology	0.0024711672872856	0	1	0.6431935215825413	0.0040126618430333	0.0593220338983051
cell survival/drug effects	thioredoxins/administration & dosage	6.386755461718074e-06	0	1	0.6431935215825413	1.444206931088268e-05	0.0593220338983051
cell survival/drug effects	cell cycle/drug effects	0.0024711672872856	0	1	0.6431935215825413	0.0040126618430333	0.0593220338983051
cell survival/drug effects	mebendazole/analogs & derivatives	0.0024711672872856	0	1	0.6431935215825413	0.0040126618430333	0.0593220338983051
cell survival/drug effects	dose-response relationship drug	0.0003601294793559	0	1	0.6431935215825413	0.000663231652646	0.0593220338983051
cell survival/drug effects	rna small interfering	0.0034576698058652	0	1	0.6431935215825413	0.0055062826679677	0.0593220338983051
cell survival/drug effects	mptp poisoning/drug therapy	6.386755461718074e-06	0	1	0.6431935215825413	1.444206931088268e-05	0.0593220338983051
cell survival/drug effects	reactive oxygen species/metabolism	0.002508959403018	0	4	0.0434987478385336	0.0040726712761183	0.0081397377180895
cell survival/drug effects	malondialdehyde/metabolism	0.0034576698058652	0	1	0.6431935215825413	0.0055062826679677	0.0593220338983051
cell survival/drug effects	EDN3	6.386755461718074e-06	0	1	0.6431935215825413	1.444206931088268e-05	0.0593220338983051
cell survival/drug effects	EDNRB	6.386755461718074e-06	0	1	0.6431935215825413	1.444206931088268e-05	0.0593220338983051
cell survival/drug effects	MMP2	0.0003601294793559	0	1	0.6431935215825413	0.000663231652646	0.0593220338983051
cell survival/drug effects	SRF	0.0003601294793559	0	1	0.6431935215825413	0.000663231652646	0.0593220338983051
cell survival/drug effects	TP53	0.0024711672872856	0	1	0.6431935215825413	0.0040126618430333	0.0593220338983051
diosgenin/analogs & derivatives	phenylenediamines/pharmacology	3.647442603504914e-07	0	1	0.6431935215825413	9.344893694468688e-07	0.0169491525423728
diosgenin/analogs & derivatives	transferrin/genetics	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
diosgenin/analogs & derivatives	antineoplastic agents/pharmacology	0.0014592816657932	0	1	0.6431935215825413	0.0024614328686086	0.0423728813559322
diosgenin/analogs & derivatives	cyclohexylamines/pharmacology	3.647442603504914e-07	0	1	0.6431935215825413	9.344893694468688e-07	0.0169491525423728
diosgenin/analogs & derivatives	rna small interfering	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
diosgenin/analogs & derivatives	malondialdehyde/metabolism	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
antineoplastic agents/pharmacology	transferrin/genetics	0.0014592816657932	0	1	0.6431935215825413	0.0024614328686086	0.0423728813559322
antineoplastic agents/pharmacology	biomarkers tumor	0.0028023171301814	0	1	0.6431935215825413	0.0045187595550542	0.0832971171954223
antineoplastic agents/pharmacology	liver neoplasms/drug therapy	0.0002120713226091	0	1	0.6431935215825413	0.0004133694220297	0.0423728813559322
antineoplastic agents/pharmacology	tumor suppressor protein p53/genetics	0.0009891637291119	0	1	0.6431935215825413	0.0017141517965727	0.0423728813559322
antineoplastic agents/pharmacology	crispr-cas systems	4.630460946586368e-05	0	1	0.6431935215825413	9.659347685237744e-05	0.0423728813559322
antineoplastic agents/pharmacology	carcinoma hepatocellular/diagnosis	4.630460946586368e-05	0	1	0.6431935215825413	9.659347685237744e-05	0.0423728813559322
antineoplastic agents/pharmacology	anthelmintics/pharmacology	0.0009891637291119	0	1	0.6431935215825413	0.0017141517965727	0.0423728813559322
antineoplastic agents/pharmacology	energy metabolism/drug effects	0.0002120713226091	0	1	0.6431935215825413	0.0004133694220297	0.0423728813559322
antineoplastic agents/pharmacology	cell cycle/drug effects	0.0009891637291119	0	1	0.6431935215825413	0.0017141517965727	0.0423728813559322
antineoplastic agents/pharmacology	mebendazole/analogs & derivatives	0.0009891637291119	0	1	0.6431935215825413	0.0017141517965727	0.0423728813559322
antineoplastic agents/pharmacology	phosphotransferases (alcohol group acceptor)/antagonists & inhibitors	4.630460946586368e-05	0	1	0.6431935215825413	9.659347685237744e-05	0.0423728813559322
antineoplastic agents/pharmacology	depression chemical	0.0002120713226091	0	1	0.6431935215825413	0.0004133694220297	0.0423728813559322
antineoplastic agents/pharmacology	rna small interfering	0.0014592816657932	0	1	0.6431935215825413	0.0024614328686086	0.0423728813559322
antineoplastic agents/pharmacology	malondialdehyde/metabolism	0.0014592816657932	0	1	0.6431935215825413	0.0024614328686086	0.0423728813559322
antineoplastic agents/pharmacology	PSTK	4.630460946586368e-05	0	1	0.6431935215825413	9.659347685237744e-05	0.0423728813559322
antineoplastic agents/pharmacology	TP53	0.0009891637291119	0	1	0.6431935215825413	0.0017141517965727	0.0423728813559322
cyclohexylamines/pharmacology	phenylenediamines/pharmacology	2.4424906541753444e-15	0	2	0.3223370757289844	1.6906614996869962e-14	0.0001448645516442
cyclohexylamines/pharmacology	transferrin/genetics	3.647442603504914e-07	0	1	0.6431935215825413	9.344893694468688e-07	0.0169491525423728
cyclohexylamines/pharmacology	pc12 cells	8.187841766815751e-07	0	1	0.6431935215825413	1.996964611095753e-06	0.0337534405331015
cyclohexylamines/pharmacology	neurons/drug effects	1.0240908121517124e-10	0	1	0.6431935215825413	3.792093106090649e-10	0.0169491525423728
cyclohexylamines/pharmacology	neurotoxicity syndromes/etiology	1.0240908121517124e-10	0	1	0.6431935215825413	3.792093106090649e-10	0.0169491525423728
cyclohexylamines/pharmacology	anthracenes/pharmacology	1.0240908121517124e-10	0	1	0.6431935215825413	3.792093106090649e-10	0.0169491525423728
cyclohexylamines/pharmacology	lung/drug effects	1.0240908121517124e-10	0	1	0.6431935215825413	3.792093106090649e-10	0.0169491525423728
cyclohexylamines/pharmacology	zinc oxide/administration & dosage	1.0240908121517124e-10	0	1	0.6431935215825413	3.792093106090649e-10	0.0169491525423728
cyclohexylamines/pharmacology	rna small interfering	3.647442603504914e-07	0	1	0.6431935215825413	9.344893694468688e-07	0.0169491525423728
cyclohexylamines/pharmacology	cerebral cortex/drug effects	1.0240908121517124e-10	0	1	0.6431935215825413	3.792093106090649e-10	0.0169491525423728
cyclohexylamines/pharmacology	malondialdehyde/metabolism	3.647442603504914e-07	0	1	0.6431935215825413	9.344893694468688e-07	0.0169491525423728
cyclohexylamines/pharmacology	MAPK8	1.0240908121517124e-10	0	1	0.6431935215825413	3.792093106090649e-10	0.0169491525423728
rna small interfering	phenylenediamines/pharmacology	3.647442603504914e-07	0	1	0.6431935215825413	9.344893694468688e-07	0.0169491525423728
rna small interfering	transferrin/genetics	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
rna small interfering	malondialdehyde/metabolism	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
malondialdehyde/metabolism	phenylenediamines/pharmacology	3.647442603504914e-07	0	1	0.6431935215825413	9.344893694468688e-07	0.0169491525423728
malondialdehyde/metabolism	transferrin/genetics	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
phenylenediamines/pharmacology	pc12 cells	8.187841766815751e-07	0	1	0.6431935215825413	1.996964611095753e-06	0.0337534405331015
phenylenediamines/pharmacology	transferrin/genetics	3.647442603504914e-07	0	1	0.6431935215825413	9.344893694468688e-07	0.0169491525423728
phenylenediamines/pharmacology	anthracenes/pharmacology	1.0240908121517124e-10	0	1	0.6431935215825413	3.792093106090649e-10	0.0169491525423728
phenylenediamines/pharmacology	lung/drug effects	1.0240908121517124e-10	0	1	0.6431935215825413	3.792093106090649e-10	0.0169491525423728
phenylenediamines/pharmacology	neurons/drug effects	1.0240908121517124e-10	0	1	0.6431935215825413	3.792093106090649e-10	0.0169491525423728
phenylenediamines/pharmacology	neurotoxicity syndromes/etiology	1.0240908121517124e-10	0	1	0.6431935215825413	3.792093106090649e-10	0.0169491525423728
phenylenediamines/pharmacology	zinc oxide/administration & dosage	1.0240908121517124e-10	0	1	0.6431935215825413	3.792093106090649e-10	0.0169491525423728
phenylenediamines/pharmacology	cerebral cortex/drug effects	1.0240908121517124e-10	0	1	0.6431935215825413	3.792093106090649e-10	0.0169491525423728
phenylenediamines/pharmacology	MAPK8	1.0240908121517124e-10	0	1	0.6431935215825413	3.792093106090649e-10	0.0169491525423728
doxorubicin/administration & dosage	antibiotics antineoplastic/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
doxorubicin/administration & dosage	carbon monoxide/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
doxorubicin/administration & dosage	iron compounds/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
calreticulin/metabolism	oxidative stress	7.719753024604259e-07	0	1	0.6431935215825413	1.92914648661008e-06	0.0338983050847457
calreticulin/metabolism	ascorbic acid/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
calreticulin/metabolism	ferric compounds/chemistry	1.1102230246251563e-16	0	1	0.6431935215825413	8.259720303814333e-16	0.0169491525423728
calreticulin/metabolism	t-lymphocytes cytotoxic/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
calreticulin/metabolism	CALR	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
iron compounds/administration & dosage	antibiotics antineoplastic/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
iron compounds/administration & dosage	carbon monoxide/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
ascorbic acid/pharmacology	oxidative stress	7.719753024604259e-07	0	1	0.6431935215825413	1.92914648661008e-06	0.0338983050847457
ascorbic acid/pharmacology	ferric compounds/chemistry	1.1102230246251563e-16	0	1	0.6431935215825413	8.259720303814333e-16	0.0169491525423728
ascorbic acid/pharmacology	t-lymphocytes cytotoxic/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
ascorbic acid/pharmacology	CALR	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
antibiotics antineoplastic/administration & dosage	carbon monoxide/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
ferric compounds/chemistry	oxidative stress	0.0021879636935716	0	1	0.6431935215825413	0.0036007926642265	0.0669274228596264
ferric compounds/chemistry	tumor microenvironment/drug effects	5.747081538332033e-06	0	1	0.6431935215825413	1.3044028102604564e-05	0.0337534405331015
ferric compounds/chemistry	gallic acid/chemistry	1.683175820943461e-11	0	1	0.6431935215825413	6.818051351169979e-11	0.0169491525423728
ferric compounds/chemistry	zeolites/chemistry	1.683175820943461e-11	0	1	0.6431935215825413	6.818051351169979e-11	0.0169491525423728
ferric compounds/chemistry	tumor hypoxia/drug effects	1.683175820943461e-11	0	1	0.6431935215825413	6.818051351169979e-11	0.0169491525423728
ferric compounds/chemistry	glucose oxidase/chemistry	1.683175820943461e-11	0	1	0.6431935215825413	6.818051351169979e-11	0.0169491525423728
ferric compounds/chemistry	mcf-7 cells	1.35968064929326e-06	0	1	0.6431935215825413	3.2494967160402437e-06	0.0504128639721861
ferric compounds/chemistry	t-lymphocytes cytotoxic/metabolism	1.1102230246251563e-16	0	1	0.6431935215825413	8.259720303814333e-16	0.0169491525423728
ferric compounds/chemistry	CALR	1.1102230246251563e-16	0	1	0.6431935215825413	8.259720303814333e-16	0.0169491525423728
ferric compounds/chemistry	azo compounds/chemistry	1.683175820943461e-11	0	1	0.6431935215825413	6.818051351169979e-11	0.0169491525423728
t-lymphocytes cytotoxic/metabolism	oxidative stress	7.719753024604259e-07	0	1	0.6431935215825413	1.92914648661008e-06	0.0338983050847457
t-lymphocytes cytotoxic/metabolism	CALR	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
CALR	oxidative stress	7.719753024604259e-07	0	1	0.6431935215825413	1.92914648661008e-06	0.0338983050847457
phospholipid hydroperoxide glutathione peroxidase/biosynthesis	pc12 cells	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
phospholipid hydroperoxide glutathione peroxidase/biosynthesis	1-methyl-4-phenylpyridinium/toxicity	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
phospholipid hydroperoxide glutathione peroxidase/biosynthesis	thioredoxins/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
phospholipid hydroperoxide glutathione peroxidase/biosynthesis	mptp poisoning/drug therapy	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hemoglobins/chemistry	breast neoplasms/drug therapy	5.707109562713697e-09	0	1	0.6431935215825413	1.8715171533717257e-08	0.0338983050847457
hemoglobins/chemistry	antineoplastic agents/analysis	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hemoglobins/chemistry	oxygen/analysis	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hemoglobins/chemistry	photosensitizing agents/analysis	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hemoglobins/chemistry	dose-response relationship drug	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hemoglobins/chemistry	IFNG	5.6210813781376594e-11	0	1	0.6431935215825413	2.175657629520637e-10	0.0254237288135593
hemoglobins/chemistry	MMP2	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hemoglobins/chemistry	SRF	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
antineoplastic agents/analysis	breast neoplasms/drug therapy	5.707109562713697e-09	0	1	0.6431935215825413	1.8715171533717257e-08	0.0338983050847457
antineoplastic agents/analysis	oxygen/analysis	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
antineoplastic agents/analysis	photosensitizing agents/analysis	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
antineoplastic agents/analysis	dose-response relationship drug	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
antineoplastic agents/analysis	IFNG	5.6210813781376594e-11	0	1	0.6431935215825413	2.175657629520637e-10	0.0254237288135593
antineoplastic agents/analysis	MMP2	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
antineoplastic agents/analysis	SRF	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
oxygen/analysis	breast neoplasms/drug therapy	5.707109562713697e-09	0	1	0.6431935215825413	1.8715171533717257e-08	0.0338983050847457
oxygen/analysis	photosensitizing agents/analysis	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
oxygen/analysis	dose-response relationship drug	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
oxygen/analysis	IFNG	5.6210813781376594e-11	0	1	0.6431935215825413	2.175657629520637e-10	0.0254237288135593
oxygen/analysis	MMP2	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
oxygen/analysis	SRF	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
pc12 cells	anthracenes/pharmacology	1.1102230246251563e-15	0	1	0.6431935215825413	7.818087859824261e-15	0.0169491525423728
pc12 cells	1-methyl-4-phenylpyridinium/toxicity	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
pc12 cells	lung/drug effects	1.1102230246251563e-15	0	1	0.6431935215825413	7.818087859824261e-15	0.0169491525423728
pc12 cells	thioredoxins/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
pc12 cells	neurons/drug effects	1.1102230246251563e-15	0	1	0.6431935215825413	7.818087859824261e-15	0.0169491525423728
pc12 cells	neurotoxicity syndromes/etiology	1.1102230246251563e-15	0	1	0.6431935215825413	7.818087859824261e-15	0.0169491525423728
pc12 cells	zinc oxide/administration & dosage	1.1102230246251563e-15	0	1	0.6431935215825413	7.818087859824261e-15	0.0169491525423728
pc12 cells	cerebral cortex/drug effects	1.1102230246251563e-15	0	1	0.6431935215825413	7.818087859824261e-15	0.0169491525423728
pc12 cells	mptp poisoning/drug therapy	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
pc12 cells	MAPK8	1.1102230246251563e-15	0	1	0.6431935215825413	7.818087859824261e-15	0.0169491525423728
photosensitizing agents/analysis	breast neoplasms/drug therapy	5.707109562713697e-09	0	1	0.6431935215825413	1.8715171533717257e-08	0.0338983050847457
photosensitizing agents/analysis	dose-response relationship drug	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
photosensitizing agents/analysis	IFNG	5.6210813781376594e-11	0	1	0.6431935215825413	2.175657629520637e-10	0.0254237288135593
photosensitizing agents/analysis	MMP2	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
photosensitizing agents/analysis	SRF	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
tumor suppressor protein p53/genetics	anthelmintics/pharmacology	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
tumor suppressor protein p53/genetics	cell cycle/drug effects	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
tumor suppressor protein p53/genetics	mebendazole/analogs & derivatives	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
tumor suppressor protein p53/genetics	fluorouracil/pharmacology	4.157156320294675e-07	0	1	0.6431935215825413	1.0523544285088806e-06	0.0169491525423728
tumor suppressor protein p53/genetics	TP53	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
receptor endothelin b/metabolism	reactive oxygen species/metabolism	0.0023324532785861	0	1	0.6431935215825413	0.0038000818544132	0.144067796610169
receptor endothelin b/metabolism	EDN3	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
receptor endothelin b/metabolism	EDNRB	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
1-methyl-4-phenylpyridinium/toxicity	thioredoxins/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
1-methyl-4-phenylpyridinium/toxicity	mptp poisoning/drug therapy	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
anthelmintics/pharmacology	cell cycle/drug effects	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
anthelmintics/pharmacology	mebendazole/analogs & derivatives	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
anthelmintics/pharmacology	fluorouracil/pharmacology	4.157156320294675e-07	0	1	0.6431935215825413	1.0523544285088806e-06	0.0169491525423728
anthelmintics/pharmacology	TP53	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
thioredoxins/administration & dosage	mptp poisoning/drug therapy	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cell cycle/drug effects	mebendazole/analogs & derivatives	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
cell cycle/drug effects	fluorouracil/pharmacology	4.157156320294675e-07	0	1	0.6431935215825413	1.0523544285088806e-06	0.0169491525423728
cell cycle/drug effects	TP53	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
mebendazole/analogs & derivatives	fluorouracil/pharmacology	4.157156320294675e-07	0	1	0.6431935215825413	1.0523544285088806e-06	0.0169491525423728
mebendazole/analogs & derivatives	TP53	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0084745762711864
dose-response relationship drug	breast neoplasms/drug therapy	5.707109562713697e-09	0	1	0.6431935215825413	1.8715171533717257e-08	0.0338983050847457
dose-response relationship drug	IFNG	5.6210813781376594e-11	0	1	0.6431935215825413	2.175657629520637e-10	0.0254237288135593
dose-response relationship drug	MMP2	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
dose-response relationship drug	SRF	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
reactive oxygen species/metabolism	keloid/drug therapy	0.0023324532785861	0	1	0.6431935215825413	0.0038000818544132	0.144067796610169
reactive oxygen species/metabolism	digestive system diseases/drug therapy	0.0009513001672776	0	1	0.6431935215825413	0.0016561935388152	0.144067796610169
reactive oxygen species/metabolism	urologic diseases/drug therapy	0.0009513001672776	0	1	0.6431935215825413	0.0016561935388152	0.144067796610169
reactive oxygen species/metabolism	gene expression regulation/drug effects	0.0009513001672776	0	1	0.6431935215825413	0.0016561935388152	0.144067796610169
reactive oxygen species/metabolism	gene regulatory networks/drug effects	0.0009513001672776	0	1	0.6431935215825413	0.0016561935388152	0.144067796610169
reactive oxygen species/metabolism	EDN3	0.0023324532785861	0	1	0.6431935215825413	0.0038000818544132	0.1440677966101693
reactive oxygen species/metabolism	EDNRB	0.0023324532785861	0	1	0.6431935215825413	0.0038000818544132	0.1440677966101693
reactive oxygen species/metabolism	fibroblasts	0.0023324532785861	0	1	0.6431935215825413	0.0038000818544132	0.144067796610169
reactive oxygen species/metabolism	nervous system diseases/drug therapy	0.0009513001672776	0	1	0.6431935215825413	0.0016561935388152	0.144067796610169
reactive oxygen species/metabolism	aminolevulinic acid/pharmacology	0.0023324532785861	0	1	0.6431935215825413	0.0038000818544132	0.144067796610169
EDN3	EDNRB	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
MMP2	breast neoplasms/drug therapy	5.707109562713697e-09	0	1	0.6431935215825413	1.8715171533717257e-08	0.0338983050847457
MMP2	IFNG	5.6210813781376594e-11	0	1	0.6431935215825413	2.175657629520637e-10	0.0254237288135593
MMP2	SRF	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
SRF	breast neoplasms/drug therapy	5.707109562713697e-09	0	1	0.6431935215825413	1.8715171533717257e-08	0.0338983050847457
SRF	IFNG	5.6210813781376594e-11	0	1	0.6431935215825413	2.175657629520637e-10	0.0254237288135593
TP53	fluorouracil/pharmacology	4.157156320294675e-07	0	1	0.6431935215825413	1.0523544285088806e-06	0.0169491525423728
keloid/drug therapy	SLC7A11	0.0011228545236436	0	1	0.6431935215825413	0.0019334523299348	0.0847457627118643
keloid/drug therapy	aminolevulinic acid/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
keloid/drug therapy	fibroblasts	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
gallic acid/chemistry	tumor microenvironment/drug effects	3.831546191435109e-09	0	1	0.6431935215825413	1.2649813408443961e-08	0.0169491525423728
gallic acid/chemistry	azo compounds/chemistry	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
gallic acid/chemistry	tumor hypoxia/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
gallic acid/chemistry	glucose oxidase/chemistry	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
gallic acid/chemistry	mcf-7 cells	3.6034164541121067e-10	0	1	0.6431935215825413	1.288294085171555e-09	0.0254237288135593
gallic acid/chemistry	zeolites/chemistry	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
zeolites/chemistry	tumor microenvironment/drug effects	3.831546191435109e-09	0	1	0.6431935215825413	1.2649813408443961e-08	0.0169491525423728
zeolites/chemistry	azo compounds/chemistry	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
zeolites/chemistry	tumor hypoxia/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
zeolites/chemistry	glucose oxidase/chemistry	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
zeolites/chemistry	mcf-7 cells	3.6034164541121067e-10	0	1	0.6431935215825413	1.288294085171555e-09	0.0254237288135593
tumor hypoxia/drug effects	tumor microenvironment/drug effects	3.831546191435109e-09	0	1	0.6431935215825413	1.2649813408443961e-08	0.0169491525423728
tumor hypoxia/drug effects	azo compounds/chemistry	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
tumor hypoxia/drug effects	glucose oxidase/chemistry	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
tumor hypoxia/drug effects	mcf-7 cells	3.6034164541121067e-10	0	1	0.6431935215825413	1.288294085171555e-09	0.0254237288135593
azo compounds/chemistry	tumor microenvironment/drug effects	3.831546191435109e-09	0	1	0.6431935215825413	1.2649813408443961e-08	0.0169491525423728
azo compounds/chemistry	glucose oxidase/chemistry	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
azo compounds/chemistry	mcf-7 cells	3.6034164541121067e-10	0	1	0.6431935215825413	1.288294085171555e-09	0.0254237288135593
glucose oxidase/chemistry	tumor microenvironment/drug effects	3.831546191435109e-09	0	1	0.6431935215825413	1.2649813408443961e-08	0.0169491525423728
glucose oxidase/chemistry	mcf-7 cells	3.6034164541121067e-10	0	1	0.6431935215825413	1.288294085171555e-09	0.0254237288135593
aminolevulinic acid/pharmacology	SLC7A11	0.0011228545236436	0	1	0.6431935215825413	0.0019334523299348	0.0847457627118643
aminolevulinic acid/pharmacology	fibroblasts	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
fibroblasts	SLC7A11	0.0011228545236436	0	1	0.6431935215825413	0.0019334523299348	0.0847457627118643
coenzyme a ligases/genetics	ACSL4	2.376754903998801e-09	0	1	0.6431935215825413	8.048593917433051e-09	0.0423728813559322
coenzyme a ligases/genetics	biomarkers tumor	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
coenzyme a ligases/genetics	breast neoplasms/diagnosis	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
everolimus/administration & dosage	carcinoma renal cell/drug therapy	3.5638159090467525e-14	0	1	0.6431935215825413	2.3001953542761363e-13	0.0169491525423728
everolimus/administration & dosage	carbolines/administration & dosage	6.8833827526759706e-15	0	1	0.6431935215825413	4.639380934134164e-14	0.0169491525423728
everolimus/administration & dosage	tor serine-threonine kinases/antagonists & inhibitors	1.683175820943461e-11	0	1	0.6431935215825413	6.818051351169979e-11	0.0169491525423728
everolimus/administration & dosage	piperazines/administration & dosage	4.8268178343136e-10	0	1	0.6431935215825413	1.7193774346937262e-09	0.0254237288135593
everolimus/administration & dosage	MTOR	1.683175820943461e-11	0	1	0.6431935215825413	6.818051351169979e-11	0.0169491525423728
biomarkers tumor	GPX4	0.0043242930505569	0	2	0.3223370757289844	0.0067409725001164	0.0334637114298129
biomarkers tumor	ACSL4	8.316309313394221e-05	0	1	0.6431935215825413	0.0001694204652348	0.0832971171954223
biomarkers tumor	crispr-cas systems	6.8833827526759706e-15	0	1	0.6431935215825413	4.639380934134164e-14	0.0169491525423728
biomarkers tumor	carcinoma hepatocellular/diagnosis	6.8833827526759706e-15	0	1	0.6431935215825413	4.639380934134164e-14	0.0169491525423728
biomarkers tumor	phosphotransferases (alcohol group acceptor)/antagonists & inhibitors	6.8833827526759706e-15	0	1	0.6431935215825413	4.639380934134164e-14	0.0169491525423728
biomarkers tumor	breast neoplasms/diagnosis	0.0	0	1	0.6431935215825413	0.0	0.0169491525423728
biomarkers tumor	PSTK	6.8833827526759706e-15	0	1	0.6431935215825413	4.639380934134164e-14	0.0169491525423728
carcinoma renal cell/drug therapy	biological transport	1.3322676295501878e-15	0	1	0.6431935215825413	9.287754161370623e-15	0.0169491525423728
carcinoma renal cell/drug therapy	glutathione disulfide/deficiency	1.3322676295501878e-15	0	1	0.6431935215825413	9.287754161370623e-15	0.0169491525423728
carcinoma renal cell/drug therapy	carbolines/administration & dosage	1.8869062534676573e-08	0	1	0.6431935215825413	5.9017292510576994e-08	0.0337534405331015
carcinoma renal cell/drug therapy	tor serine-threonine kinases/antagonists & inhibitors	1.2188883344865786e-06	0	1	0.6431935215825413	2.9158776897167883e-06	0.0337534405331015
carcinoma renal cell/drug therapy	piperazines/administration & dosage	7.379537600549213e-06	0	1	0.6431935215825413	1.6579293097038412e-05	0.0504128639721861
carcinoma renal cell/drug therapy	cystine/metabolism	1.3322676295501878e-15	0	1	0.6431935215825413	9.287754161370623e-15	0.0169491525423728
carcinoma renal cell/drug therapy	gamma-glutamyltransferase/metabolism	1.3322676295501878e-15	0	1	0.6431935215825413	9.287754161370623e-15	0.0169491525423728
carcinoma renal cell/drug therapy	GGT1	1.3322676295501878e-15	0	1	0.6431935215825413	9.287754161370623e-15	0.0169491525423728
carcinoma renal cell/drug therapy	MTOR	1.2188883344865786e-06	0	1	0.6431935215825413	2.9158776897167883e-06	0.0337534405331015
breast neoplasms/diagnosis	ACSL4	2.376754903998801e-09	0	1	0.6431935215825413	8.048593917433051e-09	0.0423728813559322
GPX4	ACSL4	1.4134525780917784e-06	0	5	0.0123899221684959	3.3763502024711942e-06	0.0001505114457113
carbolines/administration & dosage	photosensitizing agents/administration & dosage	2.6503952971213e-06	0	1	0.6431935215825413	6.212302204363682e-06	0.0504128639721861
carbolines/administration & dosage	tor serine-threonine kinases/antagonists & inhibitors	6.067571897139246e-07	0	1	0.6431935215825413	1.5209505069320752e-06	0.0337534405331015
carbolines/administration & dosage	piperazines/administration & dosage	0.0	0	2	0.3223370757289844	0.0	0.0004345936549326
carbolines/administration & dosage	MTOR	6.067571897139246e-07	0	1	0.6431935215825413	1.5209505069320752e-06	0.0337534405331015
myocardial infarction/metabolism	necroptosis/drug effects	7.507579002918874e-09	0	1	0.6431935215825413	2.432475563911148e-08	0.0338983050847457
myocardial infarction/metabolism	myocytes cardiac/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
myocardial infarction/metabolism	deferoxamine/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
myocardial infarction/metabolism	myocardial reperfusion injury/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
myocardial infarction/metabolism	pyridazines/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
myocytes cardiac/drug effects	necroptosis/drug effects	7.507579002918874e-09	0	1	0.6431935215825413	2.432475563911148e-08	0.0338983050847457
myocytes cardiac/drug effects	deferoxamine/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
myocytes cardiac/drug effects	myocardial reperfusion injury/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
myocytes cardiac/drug effects	pyridazines/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
liver neoplasms/drug therapy	HMOX1	0.0005988108866488	0	1	0.6431935215825413	0.0010731906769546	0.0423728813559322
liver neoplasms/drug therapy	GCLC	8.679791325683084e-07	0	1	0.6431935215825413	2.104309608460381e-06	0.0254237288135593
liver neoplasms/drug therapy	energy metabolism/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
liver neoplasms/drug therapy	depression chemical	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
deferoxamine/pharmacology	necroptosis/drug effects	7.507579002918874e-09	0	1	0.6431935215825413	2.432475563911148e-08	0.0338983050847457
deferoxamine/pharmacology	myocardial reperfusion injury/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
deferoxamine/pharmacology	pyridazines/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
myocardial reperfusion injury/metabolism	necroptosis/drug effects	7.507579002918874e-09	0	1	0.6431935215825413	2.432475563911148e-08	0.0338983050847457
myocardial reperfusion injury/metabolism	pyridazines/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
crispr-cas systems	carcinoma hepatocellular/diagnosis	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
crispr-cas systems	phosphotransferases (alcohol group acceptor)/antagonists & inhibitors	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
crispr-cas systems	PSTK	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
carcinoma hepatocellular/diagnosis	phosphotransferases (alcohol group acceptor)/antagonists & inhibitors	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
carcinoma hepatocellular/diagnosis	PSTK	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
pyridazines/pharmacology	necroptosis/drug effects	7.507579002918874e-09	0	1	0.6431935215825413	2.432475563911148e-08	0.0338983050847457
energy metabolism/drug effects	HMOX1	0.0005988108866488	0	1	0.6431935215825413	0.0010731906769546	0.0423728813559322
energy metabolism/drug effects	GCLC	8.679791325683084e-07	0	1	0.6431935215825413	2.104309608460381e-06	0.0254237288135593
energy metabolism/drug effects	depression chemical	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
phosphotransferases (alcohol group acceptor)/antagonists & inhibitors	PSTK	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
depression chemical	HMOX1	0.0005988108866488	0	1	0.6431935215825413	0.0010731906769546	0.0423728813559322
depression chemical	GCLC	8.679791325683084e-07	0	1	0.6431935215825413	2.104309608460381e-06	0.0254237288135593
fluorouracil/pharmacology	beta catenin/antagonists & inhibitors	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
fluorouracil/pharmacology	plant extracts/pharmacology	0.0001010832823041	0	1	0.6431935215825413	0.0002030415641666	0.0337534405331015
fluorouracil/pharmacology	antimetabolites antineoplastic/pharmacology	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
fluorouracil/pharmacology	CASP9	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
fluorouracil/pharmacology	CTNNB1	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
fluorouracil/pharmacology	GCLC	0.0015615735142621	0	1	0.6431935215825413	0.0026248871110725	0.0504128639721861
fluorouracil/pharmacology	GCLM	0.0001010832823041	0	1	0.6431935215825413	0.0002030415641666	0.0337534405331015
fluorouracil/pharmacology	TCF7L2	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
SLC7A11	biological transport	0.004400314041403	0	1	0.6431935215825413	0.0068050556406718	0.0847457627118643
SLC7A11	glutathione disulfide/deficiency	0.004400314041403	0	1	0.6431935215825413	0.0068050556406718	0.0847457627118643
SLC7A11	cystine/metabolism	0.004400314041403	0	1	0.6431935215825413	0.0068050556406718	0.0847457627118643
SLC7A11	gamma-glutamyltransferase/metabolism	0.004400314041403	0	1	0.6431935215825413	0.0068050556406718	0.0847457627118643
SLC7A11	GGT1	0.004400314041403	0	1	0.6431935215825413	0.0068050556406718	0.0847457627118643
GCLC	HMOX1	1.6838878846847652e-08	0	3	0.1299847034619319	5.297343874802363e-08	3.746497025281363e-05
GCLC	carcinogenesis/drug effects	0.0027389841559924	0	1	0.6431935215825413	0.0044416205631119	0.0749711519729055
GCLC	beta catenin/antagonists & inhibitors	2.343975940899412e-06	0	1	0.6431935215825413	5.520635456743758e-06	0.0254237288135593
GCLC	colorectal neoplasms/drug therapy	7.799212692782831e-06	0	2	0.3223370757289844	1.7506017251004483e-05	0.0025775899533935
GCLC	plant extracts/pharmacology	1.863875720431452e-11	0	2	0.3223370757289844	7.537482477728186e-11	0.0004345936549326
GCLC	antimetabolites antineoplastic/pharmacology	2.343975940899412e-06	0	1	0.6431935215825413	5.520635456743758e-06	0.0254237288135593
GCLC	CASP9	2.343975940899412e-06	0	1	0.6431935215825413	5.520635456743758e-06	0.0254237288135593
GCLC	CTNNB1	2.343975940899412e-06	0	1	0.6431935215825413	5.520635456743758e-06	0.0254237288135593
GCLC	GCLM	1.863875720431452e-11	0	2	0.3223370757289844	7.537482477728186e-11	0.0004345936549326
GCLC	TCF7L2	2.343975940899412e-06	0	1	0.6431935215825413	5.520635456743758e-06	0.0254237288135593
digestive system diseases/drug therapy	urologic diseases/drug therapy	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
digestive system diseases/drug therapy	gene expression regulation/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
digestive system diseases/drug therapy	nervous system diseases/drug therapy	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
digestive system diseases/drug therapy	gene regulatory networks/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
urologic diseases/drug therapy	gene expression regulation/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
urologic diseases/drug therapy	nervous system diseases/drug therapy	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
urologic diseases/drug therapy	gene regulatory networks/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
gene expression regulation/drug effects	nervous system diseases/drug therapy	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
gene expression regulation/drug effects	gene regulatory networks/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
gene regulatory networks/drug effects	nervous system diseases/drug therapy	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
receptors transferrin/genetics	species specificity	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
receptors transferrin/genetics	homozygote	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
receptors transferrin/genetics	carcinoma renal cell/chemically induced	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
receptors transferrin/genetics	nitrilotriacetic acid/adverse effects	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
receptors transferrin/genetics	cyclin-dependent kinase inhibitor p15/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
receptors transferrin/genetics	oxidative stress	0.0016413565879379	0	1	0.6431935215825413	0.002742911746578	0.0338983050847457
receptors transferrin/genetics	ferric compounds/adverse effects	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
receptors transferrin/genetics	cationic amino acid transporter 1/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
receptors transferrin/genetics	gene regulatory networks	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
receptors transferrin/genetics	cyclin-dependent kinase inhibitor p16/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
receptors transferrin/genetics	lipocalin-2/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
receptors transferrin/genetics	ferritins/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
receptors transferrin/genetics	sequence deletion	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
receptors transferrin/genetics	CDKN2A	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
receptors transferrin/genetics	LCN2	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
species specificity	homozygote	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
species specificity	carcinoma renal cell/chemically induced	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
species specificity	nitrilotriacetic acid/adverse effects	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
species specificity	cyclin-dependent kinase inhibitor p15/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
species specificity	oxidative stress	0.0016413565879379	0	1	0.6431935215825413	0.002742911746578	0.0338983050847457
species specificity	ferric compounds/adverse effects	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
species specificity	cationic amino acid transporter 1/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
species specificity	gene regulatory networks	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
species specificity	cyclin-dependent kinase inhibitor p16/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
species specificity	lipocalin-2/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
species specificity	ferritins/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
species specificity	sequence deletion	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
species specificity	CDKN2A	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
species specificity	LCN2	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
histones/genetics	cystine/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
histones/genetics	piperazines/therapeutic use	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
histones/genetics	sulfasalazine/therapeutic use	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
histones/genetics	glutamine/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
histones/genetics	amino acid transport system y+/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
histones/genetics	sorafenib/therapeutic use	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
histones/genetics	glucose/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
histones/genetics	glutathione/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
homozygote	carcinoma renal cell/chemically induced	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
homozygote	nitrilotriacetic acid/adverse effects	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
homozygote	cyclin-dependent kinase inhibitor p15/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
homozygote	oxidative stress	0.0016413565879379	0	1	0.6431935215825413	0.002742911746578	0.0338983050847457
homozygote	ferric compounds/adverse effects	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
homozygote	cationic amino acid transporter 1/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
homozygote	gene regulatory networks	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
homozygote	cyclin-dependent kinase inhibitor p16/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
homozygote	lipocalin-2/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
homozygote	ferritins/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
homozygote	sequence deletion	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
homozygote	CDKN2A	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
homozygote	LCN2	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
glutathione/antagonists & inhibitors	cystine/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
glutathione/antagonists & inhibitors	piperazines/therapeutic use	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
glutathione/antagonists & inhibitors	sulfasalazine/therapeutic use	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
glutathione/antagonists & inhibitors	glutamine/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
glutathione/antagonists & inhibitors	amino acid transport system y+/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
glutathione/antagonists & inhibitors	sorafenib/therapeutic use	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
glutathione/antagonists & inhibitors	glucose/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
n-acetylgalactosaminyltransferases/metabolism	EGFR	0.0001190696848334	0	1	0.6431935215825413	0.0002366340025258	0.0254237288135593
n-acetylgalactosaminyltransferases/metabolism	sirolimus/analogs & derivatives	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
n-acetylgalactosaminyltransferases/metabolism	erbb receptors/metabolism	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
n-acetylgalactosaminyltransferases/metabolism	tor serine-threonine kinases/antagonists & inhibitors	1.4029182482389048e-08	0	1	0.6431935215825413	4.416292392550505e-08	0.0169491525423728
n-acetylgalactosaminyltransferases/metabolism	ovary/pathology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
n-acetylgalactosaminyltransferases/metabolism	GALNT14	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
n-acetylgalactosaminyltransferases/metabolism	MTOR	1.4029182482389048e-08	0	1	0.6431935215825413	4.416292392550505e-08	0.0169491525423728
sirolimus/analogs & derivatives	EGFR	0.0001190696848334	0	1	0.6431935215825413	0.0002366340025258	0.0254237288135593
sirolimus/analogs & derivatives	erbb receptors/metabolism	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
sirolimus/analogs & derivatives	tor serine-threonine kinases/antagonists & inhibitors	1.4029182482389048e-08	0	1	0.6431935215825413	4.416292392550505e-08	0.0169491525423728
sirolimus/analogs & derivatives	ovary/pathology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
sirolimus/analogs & derivatives	GALNT14	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
sirolimus/analogs & derivatives	MTOR	1.4029182482389048e-08	0	1	0.6431935215825413	4.416292392550505e-08	0.0169491525423728
nitrilotriacetic acid/adverse effects	carcinoma renal cell/chemically induced	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
nitrilotriacetic acid/adverse effects	cyclin-dependent kinase inhibitor p15/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
nitrilotriacetic acid/adverse effects	oxidative stress	0.0016413565879379	0	1	0.6431935215825413	0.002742911746578	0.0338983050847457
nitrilotriacetic acid/adverse effects	ferric compounds/adverse effects	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
nitrilotriacetic acid/adverse effects	cationic amino acid transporter 1/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
nitrilotriacetic acid/adverse effects	gene regulatory networks	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
nitrilotriacetic acid/adverse effects	cyclin-dependent kinase inhibitor p16/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
nitrilotriacetic acid/adverse effects	lipocalin-2/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
nitrilotriacetic acid/adverse effects	ferritins/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
nitrilotriacetic acid/adverse effects	sequence deletion	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
nitrilotriacetic acid/adverse effects	CDKN2A	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
nitrilotriacetic acid/adverse effects	LCN2	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
cyclin-dependent kinase inhibitor p15/genetics	carcinoma renal cell/chemically induced	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
cyclin-dependent kinase inhibitor p15/genetics	oxidative stress	0.0016413565879379	0	1	0.6431935215825413	0.002742911746578	0.0338983050847457
cyclin-dependent kinase inhibitor p15/genetics	ferric compounds/adverse effects	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
cyclin-dependent kinase inhibitor p15/genetics	cationic amino acid transporter 1/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
cyclin-dependent kinase inhibitor p15/genetics	gene regulatory networks	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
cyclin-dependent kinase inhibitor p15/genetics	cyclin-dependent kinase inhibitor p16/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
cyclin-dependent kinase inhibitor p15/genetics	lipocalin-2/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
cyclin-dependent kinase inhibitor p15/genetics	ferritins/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
cyclin-dependent kinase inhibitor p15/genetics	sequence deletion	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
cyclin-dependent kinase inhibitor p15/genetics	CDKN2A	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
cyclin-dependent kinase inhibitor p15/genetics	LCN2	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
carcinoma renal cell/chemically induced	oxidative stress	0.0016413565879379	0	1	0.6431935215825413	0.002742911746578	0.0338983050847457
carcinoma renal cell/chemically induced	ferric compounds/adverse effects	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
carcinoma renal cell/chemically induced	cationic amino acid transporter 1/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
carcinoma renal cell/chemically induced	gene regulatory networks	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
carcinoma renal cell/chemically induced	cyclin-dependent kinase inhibitor p16/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
carcinoma renal cell/chemically induced	lipocalin-2/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
carcinoma renal cell/chemically induced	ferritins/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
carcinoma renal cell/chemically induced	sequence deletion	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
carcinoma renal cell/chemically induced	CDKN2A	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
carcinoma renal cell/chemically induced	LCN2	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
ferric compounds/adverse effects	oxidative stress	0.0016413565879379	0	1	0.6431935215825413	0.002742911746578	0.0338983050847457
ferric compounds/adverse effects	cationic amino acid transporter 1/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
ferric compounds/adverse effects	gene regulatory networks	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
ferric compounds/adverse effects	cyclin-dependent kinase inhibitor p16/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
ferric compounds/adverse effects	lipocalin-2/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
ferric compounds/adverse effects	ferritins/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
ferric compounds/adverse effects	sequence deletion	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
ferric compounds/adverse effects	CDKN2A	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
ferric compounds/adverse effects	LCN2	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
cystine/antagonists & inhibitors	piperazines/therapeutic use	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
cystine/antagonists & inhibitors	sulfasalazine/therapeutic use	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
cystine/antagonists & inhibitors	glutamine/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
cystine/antagonists & inhibitors	amino acid transport system y+/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
cystine/antagonists & inhibitors	sorafenib/therapeutic use	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
cystine/antagonists & inhibitors	glucose/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
cationic amino acid transporter 1/genetics	oxidative stress	0.0016413565879379	0	1	0.6431935215825413	0.002742911746578	0.0338983050847457
cationic amino acid transporter 1/genetics	LCN2	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
cationic amino acid transporter 1/genetics	gene regulatory networks	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
cationic amino acid transporter 1/genetics	cyclin-dependent kinase inhibitor p16/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
cationic amino acid transporter 1/genetics	lipocalin-2/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
cationic amino acid transporter 1/genetics	ferritins/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
cationic amino acid transporter 1/genetics	sequence deletion	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
cationic amino acid transporter 1/genetics	CDKN2A	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
gene regulatory networks	oxidative stress	0.0016413565879379	0	1	0.6431935215825413	0.002742911746578	0.0338983050847457
gene regulatory networks	cyclin-dependent kinase inhibitor p16/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
gene regulatory networks	lipocalin-2/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
gene regulatory networks	ferritins/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
gene regulatory networks	sequence deletion	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
gene regulatory networks	CDKN2A	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
gene regulatory networks	LCN2	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
glutamine/antagonists & inhibitors	piperazines/therapeutic use	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
glutamine/antagonists & inhibitors	sulfasalazine/therapeutic use	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
glutamine/antagonists & inhibitors	amino acid transport system y+/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
glutamine/antagonists & inhibitors	sorafenib/therapeutic use	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
glutamine/antagonists & inhibitors	glucose/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
piperazines/therapeutic use	sulfasalazine/therapeutic use	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
piperazines/therapeutic use	amino acid transport system y+/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
piperazines/therapeutic use	sorafenib/therapeutic use	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
piperazines/therapeutic use	glucose/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
amino acid transport system y+/antagonists & inhibitors	sulfasalazine/therapeutic use	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
amino acid transport system y+/antagonists & inhibitors	sorafenib/therapeutic use	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
amino acid transport system y+/antagonists & inhibitors	glucose/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
sorafenib/therapeutic use	sulfasalazine/therapeutic use	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
sorafenib/therapeutic use	glucose/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
erbb receptors/metabolism	EGFR	0.0001190696848334	0	1	0.6431935215825413	0.0002366340025258	0.0254237288135593
erbb receptors/metabolism	tor serine-threonine kinases/antagonists & inhibitors	1.4029182482389048e-08	0	1	0.6431935215825413	4.416292392550505e-08	0.0169491525423728
erbb receptors/metabolism	ovary/pathology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
erbb receptors/metabolism	GALNT14	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
erbb receptors/metabolism	MTOR	1.4029182482389048e-08	0	1	0.6431935215825413	4.416292392550505e-08	0.0169491525423728
ovary/pathology	EGFR	0.0001190696848334	0	1	0.6431935215825413	0.0002366340025258	0.0254237288135593
ovary/pathology	tor serine-threonine kinases/antagonists & inhibitors	1.4029182482389048e-08	0	1	0.6431935215825413	4.416292392550505e-08	0.0169491525423728
ovary/pathology	GALNT14	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
ovary/pathology	MTOR	1.4029182482389048e-08	0	1	0.6431935215825413	4.416292392550505e-08	0.0169491525423728
ferritins/genetics	oxidative stress	0.0016413565879379	0	1	0.6431935215825413	0.002742911746578	0.0338983050847457
ferritins/genetics	cyclin-dependent kinase inhibitor p16/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
ferritins/genetics	lipocalin-2/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
ferritins/genetics	sequence deletion	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
ferritins/genetics	CDKN2A	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
ferritins/genetics	LCN2	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
sequence deletion	oxidative stress	0.0016413565879379	0	1	0.6431935215825413	0.002742911746578	0.0338983050847457
sequence deletion	cyclin-dependent kinase inhibitor p16/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
sequence deletion	lipocalin-2/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
sequence deletion	CDKN2A	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
sequence deletion	LCN2	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
CDKN2A	oxidative stress	0.0016413565879379	0	1	0.6431935215825413	0.002742911746578	0.0338983050847457
CDKN2A	cyclin-dependent kinase inhibitor p16/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
CDKN2A	lipocalin-2/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
CDKN2A	LCN2	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
GALNT14	EGFR	0.0001190696848334	0	1	0.6431935215825413	0.0002366340025258	0.0254237288135593
GALNT14	tor serine-threonine kinases/antagonists & inhibitors	1.4029182482389048e-08	0	1	0.6431935215825413	4.416292392550505e-08	0.0169491525423728
GALNT14	MTOR	1.4029182482389048e-08	0	1	0.6431935215825413	4.416292392550505e-08	0.0169491525423728
LCN2	oxidative stress	0.0016413565879379	0	1	0.6431935215825413	0.002742911746578	0.0338983050847457
LCN2	cyclin-dependent kinase inhibitor p16/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
LCN2	lipocalin-2/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
sulfasalazine/therapeutic use	glucose/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
cyclin-dependent kinase inhibitor p16/genetics	oxidative stress	0.0016413565879379	0	1	0.6431935215825413	0.002742911746578	0.0338983050847457
cyclin-dependent kinase inhibitor p16/genetics	lipocalin-2/genetics	4.5239729407065e-08	0	1	0.6431935215825413	1.2728244884562806e-07	0.0084745762711864
lipocalin-2/genetics	oxidative stress	0.0016413565879379	0	1	0.6431935215825413	0.002742911746578	0.0338983050847457
folic acid/analogs & derivatives	NFE2L2	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.0508474576271186
folic acid/analogs & derivatives	quassins/chemistry	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
folic acid/analogs & derivatives	pancreatic neoplasms/drug therapy	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
folic acid/analogs & derivatives	indoles/chemistry	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
folic acid/analogs & derivatives	chlorophyllides/chemistry	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
folic acid/analogs & derivatives	nf-e2-related factor 2/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
quassins/chemistry	NFE2L2	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.0508474576271186
quassins/chemistry	pancreatic neoplasms/drug therapy	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
quassins/chemistry	indoles/chemistry	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
quassins/chemistry	chlorophyllides/chemistry	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
quassins/chemistry	nf-e2-related factor 2/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
pancreatic neoplasms/drug therapy	NFE2L2	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.0508474576271186
pancreatic neoplasms/drug therapy	indoles/chemistry	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
pancreatic neoplasms/drug therapy	chlorophyllides/chemistry	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
pancreatic neoplasms/drug therapy	nf-e2-related factor 2/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
indoles/chemistry	NFE2L2	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.0508474576271186
indoles/chemistry	chlorophyllides/chemistry	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
indoles/chemistry	nf-e2-related factor 2/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
chlorophyllides/chemistry	NFE2L2	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.0508474576271186
chlorophyllides/chemistry	nf-e2-related factor 2/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
nf-e2-related factor 2/antagonists & inhibitors	NFE2L2	0.0013300236387479	0	1	0.6431935215825413	0.0022512001360258	0.0508474576271186
ACSL4	antitubercular agents/administration & dosage	9.950676027603579e-08	0	1	0.6431935215825413	2.6760289339134786e-07	0.0423728813559322
ACSL4	liver/drug effects	0.0002828096196491	0	1	0.6431935215825413	0.0005335390153116	0.0832971171954223
ACSL4	glutathione/therapeutic use	9.950676027603579e-08	0	1	0.6431935215825413	2.6760289339134786e-07	0.0423728813559322
ACSL4	iron/administration & dosage	9.950676027603579e-08	0	1	0.6431935215825413	2.6760289339134786e-07	0.0423728813559322
ACSL4	rifampin/administration & dosage	9.950676027603579e-08	0	1	0.6431935215825413	2.6760289339134786e-07	0.0423728813559322
ACSL4	chemical and drug induced liver injury/etiology	9.950676027603579e-08	0	1	0.6431935215825413	2.6760289339134786e-07	0.0423728813559322
ACSL4	isoniazid/administration & dosage	9.950676027603579e-08	0	1	0.6431935215825413	2.6760289339134786e-07	0.0423728813559322
ACSL4	cation transport proteins	1.8869062534676573e-08	0	1	0.6431935215825413	5.9017292510576994e-08	0.0423728813559322
ACSL4	cyclooxygenase 2	1.8869062534676573e-08	0	1	0.6431935215825413	5.9017292510576994e-08	0.0423728813559322
ACSL4	cd4-positive t-lymphocytes	1.6704915228871187e-10	0	1	0.6431935215825413	6.148266760595867e-10	0.0423728813559322
ACSL4	cd8-positive t-lymphocytes	1.6704915228871187e-10	0	1	0.6431935215825413	6.148266760595867e-10	0.0423728813559322
ACSL4	IFNG	0.0005381208198234	0	1	0.6431935215825413	0.0009762705714815	0.122810172488723
ACSL4	NOX1	1.6704915228871187e-10	0	1	0.6431935215825413	6.148266760595867e-10	0.0423728813559322
ACSL4	SLC39A14	1.8869062534676573e-08	0	1	0.6431935215825413	5.9017292510576994e-08	0.0423728813559322
ACSL4	TFRC	0.0009266215874724	0	1	0.6431935215825413	0.0016195936139717	0.122810172488723
ACSL4	VDAC1	1.8869062534676573e-08	0	1	0.6431935215825413	5.9017292510576994e-08	0.0423728813559322
ACSL4	ethanol	1.8869062534676573e-08	0	1	0.6431935215825413	5.9017292510576994e-08	0.0423728813559322
biological transport	glutathione disulfide/deficiency	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
biological transport	cystine/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
biological transport	gamma-glutamyltransferase/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
biological transport	GGT1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
glutathione disulfide/deficiency	cystine/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
glutathione disulfide/deficiency	gamma-glutamyltransferase/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
glutathione disulfide/deficiency	GGT1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cystine/metabolism	gamma-glutamyltransferase/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cystine/metabolism	GGT1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
gamma-glutamyltransferase/metabolism	GGT1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
NFE2L2	plant leaves/chemistry	0.0028023171301814	0	1	0.6431935215825413	0.0045187595550542	0.0508474576271186
NFE2L2	mitochondria/pathology	0.0004975532052463	0	1	0.6431935215825413	0.0009036812408369	0.0508474576271186
NFE2L2	cell movement/physiology	0.0004975532052463	0	1	0.6431935215825413	0.0009036812408369	0.0508474576271186
NFE2L2	carcinoma non-small-cell lung/drug therapy	0.0028023171301814	0	1	0.6431935215825413	0.0045187595550542	0.0508474576271186
NFE2L2	neoplasms/pathology	0.0028023171301814	0	1	0.6431935215825413	0.0045187595550542	0.099521946979574
NFE2L2	cisplatin/administration & dosage	0.0028023171301814	0	1	0.6431935215825413	0.0045187595550542	0.0508474576271186
NFE2L2	activating transcription factor 4/metabolism	0.0004975532052463	0	1	0.6431935215825413	0.0009036812408369	0.0508474576271186
NFE2L2	membrane potential mitochondrial/drug effects	0.0028023171301814	0	1	0.6431935215825413	0.0045187595550542	0.0508474576271186
NFE2L2	nf-e2-related factor 2/metabolism	1.0733439963495073e-05	0	2	0.3223370757289844	2.3850457337944137e-05	0.0021729682746631
NFE2L2	mitophagy/physiology	0.0004975532052463	0	1	0.6431935215825413	0.0009036812408369	0.0508474576271186
NFE2L2	biflavonoids/administration & dosage	0.0028023171301814	0	1	0.6431935215825413	0.0045187595550542	0.0508474576271186
NFE2L2	a549 cells	0.0028023171301814	0	1	0.6431935215825413	0.0045187595550542	0.0508474576271186
NFE2L2	stress physiological/drug effects	0.0004975532052463	0	1	0.6431935215825413	0.0009036812408369	0.0508474576271186
NFE2L2	lipids/toxicity	0.0004975532052463	0	1	0.6431935215825413	0.0009036812408369	0.0508474576271186
NFE2L2	heme oxygenase-1/genetics	0.0028023171301814	0	1	0.6431935215825413	0.0045187595550542	0.0508474576271186
NFE2L2	erbb receptors/genetics	0.0028023171301814	0	1	0.6431935215825413	0.0045187595550542	0.0508474576271186
NFE2L2	endocytosis/drug effects	0.0004975532052463	0	1	0.6431935215825413	0.0009036812408369	0.0508474576271186
NFE2L2	DENR	0.0004975532052463	0	1	0.6431935215825413	0.0009036812408369	0.0508474576271186
NFE2L2	DNM1L	0.0004975532052463	0	1	0.6431935215825413	0.0009036812408369	0.0508474576271186
NFE2L2	disease progression	0.0004975532052463	0	1	0.6431935215825413	0.0009036812408369	0.0508474576271186
NFE2L2	FKBP8	0.0004975532052463	0	1	0.6431935215825413	0.0009036812408369	0.0508474576271186
NFE2L2	FUNDC1	0.0004975532052463	0	1	0.6431935215825413	0.0009036812408369	0.0508474576271186
NFE2L2	PINK1	0.0004975532052463	0	1	0.6431935215825413	0.0009036812408369	0.0508474576271186
NFE2L2	UTRN	0.0004975532052463	0	1	0.6431935215825413	0.0009036812408369	0.0508474576271186
HMOX1	plant leaves/chemistry	0.0032296062183333	0	1	0.6431935215825413	0.0051582665034213	0.0423728813559322
HMOX1	carcinoma non-small-cell lung/drug therapy	0.0032296062183333	0	1	0.6431935215825413	0.0051582665034213	0.0423728813559322
HMOX1	cisplatin/administration & dosage	0.0032296062183333	0	1	0.6431935215825413	0.0051582665034213	0.0423728813559322
HMOX1	membrane potential mitochondrial/drug effects	0.0032296062183333	0	1	0.6431935215825413	0.0051582665034213	0.0423728813559322
HMOX1	a549 cells	0.0032296062183333	0	1	0.6431935215825413	0.0051582665034213	0.0423728813559322
HMOX1	biflavonoids/administration & dosage	0.0032296062183333	0	1	0.6431935215825413	0.0051582665034213	0.0423728813559322
HMOX1	heme oxygenase-1/genetics	0.0032296062183333	0	1	0.6431935215825413	0.0051582665034213	0.0423728813559322
HMOX1	erbb receptors/genetics	0.0032296062183333	0	1	0.6431935215825413	0.0051582665034213	0.0423728813559322
HMOX1	EGFR	0.0023056551968343	0	2	0.3223370757289844	0.003779165077085	0.0042710066088207
HMOX1	beta catenin/antagonists & inhibitors	0.0010020122946788	0	1	0.6431935215825413	0.0017314914581454	0.0423728813559322
HMOX1	colorectal neoplasms/drug therapy	4.645272781100829e-06	0	3	0.1299847034619319	1.068763657332594e-05	0.0001479051869111
HMOX1	plant extracts/pharmacology	3.868136557172441e-06	0	2	0.3223370757289844	8.971646569776919e-06	0.0014486455164421
HMOX1	antimetabolites antineoplastic/pharmacology	0.0010020122946788	0	1	0.6431935215825413	0.0017314914581454	0.0423728813559322
HMOX1	CASP9	0.0010020122946788	0	1	0.6431935215825413	0.0017314914581454	0.0423728813559322
HMOX1	CTNNB1	0.0010020122946788	0	1	0.6431935215825413	0.0017314914581454	0.0423728813559322
HMOX1	GCLM	3.868136557172441e-06	0	2	0.3223370757289844	8.971646569776919e-06	0.0014486455164421
HMOX1	TCF7L2	0.0010020122946788	0	1	0.6431935215825413	0.0017314914581454	0.0423728813559322
pyroptosis/drug effects	breast neoplasms/drug therapy	0.0001348366100721	0	1	0.6431935215825413	0.0002659080537765	0.0991023393127427
pyroptosis/drug effects	retinal drusen/genetics	2.7580701722484946e-08	0	1	0.6431935215825413	8.431666216666824e-08	0.0254237288135593
pyroptosis/drug effects	macular degeneration/genetics	2.7580701722484946e-08	0	1	0.6431935215825413	8.431666216666824e-08	0.0254237288135593
pyroptosis/drug effects	bevacizumab/therapeutic use	2.7580701722484946e-08	0	1	0.6431935215825413	8.431666216666824e-08	0.0254237288135593
pyroptosis/drug effects	vascular endothelial growth factor a/antagonists & inhibitors	2.7580701722484946e-08	0	1	0.6431935215825413	8.431666216666824e-08	0.0254237288135593
pyroptosis/drug effects	verteporfin/therapeutic use	2.7580701722484946e-08	0	1	0.6431935215825413	8.431666216666824e-08	0.0254237288135593
pyroptosis/drug effects	aging/genetics	2.7580701722484946e-08	0	1	0.6431935215825413	8.431666216666824e-08	0.0254237288135593
pyroptosis/drug effects	ranibizumab/therapeutic use	2.7580701722484946e-08	0	1	0.6431935215825413	8.431666216666824e-08	0.0254237288135593
pyroptosis/drug effects	necroptosis/drug effects	9.488188013051511e-12	0	2	0.3223370757289844	3.914982234343778e-11	0.0025775899533935
pyroptosis/drug effects	retinal pigment epithelium/drug effects	2.7580701722484946e-08	0	1	0.6431935215825413	8.431666216666824e-08	0.0254237288135593
pyroptosis/drug effects	intracellular signaling peptides and proteins/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0254237288135593
pyroptosis/drug effects	RPE	2.7580701722484946e-08	0	1	0.6431935215825413	8.431666216666824e-08	0.0254237288135593
retinal drusen/genetics	oxidative stress	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0338983050847457
retinal drusen/genetics	macular degeneration/genetics	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
retinal drusen/genetics	bevacizumab/therapeutic use	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
retinal drusen/genetics	vascular endothelial growth factor a/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
retinal drusen/genetics	verteporfin/therapeutic use	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
retinal drusen/genetics	aging/genetics	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
retinal drusen/genetics	ranibizumab/therapeutic use	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
retinal drusen/genetics	necroptosis/drug effects	4.043901339345624e-06	0	1	0.6431935215825413	9.334879785235064e-06	0.0338983050847457
retinal drusen/genetics	retinal pigment epithelium/drug effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
retinal drusen/genetics	RPE	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
macular degeneration/genetics	oxidative stress	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0338983050847457
macular degeneration/genetics	bevacizumab/therapeutic use	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
macular degeneration/genetics	vascular endothelial growth factor a/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
macular degeneration/genetics	verteporfin/therapeutic use	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
macular degeneration/genetics	aging/genetics	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
macular degeneration/genetics	ranibizumab/therapeutic use	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
macular degeneration/genetics	necroptosis/drug effects	4.043901339345624e-06	0	1	0.6431935215825413	9.334879785235064e-06	0.0338983050847457
macular degeneration/genetics	retinal pigment epithelium/drug effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
macular degeneration/genetics	RPE	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
bevacizumab/therapeutic use	oxidative stress	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0338983050847457
bevacizumab/therapeutic use	vascular endothelial growth factor a/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
bevacizumab/therapeutic use	verteporfin/therapeutic use	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
bevacizumab/therapeutic use	aging/genetics	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
bevacizumab/therapeutic use	ranibizumab/therapeutic use	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
bevacizumab/therapeutic use	necroptosis/drug effects	4.043901339345624e-06	0	1	0.6431935215825413	9.334879785235064e-06	0.0338983050847457
bevacizumab/therapeutic use	retinal pigment epithelium/drug effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
bevacizumab/therapeutic use	RPE	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
verteporfin/therapeutic use	oxidative stress	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0338983050847457
verteporfin/therapeutic use	vascular endothelial growth factor a/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
verteporfin/therapeutic use	aging/genetics	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
verteporfin/therapeutic use	ranibizumab/therapeutic use	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
verteporfin/therapeutic use	necroptosis/drug effects	4.043901339345624e-06	0	1	0.6431935215825413	9.334879785235064e-06	0.0338983050847457
verteporfin/therapeutic use	retinal pigment epithelium/drug effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
verteporfin/therapeutic use	RPE	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
vascular endothelial growth factor a/antagonists & inhibitors	oxidative stress	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0338983050847457
vascular endothelial growth factor a/antagonists & inhibitors	aging/genetics	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
vascular endothelial growth factor a/antagonists & inhibitors	ranibizumab/therapeutic use	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
vascular endothelial growth factor a/antagonists & inhibitors	necroptosis/drug effects	4.043901339345624e-06	0	1	0.6431935215825413	9.334879785235064e-06	0.0338983050847457
vascular endothelial growth factor a/antagonists & inhibitors	retinal pigment epithelium/drug effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
vascular endothelial growth factor a/antagonists & inhibitors	RPE	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
aging/genetics	oxidative stress	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0338983050847457
aging/genetics	ranibizumab/therapeutic use	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
aging/genetics	necroptosis/drug effects	4.043901339345624e-06	0	1	0.6431935215825413	9.334879785235064e-06	0.0338983050847457
aging/genetics	retinal pigment epithelium/drug effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
aging/genetics	RPE	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
ranibizumab/therapeutic use	oxidative stress	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0338983050847457
ranibizumab/therapeutic use	necroptosis/drug effects	4.043901339345624e-06	0	1	0.6431935215825413	9.334879785235064e-06	0.0338983050847457
ranibizumab/therapeutic use	retinal pigment epithelium/drug effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
ranibizumab/therapeutic use	RPE	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
necroptosis/drug effects	breast neoplasms/drug therapy	0.0016323608618541	0	1	0.6431935215825413	0.0027419836193778	0.1304379101192554
necroptosis/drug effects	carcinogenesis/drug effects	0.0023666487764341	0	1	0.6431935215825413	0.0038493589744871	0.0991023393127427
necroptosis/drug effects	lysosomes/drug effects	0.0001274847587391	0	1	0.6431935215825413	0.0002516132966123	0.0669274228596261
necroptosis/drug effects	triple negative breast neoplasms/pathology	8.4546925016582e-10	0	1	0.6431935215825413	2.953384699683184e-09	0.0338983050847457
necroptosis/drug effects	retinal pigment epithelium/drug effects	4.043901339345624e-06	0	1	0.6431935215825413	9.334879785235064e-06	0.0338983050847457
necroptosis/drug effects	intracellular signaling peptides and proteins/metabolism	6.8833827526759706e-15	0	1	0.6431935215825413	4.639380934134164e-14	0.0338983050847457
necroptosis/drug effects	RPE	4.043901339345624e-06	0	1	0.6431935215825413	9.334879785235064e-06	0.0338983050847457
necroptosis/drug effects	methylene blue/pharmacology	8.4546925016582e-10	0	1	0.6431935215825413	2.953384699683184e-09	0.0338983050847457
necroptosis/drug effects	lipids/chemistry	8.4546925016582e-10	0	1	0.6431935215825413	2.953384699683184e-09	0.0338983050847457
RPE	oxidative stress	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0338983050847457
RPE	retinal pigment epithelium/drug effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
retinal pigment epithelium/drug effects	oxidative stress	0.000216326676547	0	1	0.6431935215825413	0.0004158421675793	0.0338983050847457
mcf-7 cells	tumor microenvironment/drug effects	2.448495818940799e-05	0	1	0.6431935215825413	5.2492389466337495e-05	0.0504128639721861
mcf-7 cells	simvastatin/chemistry	0.0	0	1	0.6431935215825413	0.0	0.0254237288135593
mcf-7 cells	triple negative breast neoplasms/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0254237288135593
mcf-7 cells	EEF1A2	0.0	0	1	0.6431935215825413	0.0	0.0254237288135593
mcf-7 cells	HMGCR	0.0	0	1	0.6431935215825413	0.0	0.0254237288135593
cation transport proteins	cyclooxygenase 2	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cation transport proteins	ethanol	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cation transport proteins	SLC39A14	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cation transport proteins	TFRC	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0254237288135593
cation transport proteins	VDAC1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cyclooxygenase 2	ethanol	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cyclooxygenase 2	SLC39A14	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cyclooxygenase 2	TFRC	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0254237288135593
cyclooxygenase 2	VDAC1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
biomarkers/metabolism	TFRC	4.3028025586977485e-11	0	1	0.6431935215825413	1.7116372953905412e-10	0.0254237288135593
biomarkers/metabolism	golgi apparatus/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
biomarkers/metabolism	antibodies monoclonal/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
biomarkers/metabolism	piperazine/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
biomarkers/metabolism	receptors transferrin/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
biomarkers/metabolism	antigens/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
biomarkers/metabolism	cell membrane/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
golgi apparatus/metabolism	TFRC	4.3028025586977485e-11	0	1	0.6431935215825413	1.7116372953905412e-10	0.0254237288135593
golgi apparatus/metabolism	antibodies monoclonal/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
golgi apparatus/metabolism	piperazine/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
golgi apparatus/metabolism	receptors transferrin/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
golgi apparatus/metabolism	antigens/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
golgi apparatus/metabolism	cell membrane/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cell membrane/drug effects	TFRC	4.3028025586977485e-11	0	1	0.6431935215825413	1.7116372953905412e-10	0.0254237288135593
cell membrane/drug effects	antibodies monoclonal/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cell membrane/drug effects	piperazine/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cell membrane/drug effects	receptors transferrin/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cell membrane/drug effects	antigens/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
antibodies monoclonal/metabolism	TFRC	4.3028025586977485e-11	0	1	0.6431935215825413	1.7116372953905412e-10	0.0254237288135593
antibodies monoclonal/metabolism	piperazine/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
antibodies monoclonal/metabolism	receptors transferrin/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
antibodies monoclonal/metabolism	antigens/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
piperazine/pharmacology	TFRC	4.3028025586977485e-11	0	1	0.6431935215825413	1.7116372953905412e-10	0.0254237288135593
piperazine/pharmacology	receptors transferrin/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
piperazine/pharmacology	antigens/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
ethanol	SLC39A14	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
ethanol	TFRC	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0254237288135593
ethanol	VDAC1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
receptors transferrin/metabolism	TFRC	4.3028025586977485e-11	0	1	0.6431935215825413	1.7116372953905412e-10	0.0254237288135593
receptors transferrin/metabolism	antigens/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
antigens/metabolism	TFRC	4.3028025586977485e-11	0	1	0.6431935215825413	1.7116372953905412e-10	0.0254237288135593
SLC39A14	TFRC	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0254237288135593
SLC39A14	VDAC1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
TFRC	VDAC1	3.527733660746435e-12	0	1	0.6431935215825413	1.4935400633203627e-11	0.0254237288135593
CD47	liver/drug effects	2.032680913588436e-07	0	1	0.6431935215825413	5.371612848110873e-07	0.0337534405331015
CD47	exosomes/metabolism	5.215827769688985e-13	0	1	0.6431935215825413	2.4322228441812848e-12	0.0169491525423728
CD47	hek293 cells/metabolism	5.215827769688985e-13	0	1	0.6431935215825413	2.4322228441812848e-12	0.0169491525423728
CD47	kidney/drug effects	5.215827769688985e-13	0	1	0.6431935215825413	2.4322228441812848e-12	0.0169491525423728
CD47	heterografts	5.215827769688985e-13	0	1	0.6431935215825413	2.4322228441812848e-12	0.0169491525423728
CD47	piperazines/metabolism	5.215827769688985e-13	0	1	0.6431935215825413	2.4322228441812848e-12	0.0169491525423728
CD47	rose bengal/metabolism	5.215827769688985e-13	0	1	0.6431935215825413	2.4322228441812848e-12	0.0169491525423728
CD47	fluorescent dyes/metabolism	5.215827769688985e-13	0	1	0.6431935215825413	2.4322228441812848e-12	0.0169491525423728
CD47	carcinoma hepatocellular/metabolism	5.215827769688985e-13	0	1	0.6431935215825413	2.4322228441812848e-12	0.0169491525423728
CD47	cd47 antigen/metabolism	5.215827769688985e-13	0	1	0.6431935215825413	2.4322228441812848e-12	0.0169491525423728
skin neoplasms/drug therapy	tumor microenvironment/drug effects	1.6826483355547597e-06	0	1	0.6431935215825413	4.017415648779198e-06	0.0337534405331015
skin neoplasms/drug therapy	hyaluronic acid/chemistry	5.145583958920952e-11	0	1	0.6431935215825413	2.0107803233217158e-10	0.0169491525423728
skin neoplasms/drug therapy	immunologic memory	5.145583958920952e-11	0	1	0.6431935215825413	2.0107803233217158e-10	0.0169491525423728
skin neoplasms/drug therapy	exosomes/drug effects	5.145583958920952e-11	0	1	0.6431935215825413	2.0107803233217158e-10	0.0169491525423728
skin neoplasms/drug therapy	cell line tumor/transplantation	5.145583958920952e-11	0	1	0.6431935215825413	2.0107803233217158e-10	0.0169491525423728
skin neoplasms/drug therapy	b7-h1 antigen/antagonists & inhibitors	5.145583958920952e-11	0	1	0.6431935215825413	2.0107803233217158e-10	0.0169491525423728
skin neoplasms/drug therapy	aniline compounds/pharmacology	5.145583958920952e-11	0	1	0.6431935215825413	2.0107803233217158e-10	0.0169491525423728
skin neoplasms/drug therapy	immune checkpoint inhibitors/pharmacology	5.145583958920952e-11	0	1	0.6431935215825413	2.0107803233217158e-10	0.0169491525423728
skin neoplasms/drug therapy	t-lymphocytes cytotoxic/drug effects	5.145583958920952e-11	0	1	0.6431935215825413	2.0107803233217158e-10	0.0169491525423728
skin neoplasms/drug therapy	tumor escape/drug effects	5.145583958920952e-11	0	1	0.6431935215825413	2.0107803233217158e-10	0.0169491525423728
skin neoplasms/drug therapy	benzylidene compounds/pharmacology	5.145583958920952e-11	0	1	0.6431935215825413	2.0107803233217158e-10	0.0169491525423728
antitubercular agents/administration & dosage	liver/drug effects	5.927480728473711e-13	0	1	0.6431935215825413	2.7404756726615176e-12	0.0169491525423728
antitubercular agents/administration & dosage	glutathione/therapeutic use	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
antitubercular agents/administration & dosage	iron/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
antitubercular agents/administration & dosage	rifampin/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
antitubercular agents/administration & dosage	chemical and drug induced liver injury/etiology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
antitubercular agents/administration & dosage	isoniazid/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
liver/drug effects	glutathione/therapeutic use	5.927480728473711e-13	0	1	0.6431935215825413	2.7404756726615176e-12	0.0169491525423728
liver/drug effects	exosomes/metabolism	6.7518213242578895e-12	0	1	0.6431935215825413	2.824173846618772e-11	0.0169491525423728
liver/drug effects	hek293 cells/metabolism	6.7518213242578895e-12	0	1	0.6431935215825413	2.824173846618772e-11	0.0169491525423728
liver/drug effects	iron/administration & dosage	5.927480728473711e-13	0	1	0.6431935215825413	2.7404756726615176e-12	0.0169491525423728
liver/drug effects	piperazines/metabolism	6.7518213242578895e-12	0	1	0.6431935215825413	2.824173846618772e-11	0.0169491525423728
liver/drug effects	rifampin/administration & dosage	5.927480728473711e-13	0	1	0.6431935215825413	2.7404756726615176e-12	0.0169491525423728
liver/drug effects	kidney/drug effects	6.7518213242578895e-12	0	1	0.6431935215825413	2.824173846618772e-11	0.0169491525423728
liver/drug effects	chemical and drug induced liver injury/etiology	5.927480728473711e-13	0	1	0.6431935215825413	2.7404756726615176e-12	0.0169491525423728
liver/drug effects	heterografts	6.7518213242578895e-12	0	1	0.6431935215825413	2.824173846618772e-11	0.0169491525423728
liver/drug effects	rose bengal/metabolism	6.7518213242578895e-12	0	1	0.6431935215825413	2.824173846618772e-11	0.0169491525423728
liver/drug effects	isoniazid/administration & dosage	5.927480728473711e-13	0	1	0.6431935215825413	2.7404756726615176e-12	0.0169491525423728
liver/drug effects	cd47 antigen/metabolism	6.7518213242578895e-12	0	1	0.6431935215825413	2.824173846618772e-11	0.0169491525423728
liver/drug effects	fluorescent dyes/metabolism	6.7518213242578895e-12	0	1	0.6431935215825413	2.824173846618772e-11	0.0169491525423728
liver/drug effects	carcinoma hepatocellular/metabolism	6.7518213242578895e-12	0	1	0.6431935215825413	2.824173846618772e-11	0.0169491525423728
glutathione/therapeutic use	iron/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
glutathione/therapeutic use	rifampin/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
glutathione/therapeutic use	chemical and drug induced liver injury/etiology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
glutathione/therapeutic use	isoniazid/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
iron/administration & dosage	rifampin/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
iron/administration & dosage	chemical and drug induced liver injury/etiology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
iron/administration & dosage	isoniazid/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
rifampin/administration & dosage	chemical and drug induced liver injury/etiology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
rifampin/administration & dosage	isoniazid/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
chemical and drug induced liver injury/etiology	isoniazid/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
exosomes/metabolism	hek293 cells/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
exosomes/metabolism	piperazines/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
exosomes/metabolism	kidney/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
exosomes/metabolism	heterografts	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
exosomes/metabolism	rose bengal/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
exosomes/metabolism	cd47 antigen/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
exosomes/metabolism	fluorescent dyes/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
exosomes/metabolism	carcinoma hepatocellular/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hek293 cells/metabolism	piperazines/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hek293 cells/metabolism	kidney/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hek293 cells/metabolism	heterografts	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hek293 cells/metabolism	rose bengal/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hek293 cells/metabolism	cd47 antigen/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hek293 cells/metabolism	fluorescent dyes/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hek293 cells/metabolism	carcinoma hepatocellular/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
piperazines/metabolism	kidney/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
piperazines/metabolism	heterografts	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
piperazines/metabolism	rose bengal/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
piperazines/metabolism	cd47 antigen/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
piperazines/metabolism	fluorescent dyes/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
piperazines/metabolism	carcinoma hepatocellular/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
kidney/drug effects	heterografts	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
kidney/drug effects	rose bengal/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
kidney/drug effects	cd47 antigen/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
kidney/drug effects	fluorescent dyes/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
kidney/drug effects	carcinoma hepatocellular/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
heterografts	rose bengal/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
heterografts	cd47 antigen/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
heterografts	fluorescent dyes/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
heterografts	carcinoma hepatocellular/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
rose bengal/metabolism	cd47 antigen/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
rose bengal/metabolism	fluorescent dyes/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
rose bengal/metabolism	carcinoma hepatocellular/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cd47 antigen/metabolism	fluorescent dyes/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cd47 antigen/metabolism	carcinoma hepatocellular/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
fluorescent dyes/metabolism	carcinoma hepatocellular/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
EIF2S1	nf-e2-related factor 2/metabolism	4.899385134715661e-05	0	1	0.6431935215825413	0.0001019415190498	0.0337534405331015
EIF2S1	lysosomes/drug effects	1.35968064929326e-06	0	1	0.6431935215825413	3.2494967160402437e-06	0.0337534405331015
EIF2S1	activating transcription factor 4/metabolism	3.6034164541121067e-10	0	1	0.6431935215825413	1.288294085171555e-09	0.0169491525423728
EIF2S1	stress physiological/drug effects	3.6034164541121067e-10	0	1	0.6431935215825413	1.288294085171555e-09	0.0169491525423728
EIF2S1	lipids/toxicity	3.6034164541121067e-10	0	1	0.6431935215825413	1.288294085171555e-09	0.0169491525423728
EIF2S1	endocytosis/drug effects	3.6034164541121067e-10	0	1	0.6431935215825413	1.288294085171555e-09	0.0169491525423728
breast neoplasms/drug therapy	quinolines/pharmacology	2.3581137043038325e-13	0	1	0.6431935215825413	1.1221765704172437e-12	0.0338983050847457
breast neoplasms/drug therapy	brain neoplasms/prevention & control	2.3581137043038325e-13	0	1	0.6431935215825413	1.1221765704172437e-12	0.0338983050847457
breast neoplasms/drug therapy	isografts	2.3581137043038325e-13	0	1	0.6431935215825413	1.1221765704172437e-12	0.0338983050847457
breast neoplasms/drug therapy	receptor erbb-2/antagonists & inhibitors	2.3581137043038325e-13	0	1	0.6431935215825413	1.1221765704172437e-12	0.0338983050847457
breast neoplasms/drug therapy	intracellular signaling peptides and proteins/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0338983050847457
breast neoplasms/drug therapy	ERBB2	2.3581137043038325e-13	0	1	0.6431935215825413	1.1221765704172437e-12	0.0338983050847457
breast neoplasms/drug therapy	IFNG	6.691924545787487e-05	0	1	0.6431935215825413	0.0001377100857754	0.0991023393127429
IFNG	colorectal neoplasms/drug therapy	0.0037411535890364	0	1	0.6431935215825413	0.0059305925307009	0.0991023393127429
IFNG	cd4-positive t-lymphocytes	2.220446049250313e-16	0	1	0.6431935215825413	1.6369491071099513e-15	0.0254237288135593
IFNG	cd8-positive t-lymphocytes	2.220446049250313e-16	0	1	0.6431935215825413	1.6369491071099513e-15	0.0254237288135593
IFNG	NOX1	2.220446049250313e-16	0	1	0.6431935215825413	1.6369491071099513e-15	0.0254237288135593
neurons/drug effects	anthracenes/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
neurons/drug effects	lung/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
neurons/drug effects	neurotoxicity syndromes/etiology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
neurons/drug effects	zinc oxide/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
neurons/drug effects	cerebral cortex/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
neurons/drug effects	MAPK8	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
neurotoxicity syndromes/etiology	anthracenes/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
neurotoxicity syndromes/etiology	lung/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
neurotoxicity syndromes/etiology	zinc oxide/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
neurotoxicity syndromes/etiology	cerebral cortex/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
neurotoxicity syndromes/etiology	MAPK8	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
anthracenes/pharmacology	lung/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
anthracenes/pharmacology	zinc oxide/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
anthracenes/pharmacology	cerebral cortex/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
anthracenes/pharmacology	MAPK8	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
lung/drug effects	zinc oxide/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
lung/drug effects	cerebral cortex/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
lung/drug effects	MAPK8	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
zinc oxide/administration & dosage	cerebral cortex/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
zinc oxide/administration & dosage	MAPK8	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cerebral cortex/drug effects	MAPK8	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
brain neoplasms/genetics	piperazines	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
brain neoplasms/genetics	glioblastoma/genetics	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
brain neoplasms/genetics	hsp27 heat-shock proteins/genetics	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
brain neoplasms/genetics	HSPB1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
brain neoplasms/genetics	HSPB2	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
piperazines	glioblastoma/genetics	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
piperazines	hsp27 heat-shock proteins/genetics	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
piperazines	HSPB1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
piperazines	HSPB2	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hsp27 heat-shock proteins/genetics	glioblastoma/genetics	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hsp27 heat-shock proteins/genetics	HSPB1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
hsp27 heat-shock proteins/genetics	HSPB2	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
HSPB1	glioblastoma/genetics	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
HSPB1	HSPB2	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
HSPB2	glioblastoma/genetics	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
lysosomes/drug effects	nf-e2-related factor 2/metabolism	1.269586845653592e-05	0	1	0.6431935215825413	2.7780407269285823e-05	0.0337534405331015
lysosomes/drug effects	carcinogenesis/drug effects	3.454719434703435e-05	0	1	0.6431935215825413	7.300454382181196e-05	0.0504128639721861
lysosomes/drug effects	activating transcription factor 4/metabolism	1.683175820943461e-11	0	1	0.6431935215825413	6.818051351169979e-11	0.0169491525423728
lysosomes/drug effects	methylene blue/pharmacology	1.1102230246251563e-16	0	1	0.6431935215825413	8.259720303814333e-16	0.0169491525423728
lysosomes/drug effects	lipids/chemistry	1.1102230246251563e-16	0	1	0.6431935215825413	8.259720303814333e-16	0.0169491525423728
lysosomes/drug effects	triple negative breast neoplasms/pathology	1.1102230246251563e-16	0	1	0.6431935215825413	8.259720303814333e-16	0.0169491525423728
lysosomes/drug effects	stress physiological/drug effects	1.683175820943461e-11	0	1	0.6431935215825413	6.818051351169979e-11	0.0169491525423728
lysosomes/drug effects	lipids/toxicity	1.683175820943461e-11	0	1	0.6431935215825413	6.818051351169979e-11	0.0169491525423728
lysosomes/drug effects	endocytosis/drug effects	1.683175820943461e-11	0	1	0.6431935215825413	6.818051351169979e-11	0.0169491525423728
activating transcription factor 4/metabolism	nf-e2-related factor 2/metabolism	1.4029182482389048e-08	0	1	0.6431935215825413	4.416292392550505e-08	0.0169491525423728
activating transcription factor 4/metabolism	stress physiological/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
activating transcription factor 4/metabolism	lipids/toxicity	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
activating transcription factor 4/metabolism	endocytosis/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
nf-e2-related factor 2/metabolism	plant leaves/chemistry	9.73918094393511e-07	0	1	0.6431935215825413	2.3413433024072912e-06	0.0169491525423728
nf-e2-related factor 2/metabolism	carcinoma non-small-cell lung/drug therapy	9.73918094393511e-07	0	1	0.6431935215825413	2.3413433024072912e-06	0.0169491525423728
nf-e2-related factor 2/metabolism	cisplatin/administration & dosage	9.73918094393511e-07	0	1	0.6431935215825413	2.3413433024072912e-06	0.0169491525423728
nf-e2-related factor 2/metabolism	membrane potential mitochondrial/drug effects	9.73918094393511e-07	0	1	0.6431935215825413	2.3413433024072912e-06	0.0169491525423728
nf-e2-related factor 2/metabolism	a549 cells	9.73918094393511e-07	0	1	0.6431935215825413	2.3413433024072912e-06	0.0169491525423728
nf-e2-related factor 2/metabolism	biflavonoids/administration & dosage	9.73918094393511e-07	0	1	0.6431935215825413	2.3413433024072912e-06	0.0169491525423728
nf-e2-related factor 2/metabolism	heme oxygenase-1/genetics	9.73918094393511e-07	0	1	0.6431935215825413	2.3413433024072912e-06	0.0169491525423728
nf-e2-related factor 2/metabolism	stress physiological/drug effects	1.4029182482389048e-08	0	1	0.6431935215825413	4.416292392550505e-08	0.0169491525423728
nf-e2-related factor 2/metabolism	erbb receptors/genetics	9.73918094393511e-07	0	1	0.6431935215825413	2.3413433024072912e-06	0.0169491525423728
nf-e2-related factor 2/metabolism	lipids/toxicity	1.4029182482389048e-08	0	1	0.6431935215825413	4.416292392550505e-08	0.0169491525423728
nf-e2-related factor 2/metabolism	endocytosis/drug effects	1.4029182482389048e-08	0	1	0.6431935215825413	4.416292392550505e-08	0.0169491525423728
stress physiological/drug effects	lipids/toxicity	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
stress physiological/drug effects	endocytosis/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
lipids/toxicity	endocytosis/drug effects	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
tor serine-threonine kinases/antagonists & inhibitors	EGFR	0.0038180553533372	0	1	0.6431935215825413	0.0060133754805469	0.0504128639721861
tor serine-threonine kinases/antagonists & inhibitors	piperazines/administration & dosage	7.141548729572289e-05	0	1	0.6431935215825413	0.0001462831734308	0.0504128639721861
tor serine-threonine kinases/antagonists & inhibitors	MTOR	0.0	0	2	0.3223370757289844	0.0	0.0001448645516442
piperazines/administration & dosage	photosensitizing agents/administration & dosage	8.215650382226158e-14	0	2	0.3223370757289844	4.242388618620518e-13	0.0012962879707473
piperazines/administration & dosage	carcinoma squamous cell/drug therapy	4.8268178343136e-10	0	1	0.6431935215825413	1.7193774346937262e-09	0.0254237288135593
piperazines/administration & dosage	macromolecular substances/administration & dosage	4.8268178343136e-10	0	1	0.6431935215825413	1.7193774346937262e-09	0.0254237288135593
piperazines/administration & dosage	tongue neoplasms/drug therapy	4.8268178343136e-10	0	1	0.6431935215825413	1.7193774346937262e-09	0.0254237288135593
piperazines/administration & dosage	amino acid transport system y+/analysis	4.8268178343136e-10	0	1	0.6431935215825413	1.7193774346937262e-09	0.0254237288135593
piperazines/administration & dosage	MTOR	7.141548729572289e-05	0	1	0.6431935215825413	0.0001462831734308	0.0504128639721861
MTOR	EGFR	0.0038180553533372	0	1	0.6431935215825413	0.0060133754805469	0.0504128639721861
plant leaves/chemistry	carcinoma non-small-cell lung/drug therapy	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
plant leaves/chemistry	cisplatin/administration & dosage	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
plant leaves/chemistry	membrane potential mitochondrial/drug effects	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
plant leaves/chemistry	a549 cells	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
plant leaves/chemistry	biflavonoids/administration & dosage	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
plant leaves/chemistry	heme oxygenase-1/genetics	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
plant leaves/chemistry	erbb receptors/genetics	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
plant leaves/chemistry	EGFR	0.0003328270951356	0	1	0.6431935215825413	0.0006164448630162	0.0254237288135593
mitochondria/pathology	neoplasms/pathology	4.8405723873656825e-14	0	1	0.6431935215825413	3.071368391098044e-13	0.0169491525423728
mitochondria/pathology	cell movement/physiology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
mitochondria/pathology	mitophagy/physiology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
mitochondria/pathology	disease progression	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
mitochondria/pathology	DENR	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
mitochondria/pathology	DNM1L	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
mitochondria/pathology	FKBP8	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
mitochondria/pathology	FUNDC1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
mitochondria/pathology	PINK1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
mitochondria/pathology	UTRN	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cell movement/physiology	neoplasms/pathology	4.8405723873656825e-14	0	1	0.6431935215825413	3.071368391098044e-13	0.0169491525423728
cell movement/physiology	mitophagy/physiology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cell movement/physiology	disease progression	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cell movement/physiology	DENR	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cell movement/physiology	DNM1L	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cell movement/physiology	FKBP8	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cell movement/physiology	FUNDC1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cell movement/physiology	PINK1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cell movement/physiology	UTRN	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
carcinoma non-small-cell lung/drug therapy	cisplatin/administration & dosage	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
carcinoma non-small-cell lung/drug therapy	membrane potential mitochondrial/drug effects	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
carcinoma non-small-cell lung/drug therapy	a549 cells	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
carcinoma non-small-cell lung/drug therapy	biflavonoids/administration & dosage	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
carcinoma non-small-cell lung/drug therapy	heme oxygenase-1/genetics	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
carcinoma non-small-cell lung/drug therapy	erbb receptors/genetics	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
carcinoma non-small-cell lung/drug therapy	EGFR	0.0003328270951356	0	1	0.6431935215825413	0.0006164448630162	0.0254237288135593
neoplasms/pathology	mitophagy/physiology	4.8405723873656825e-14	0	1	0.6431935215825413	3.071368391098044e-13	0.0169491525423728
neoplasms/pathology	disease progression	4.8405723873656825e-14	0	1	0.6431935215825413	3.071368391098044e-13	0.0169491525423728
neoplasms/pathology	DENR	4.8405723873656825e-14	0	1	0.6431935215825413	3.071368391098044e-13	0.0169491525423728
neoplasms/pathology	DNM1L	4.8405723873656825e-14	0	1	0.6431935215825413	3.071368391098044e-13	0.0169491525423728
neoplasms/pathology	FKBP8	4.8405723873656825e-14	0	1	0.6431935215825413	3.071368391098044e-13	0.0169491525423728
neoplasms/pathology	FUNDC1	4.8405723873656825e-14	0	1	0.6431935215825413	3.071368391098044e-13	0.0169491525423728
neoplasms/pathology	PINK1	4.8405723873656825e-14	0	1	0.6431935215825413	3.071368391098044e-13	0.0169491525423728
neoplasms/pathology	UTRN	4.8405723873656825e-14	0	1	0.6431935215825413	3.071368391098044e-13	0.0169491525423728
cisplatin/administration & dosage	membrane potential mitochondrial/drug effects	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
cisplatin/administration & dosage	a549 cells	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
cisplatin/administration & dosage	biflavonoids/administration & dosage	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
cisplatin/administration & dosage	heme oxygenase-1/genetics	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
cisplatin/administration & dosage	erbb receptors/genetics	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
cisplatin/administration & dosage	EGFR	0.0003328270951356	0	1	0.6431935215825413	0.0006164448630162	0.0254237288135593
membrane potential mitochondrial/drug effects	a549 cells	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
membrane potential mitochondrial/drug effects	biflavonoids/administration & dosage	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
membrane potential mitochondrial/drug effects	heme oxygenase-1/genetics	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
membrane potential mitochondrial/drug effects	erbb receptors/genetics	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
membrane potential mitochondrial/drug effects	EGFR	0.0003328270951356	0	1	0.6431935215825413	0.0006164448630162	0.0254237288135593
mitophagy/physiology	disease progression	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
mitophagy/physiology	DENR	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
mitophagy/physiology	DNM1L	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
mitophagy/physiology	FKBP8	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
mitophagy/physiology	FUNDC1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
mitophagy/physiology	PINK1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
mitophagy/physiology	UTRN	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
biflavonoids/administration & dosage	a549 cells	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
biflavonoids/administration & dosage	heme oxygenase-1/genetics	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
biflavonoids/administration & dosage	erbb receptors/genetics	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
biflavonoids/administration & dosage	EGFR	0.0003328270951356	0	1	0.6431935215825413	0.0006164448630162	0.0254237288135593
a549 cells	heme oxygenase-1/genetics	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
a549 cells	erbb receptors/genetics	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
a549 cells	EGFR	0.0003328270951356	0	1	0.6431935215825413	0.0006164448630162	0.0254237288135593
heme oxygenase-1/genetics	erbb receptors/genetics	7.297873416689525e-11	0	1	0.6431935215825413	2.731377662022125e-10	0.0084745762711864
heme oxygenase-1/genetics	EGFR	0.0003328270951356	0	1	0.6431935215825413	0.0006164448630162	0.0254237288135593
erbb receptors/genetics	EGFR	0.0003328270951356	0	1	0.6431935215825413	0.0006164448630162	0.0254237288135593
DENR	disease progression	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
DENR	DNM1L	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
DENR	FKBP8	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
DENR	FUNDC1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
DENR	PINK1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
DENR	UTRN	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
DNM1L	disease progression	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
DNM1L	FKBP8	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
DNM1L	FUNDC1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
DNM1L	PINK1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
DNM1L	UTRN	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
disease progression	FKBP8	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
disease progression	FUNDC1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
disease progression	PINK1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
disease progression	UTRN	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
FKBP8	FUNDC1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
FKBP8	PINK1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
FKBP8	UTRN	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
FUNDC1	PINK1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
FUNDC1	UTRN	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
PINK1	UTRN	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cd4-positive t-lymphocytes	colorectal neoplasms/drug therapy	6.918291406421417e-08	0	1	0.6431935215825413	1.8961099000838905e-07	0.0338983050847457
cd4-positive t-lymphocytes	cd8-positive t-lymphocytes	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cd4-positive t-lymphocytes	NOX1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
cd8-positive t-lymphocytes	colorectal neoplasms/drug therapy	6.918291406421417e-08	0	1	0.6431935215825413	1.8961099000838905e-07	0.0338983050847457
cd8-positive t-lymphocytes	NOX1	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
NOX1	colorectal neoplasms/drug therapy	6.918291406421417e-08	0	1	0.6431935215825413	1.8961099000838905e-07	0.0338983050847457
photosensitizing agents/administration & dosage	tongue neoplasms/drug therapy	2.287315892246511e-10	0	1	0.6431935215825413	8.330411317576418e-10	0.0254237288135593
photosensitizing agents/administration & dosage	carcinoma squamous cell/drug therapy	2.287315892246511e-10	0	1	0.6431935215825413	8.330411317576418e-10	0.0254237288135593
photosensitizing agents/administration & dosage	macromolecular substances/administration & dosage	2.287315892246511e-10	0	1	0.6431935215825413	8.330411317576418e-10	0.0254237288135593
photosensitizing agents/administration & dosage	amino acid transport system y+/analysis	2.287315892246511e-10	0	1	0.6431935215825413	8.330411317576418e-10	0.0254237288135593
tongue neoplasms/drug therapy	carcinoma squamous cell/drug therapy	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
tongue neoplasms/drug therapy	macromolecular substances/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
tongue neoplasms/drug therapy	amino acid transport system y+/analysis	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
carcinoma squamous cell/drug therapy	macromolecular substances/administration & dosage	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
carcinoma squamous cell/drug therapy	amino acid transport system y+/analysis	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
macromolecular substances/administration & dosage	amino acid transport system y+/analysis	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
beta catenin/antagonists & inhibitors	antimetabolites antineoplastic/pharmacology	8.881784197001252e-16	0	1	0.6431935215825413	6.3183845827718386e-15	0.0084745762711864
beta catenin/antagonists & inhibitors	CASP9	8.881784197001252e-16	0	1	0.6431935215825413	6.3183845827718386e-15	0.0084745762711864
beta catenin/antagonists & inhibitors	CTNNB1	8.881784197001252e-16	0	1	0.6431935215825413	6.3183845827718386e-15	0.0084745762711864
beta catenin/antagonists & inhibitors	GCLM	7.922876021915215e-09	0	1	0.6431935215825413	2.5416836639099963e-08	0.0169491525423728
beta catenin/antagonists & inhibitors	TCF7L2	8.881784197001252e-16	0	1	0.6431935215825413	6.3183845827718386e-15	0.0084745762711864
beta catenin/antagonists & inhibitors	colorectal neoplasms/drug therapy	8.84761223609587e-05	0	1	0.6431935215825413	0.000179793221128	0.0338983050847457
beta catenin/antagonists & inhibitors	plant extracts/pharmacology	7.922876021915215e-09	0	1	0.6431935215825413	2.5416836639099963e-08	0.0169491525423728
colorectal neoplasms/drug therapy	plant extracts/pharmacology	2.9470705875667136e-08	0	2	0.3223370757289844	8.964466275413606e-08	0.0008691873098652
colorectal neoplasms/drug therapy	antimetabolites antineoplastic/pharmacology	8.84761223609587e-05	0	1	0.6431935215825413	0.000179793221128	0.0338983050847457
colorectal neoplasms/drug therapy	CASP9	8.84761223609587e-05	0	1	0.6431935215825413	0.000179793221128	0.0338983050847457
colorectal neoplasms/drug therapy	CTNNB1	8.84761223609587e-05	0	1	0.6431935215825413	0.000179793221128	0.0338983050847457
colorectal neoplasms/drug therapy	GCLM	2.9470705875667136e-08	0	2	0.3223370757289844	8.964466275413606e-08	0.0008691873098652
colorectal neoplasms/drug therapy	TCF7L2	8.84761223609587e-05	0	1	0.6431935215825413	0.000179793221128	0.0338983050847457
plant extracts/pharmacology	carcinogenesis/drug effects	0.0002272434002398	0	1	0.6431935215825413	0.000434939940836	0.0504128639721861
plant extracts/pharmacology	antimetabolites antineoplastic/pharmacology	7.922876021915215e-09	0	1	0.6431935215825413	2.5416836639099963e-08	0.0169491525423728
plant extracts/pharmacology	CASP9	7.922876021915215e-09	0	1	0.6431935215825413	2.5416836639099963e-08	0.0169491525423728
plant extracts/pharmacology	CTNNB1	7.922876021915215e-09	0	1	0.6431935215825413	2.5416836639099963e-08	0.0169491525423728
plant extracts/pharmacology	GCLM	1.1102230246251563e-16	0	2	0.3223370757289844	8.259720303814333e-16	0.0001448645516442
plant extracts/pharmacology	TCF7L2	7.922876021915215e-09	0	1	0.6431935215825413	2.5416836639099963e-08	0.0169491525423728
antimetabolites antineoplastic/pharmacology	CASP9	8.881784197001252e-16	0	1	0.6431935215825413	6.3183845827718386e-15	0.0084745762711864
antimetabolites antineoplastic/pharmacology	CTNNB1	8.881784197001252e-16	0	1	0.6431935215825413	6.3183845827718386e-15	0.0084745762711864
antimetabolites antineoplastic/pharmacology	GCLM	7.922876021915215e-09	0	1	0.6431935215825413	2.5416836639099963e-08	0.0169491525423728
antimetabolites antineoplastic/pharmacology	TCF7L2	8.881784197001252e-16	0	1	0.6431935215825413	6.3183845827718386e-15	0.0084745762711864
CASP9	CTNNB1	8.881784197001252e-16	0	1	0.6431935215825413	6.3183845827718386e-15	0.0084745762711864
CASP9	GCLM	7.922876021915215e-09	0	1	0.6431935215825413	2.5416836639099963e-08	0.0169491525423728
CASP9	TCF7L2	8.881784197001252e-16	0	1	0.6431935215825413	6.3183845827718386e-15	0.0084745762711864
CTNNB1	GCLM	7.922876021915215e-09	0	1	0.6431935215825413	2.5416836639099963e-08	0.0169491525423728
CTNNB1	TCF7L2	8.881784197001252e-16	0	1	0.6431935215825413	6.3183845827718386e-15	0.0084745762711864
GCLM	carcinogenesis/drug effects	0.0002272434002398	0	1	0.6431935215825413	0.000434939940836	0.0504128639721861
GCLM	TCF7L2	7.922876021915215e-09	0	1	0.6431935215825413	2.5416836639099963e-08	0.0169491525423728
quinolines/pharmacology	brain neoplasms/prevention & control	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
quinolines/pharmacology	isografts	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
quinolines/pharmacology	receptor erbb-2/antagonists & inhibitors	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
quinolines/pharmacology	ERBB2	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
brain neoplasms/prevention & control	isografts	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
brain neoplasms/prevention & control	receptor erbb-2/antagonists & inhibitors	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
brain neoplasms/prevention & control	ERBB2	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
isografts	receptor erbb-2/antagonists & inhibitors	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
isografts	ERBB2	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
receptor erbb-2/antagonists & inhibitors	ERBB2	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
carcinogenesis/drug effects	methylene blue/pharmacology	3.5878189308391484e-11	0	1	0.6431935215825413	1.4389663909447878e-10	0.0254237288135593
carcinogenesis/drug effects	lipids/chemistry	3.5878189308391484e-11	0	1	0.6431935215825413	1.4389663909447878e-10	0.0254237288135593
carcinogenesis/drug effects	triple negative breast neoplasms/pathology	3.5878189308391484e-11	0	1	0.6431935215825413	1.4389663909447878e-10	0.0254237288135593
triple negative breast neoplasms/pathology	methylene blue/pharmacology	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
triple negative breast neoplasms/pathology	lipids/chemistry	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
methylene blue/pharmacology	lipids/chemistry	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
disease/etiology	metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
tumor microenvironment/drug effects	hyaluronic acid/chemistry	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
tumor microenvironment/drug effects	immunologic memory	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
tumor microenvironment/drug effects	exosomes/drug effects	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
tumor microenvironment/drug effects	cell line tumor/transplantation	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
tumor microenvironment/drug effects	b7-h1 antigen/antagonists & inhibitors	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
tumor microenvironment/drug effects	aniline compounds/pharmacology	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
tumor microenvironment/drug effects	immune checkpoint inhibitors/pharmacology	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
tumor microenvironment/drug effects	t-lymphocytes cytotoxic/drug effects	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
tumor microenvironment/drug effects	tumor escape/drug effects	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
tumor microenvironment/drug effects	benzylidene compounds/pharmacology	5.1512398679953726e-08	0	1	0.6431935215825413	1.4197959206301725e-07	0.0169491525423728
hyaluronic acid/chemistry	immunologic memory	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
hyaluronic acid/chemistry	exosomes/drug effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
hyaluronic acid/chemistry	cell line tumor/transplantation	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
hyaluronic acid/chemistry	b7-h1 antigen/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
hyaluronic acid/chemistry	aniline compounds/pharmacology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
hyaluronic acid/chemistry	immune checkpoint inhibitors/pharmacology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
hyaluronic acid/chemistry	t-lymphocytes cytotoxic/drug effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
hyaluronic acid/chemistry	tumor escape/drug effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
hyaluronic acid/chemistry	benzylidene compounds/pharmacology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
immunologic memory	exosomes/drug effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
immunologic memory	cell line tumor/transplantation	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
immunologic memory	b7-h1 antigen/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
immunologic memory	aniline compounds/pharmacology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
immunologic memory	immune checkpoint inhibitors/pharmacology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
immunologic memory	t-lymphocytes cytotoxic/drug effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
immunologic memory	tumor escape/drug effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
immunologic memory	benzylidene compounds/pharmacology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
t-lymphocytes cytotoxic/drug effects	exosomes/drug effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
t-lymphocytes cytotoxic/drug effects	cell line tumor/transplantation	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
t-lymphocytes cytotoxic/drug effects	b7-h1 antigen/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
t-lymphocytes cytotoxic/drug effects	aniline compounds/pharmacology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
t-lymphocytes cytotoxic/drug effects	immune checkpoint inhibitors/pharmacology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
t-lymphocytes cytotoxic/drug effects	tumor escape/drug effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
t-lymphocytes cytotoxic/drug effects	benzylidene compounds/pharmacology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
cell line tumor/transplantation	exosomes/drug effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
cell line tumor/transplantation	b7-h1 antigen/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
cell line tumor/transplantation	aniline compounds/pharmacology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
cell line tumor/transplantation	immune checkpoint inhibitors/pharmacology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
cell line tumor/transplantation	tumor escape/drug effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
cell line tumor/transplantation	benzylidene compounds/pharmacology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
tumor escape/drug effects	exosomes/drug effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
tumor escape/drug effects	b7-h1 antigen/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
tumor escape/drug effects	aniline compounds/pharmacology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
tumor escape/drug effects	immune checkpoint inhibitors/pharmacology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
tumor escape/drug effects	benzylidene compounds/pharmacology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
aniline compounds/pharmacology	exosomes/drug effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
aniline compounds/pharmacology	b7-h1 antigen/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
aniline compounds/pharmacology	immune checkpoint inhibitors/pharmacology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
aniline compounds/pharmacology	benzylidene compounds/pharmacology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
benzylidene compounds/pharmacology	exosomes/drug effects	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
benzylidene compounds/pharmacology	b7-h1 antigen/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
benzylidene compounds/pharmacology	immune checkpoint inhibitors/pharmacology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
exosomes/drug effects	b7-h1 antigen/antagonists & inhibitors	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
exosomes/drug effects	immune checkpoint inhibitors/pharmacology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
b7-h1 antigen/antagonists & inhibitors	immune checkpoint inhibitors/pharmacology	8.79296635503124e-14	0	1	0.6431935215825413	4.242388618620518e-13	0.0084745762711864
simvastatin/chemistry	triple negative breast neoplasms/metabolism	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
simvastatin/chemistry	EEF1A2	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
simvastatin/chemistry	HMGCR	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
triple negative breast neoplasms/metabolism	EEF1A2	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
triple negative breast neoplasms/metabolism	HMGCR	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
EEF1A2	HMGCR	0.0	0	1	0.6431935215825413	0.0	0.0084745762711864
